1
|
Leitner M, Pötz G, Berger M, Fellner M, Spat S, Koini M. Characteristics and burden of acute COVID-19 and long-COVID: Demographic, physical, mental health, and economic perspectives. PLoS One 2024; 19:e0297207. [PMID: 38252638 PMCID: PMC10802963 DOI: 10.1371/journal.pone.0297207] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/26/2023] [Accepted: 12/30/2023] [Indexed: 01/24/2024] Open
Abstract
BACKGROUND COVID-19 infection and its associated consequence, known as long-COVID, lead to a significant burden on the global healthcare system and limitations in people's personal and work lives. This study aims to provide further insight into the impact of acute and ongoing COVID-19 symptoms and investigates the role of patients' gender and vaccination status. METHODS 416 individuals (73.9% female) between the ages of 16 and 80 years (M = 44.18, SD = 12.90) with self-reported symptoms of long-COVID participated in an online survey conducted between March and May 2022. RESULTS 6.0%, 74.3%, and 19.7% of all respondents reported having had an asymptomatic, mild, or severe acute illness, respectively. Out of all participants, 7.8% required hospitalization. The most prevalent symptoms during the acute infection (Mdn = 23.50 symptoms, IQR = 13-39) included fatigue, exhaustion, cough, brain fog, and memory problems. The median long-COVID disease duration was 12.10 months (IQR = 2.8-17.4). Among 64 inquired long-COVID symptoms (Mdn = 17.00 symptoms, IQR = 9-27), participants reported fatigue, exhaustion, memory problems, brain fog, and dyspnea as the most common ongoing symptoms, which were generally experienced as fluctuating and deteriorating after physical or cognitive activity. Common consequences of long-COVID included financial losses (40.5%), changes in the participants' profession (41.0%), stress resistance (87.5%), sexual life (38.1%), and mood (72.1%), as well as breathing difficulties (41.3%), or an increased drug intake (e.g., medicine, alcohol; 44.6%). In addition, vaccinated individuals exhibited a shorter acute illness duration and an earlier onset of long-COVID symptoms. In general, women reported more long-COVID symptoms than men. CONCLUSION Long-COVID represents a heterogeneous disease and impacts multiple life aspects of those affected. Tailored rehabilitation programs targeting the plurality of physical and mental symptoms are needed.
Collapse
Affiliation(s)
- Manuel Leitner
- Division of Neurogeriatrics, Department of Neurology, Medical University of Graz, Graz, Austria
| | | | - Martin Berger
- Division of Neurogeriatrics, Department of Neurology, Medical University of Graz, Graz, Austria
| | | | | | - Marisa Koini
- Division of Neurogeriatrics, Department of Neurology, Medical University of Graz, Graz, Austria
| |
Collapse
|
2
|
Trauzeddel RF, Leitner M, Dehé L, Nordine M, Piper SK, Habicher M, Sander M, Perka C, Treskatsch S. Goal-directed fluid therapy using uncalibrated pulse contour analysis and balanced crystalloid solutions during hip revision arthroplasty: a quality implementation project. J Orthop Surg Res 2023; 18:281. [PMID: 37024966 PMCID: PMC10078091 DOI: 10.1186/s13018-023-03738-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/03/2022] [Accepted: 03/21/2023] [Indexed: 04/08/2023] Open
Abstract
BACKGROUND To implement a goal-directed fluid therapy (GDFT) protocol using crystalloids in hip revision arthroplasty surgery within a quality management project at a tertiary hospital using a monocentric, prospective observational study. METHODS Adult patients scheduled for elective hip revision arthroplasty surgery were screened for inclusion in this prospective study. Intraoperatively stroke volume (SV) was optimized within a previously published protocol using uncalibrated pulse contour analysis and balanced crystalloids. Quality of perioperative GDFT was assessed by protocol adherence, SV increase as well as the rate of perioperative complications. Findings were then compared to two different historical groups of a former trial: one receiving GDFT with colloids (prospective colloid group) and one standard fluid therapy (retrospective control group) throughout surgery. Statistical analysis constitutes exploratory data analyses and results are expressed as median with 25th and 75th percentiles, absolute and relative frequencies, and complication rates are further given with 95% confidence intervals for proportions using the normal approximation without continuity correction. RESULTS Sixty-six patients underwent GDFT using balanced crystalloids and were compared to 130 patients with GDFT using balanced colloids and 130 controls without GDFT fluid resuscitation. There was a comparable increase in SV (crystalloids: 65 (54-74 ml; colloids: 67.5 (60-75.25 ml) and total volume infused (crystalloids: 2575 (2000-4210) ml; colloids: 2435 (1760-3480) ml; and controls: 2210 (1658-3000) ml). Overall perioperative complications rates were similar (42.4% (95%CI 30.3-55.2%) for crystalloids and 49.2% (95%CI 40.4-58.1%) for colloids and lower compared to controls: 66.9% (95%CI 58.1-74.9)). Interestingly, a reduced number of hemorrhagic complications was observed within crystalloids: 30% (95%CI 19.6-42.9); colloids: 43% (95%CI 34.4-52.0); and controls: 62% (95%CI 52.6-69.9). There were no differences in the rate of admission to the post-anesthesia care unit or intensive care unit as well as the length of stay. CONCLUSIONS Perioperative fluid management using a GDFT protocol with crystalloids in hip revision arthroplasty surgery was successfully implemented in daily clinical routine. Perioperative complications rates were reduced compared to a previous management without GDFT and comparable when using colloids. TRIAL REGISTRATION ClinicalTrials.gov identifier: NCT01753050.
Collapse
Affiliation(s)
- R F Trauzeddel
- Department of Anesthesiology and Intensive Care Medicine, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität and Humboldt Universität zu Berlin, Charité Campus Benjamin Franklin, Hindenburgdamm 30, 12203, Berlin, Germany
| | - M Leitner
- Department of Anesthesiology and Intensive Care Medicine, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität and Humboldt Universität zu Berlin, Charité Campus Benjamin Franklin, Hindenburgdamm 30, 12203, Berlin, Germany
| | - L Dehé
- Department of Anesthesiology and Intensive Care Medicine, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität and Humboldt Universität zu Berlin, Charité Campus Benjamin Franklin, Hindenburgdamm 30, 12203, Berlin, Germany
| | - M Nordine
- Department of Anesthesiology and Intensive Care Medicine, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität and Humboldt Universität zu Berlin, Charité Campus Benjamin Franklin, Hindenburgdamm 30, 12203, Berlin, Germany
| | - S K Piper
- Institute of Medical Informatics, Charité -Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charitéplatz 1, 10117, Berlin, Germany
- Institute of Biometry and Clinical Epidemiology, Charité -Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charitéplatz 1, 10117, Berlin, Germany
| | - M Habicher
- Department of Anesthesiology, Operative Intensive Care Medicine and Pain Therapy, Justus Liebig University of Giessen, Rudolf-Buchheim-Straße 7, 35392, Gießen, Germany
| | - M Sander
- Department of Anesthesiology, Operative Intensive Care Medicine and Pain Therapy, Justus Liebig University of Giessen, Rudolf-Buchheim-Straße 7, 35392, Gießen, Germany
| | - C Perka
- Center for Musculoskeletal Surgery, Charité -Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Campus Charité Mitte and Virchow-Klinikum, Charitéplatz 1, 10117, Berlin, Germany
| | - S Treskatsch
- Department of Anesthesiology and Intensive Care Medicine, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität and Humboldt Universität zu Berlin, Charité Campus Benjamin Franklin, Hindenburgdamm 30, 12203, Berlin, Germany.
| |
Collapse
|
3
|
Kohlmaier B, Leitner M, Hagedoorn NN, Borensztajn DM, von Both U, Carrol ED, Emonts M, van der Flier M, de Groot R, Herberg J, Levin M, Lim E, Maconochie IK, Martinon-Torres F, Nijman RG, Pokorn M, Rivero-Calle I, Tan CD, Tsolia M, Vermont CL, Zachariasse JM, Zavadska D, Moll HA, Zenz W. European study confirms the combination of fever and petechial rash as an important warning sign for childhood sepsis and meningitis. Acta Paediatr 2023; 112:1058-1066. [PMID: 36866956 DOI: 10.1111/apa.16740] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/05/2022] [Revised: 02/03/2023] [Accepted: 02/28/2023] [Indexed: 03/04/2023]
Abstract
AIM This study investigated febrile children with petechial rashes who presented to European emergency departments (EDs) and investigated the role that mechanical causes played in diagnoses. METHODS Consecutive patients with fever presenting to EDs in 11 European emergency departments in 2017-2018 were enrolled. The cause and focus of infection were identified and a detailed analysis was performed on children with petechial rashes. The results are presented as odds ratios (OR) with 95% confidence intervals (CI). RESULTS We found that 453/34010 (1.3%) febrile children had petechial rashes. The focus of the infection included sepsis (10/453, 2.2%) and meningitis (14/453, 3.1%). Children with a petechial rash were more likely than other febrile children to have sepsis or meningitis (OR 8.5, 95% CI 5.3-13.1) and bacterial infections (OR 1.4, 95% CI 1.0-1.8) as well as need for immediate life-saving interventions (OR 6.6, 95% CI 4.4-9.5) and intensive care unit admissions (OR 6.5, 95% CI 3.0-12.5). CONCLUSION The combination of fever and petechial rash is still an important warning sign for childhood sepsis and meningitis. Ruling out coughing and/or vomiting was insufficient to safely identify low-risk patients.
Collapse
Affiliation(s)
- Benno Kohlmaier
- Department of General Paediatrics, Medical University of Graz, Graz, Austria
| | - Manuel Leitner
- Department of General Paediatrics, Medical University of Graz, Graz, Austria
| | - Nienke N Hagedoorn
- Department of General Paediatrics, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands
| | - Dorine M Borensztajn
- Department of General Paediatrics, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands
| | - Ulrich von Both
- Division of Paediatric Infectious Diseases, Dr. von Hauner Children's Hospital, University Hospital, Ludwig-Maximilians-University Munich, Munich, Germany
- German Centre for Infection Research, DZIF, Munich, Germany
| | - Enitan D Carrol
- Institute of Infection, Veterinary and Ecological Sciences Liverpool, University of Liverpool, Liverpool, UK
- Alder Hey Children's NHS Foundation Trust, Liverpool, UK
| | - Marieke Emonts
- Great North Children's Hospital, Paediatric Immunology, Infectious Diseases & Allergy, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK
- Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK
- NIHR Newcastle Biomedical Research Centre based at Newcastle upon Tyne Hospitals NHS Trust and Newcastle University, Newcastle upon Tyne, UK
| | - Michiel van der Flier
- Section of Paediatric Infectious Diseases, Laboratory of Medical Immunology, Radboud Center for Infectious Diseases, Radboud Institute for Molecular Life Sciences, RadboudUMC, Nijmegen, The Netherlands
- Paediatric Infectious Diseases and Immunology, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, The Netherlands
| | - Ronald de Groot
- Section of Paediatric Infectious Diseases, Laboratory of Medical Immunology, Radboud Center for Infectious Diseases, Radboud Institute for Molecular Life Sciences, RadboudUMC, Nijmegen, The Netherlands
| | - Jethro Herberg
- Section of Paediatric Infectious Diseases, Imperial College, London, UK
| | - Michael Levin
- Section of Paediatric Infectious Diseases, Imperial College, London, UK
| | - Emma Lim
- Great North Children's Hospital, Paediatric Immunology, Infectious Diseases & Allergy, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK
| | - Ian K Maconochie
- Paediatric Emergency Medicine, Imperial College Healthcare Trust NHS, London, UK
| | - Federico Martinon-Torres
- Genetics, Vaccines, Infections and Paediatrics Research group (GENVIP), Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain
| | - Ruud G Nijman
- Section of Paediatric Infectious Diseases, Imperial College, London, UK
| | - Marko Pokorn
- University Medical Centre Ljubljana, Department of Infectious Diseases and Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
| | - Irene Rivero-Calle
- Genetics, Vaccines, Infections and Paediatrics Research group (GENVIP), Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain
| | - Chantal D Tan
- Department of General Paediatrics, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands
| | - Maria Tsolia
- Second Department of Paediatrics, P. and A. Kyriakou Children's Hospital, National and Kapodistrian University of Athens, Athens, Greece
| | - Clementien L Vermont
- Department of Paediatric Infectious Diseases and Immunology, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands
| | - Joany M Zachariasse
- Department of General Paediatrics, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands
| | - Dace Zavadska
- Department of Paediatrics, Children Clinical University Hospital, Rīga Stradiņa Universitāte, Riga, Latvia
| | - Henriette A Moll
- Department of General Paediatrics, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands
| | - Werner Zenz
- Department of General Paediatrics, Medical University of Graz, Graz, Austria
| | | |
Collapse
|
4
|
van der Velden FJS, de Vries G, Martin A, Lim E, von Both U, Kolberg L, Carrol ED, Khanijau A, Herberg JA, De T, Galassini R, Kuijpers TW, Martinón-Torres F, Rivero-Calle I, Vermont CL, Hagedoorn NN, Pokorn M, Pollard AJ, Schlapbach LJ, Tsolia M, Elefhteriou I, Yeung S, Zavadska D, Fink C, Voice M, Zenz W, Kohlmaier B, Agyeman PKA, Usuf E, Secka F, de Groot R, Levin M, van der Flier M, Emonts M, Cunnington A, De T, Herberg J, Kaforou M, Wright V, Baumard L, Bellos E, D’Souza G, Galassini R, Habgood-Coote D, Hamilton S, Hoggart C, Hourmat S, Jackson H, Maconochie I, Menikou S, Lin N, Nichols S, Nijman R, Powell O, Pena Paz I, Shah P, Shen CF, Vito O, Wilson C, Abdulla A, Ali L, Darnell S, Jorgensen R, Mustafa S, Persand S, Stevens MM, Kim N, Kim E, Fidler K, Dudley J, Richmond V, Tavliavini E, Shen CF, Liu CC, Wang SM, Martinón-Torres F, Salas A, González FÁ, Farto CB, Barral-Arca R, Castro MB, Bello X, García MB, Carnota S, Cebey-López M, Curras-Tuala MJ, Suárez CD, Vicente LG, Gómez-Carballa A, Rial JG, Iglesias PL, Martinón-Torres F, Martinón-Torres N, Sánchez JMM, Pérez BM, Pardo-Seco J, Rodríguez LP, Pischedda S, Vázquez SR, Calle IR, Rodríguez-Tenreiro C, Redondo-Collazo L, Ora MS, Salas A, Fernández SS, Trasorras CS, Iglesias MV, Zavadska D, Balode A, Bārzdiņa A, Deksne D, Gardovska D, Grāvele D, Grope I, Meiere A, Nokalna I, Pavāre J, Pučuka Z, Selecka K, Rudzāte A, Svile D, Urbāne UN, Usuf E, Bojang K, Zaman SMA, Secka F, Anderson S, Sarr AR, Saidykhan M, Darboe S, Ceesay S, D’alessandro U, Moll HA, Vermont CL, Borensztajn DM, Hagedoorn NN, Tan C, Zachariasse J, Dik W, Agyeman PKA, Berger C, Giannoni E, Stocker M, Posfay-Barbe KM, Heininger U, Bernhard-Stirnemann S, Niederer-Loher A, Kahlert CR, Natalucci G, Relly C, Riedel T, Aebi C, Schlapbach LJ, Carrol ED, Cocklin E, Jennings R, Johnston J, Khanijau A, Leigh S, Lewis-Burke N, Newall K, Romaine S, Tsolia M, Eleftheriou I, Tambouratzi M, Marmarinos A, Xagorari M, Syggelou K, Fink C, Voice M, Calvo-Bado L, Zenz W, Kohlmaier B, Schweintzger NA, Sagmeister MG, Kohlfürst DS, Zurl C, Binder A, Hösele S, Leitner M, Pölz L, Rajic G, Bauchinger S, Baumgart H, Benesch M, Ceolotto A, Eber E, Gallistl S, Gores G, Haidl H, Hauer A, Hude C, Keldorfer M, Krenn L, Pilch H, Pfleger A, Pfurtscheller K, Nordberg G, Niedrist T, Rödl S, Skrabl-Baumgartner A, Sperl M, Stampfer L, Strenger V, Till H, Trobisch A, Löffler S, Yeung S, Dewez JE, Hibberd M, Bath D, Miners A, Nijman R, Fitchett E, de Groot R, van der Flier M, de Jonge MI, van Aerde K, Alkema W, van den Broek B, Gloerich J, van Gool AJ, Henriet S, Huijnen M, Philipsen R, Willems E, Gerrits G, van Leur M, Heidema J, de Haan L, Miedema C, Neeleman C, Obihara C, Tramper-Stranders G, Pollard AJ, Kandasamy R, Paulus S, Carter MJ, O’Connor D, Bibi S, Kelly DF, Gurung M, Thorson S, Ansari I, Murdoch DR, Shrestha S, Oliver Z, Emonts M, Lim E, Valentine L, Allen K, Bell K, Chan A, Crulley S, Devine K, Fabian D, King S, McAlinden P, McDonald S, McDonnell A, Pickering A, Thomson E, Wood A, Wallia D, Woodsford P, Baxter F, Bell A, Rhodes M, Agbeko R, Mackerness C, Baas B, Kloosterhuis L, Oosthoek W, Arif T, Bennet J, Collings K, van der Giessen I, Martin A, Rashid A, Rowlands E, de Vries G, van der Velden F, Soon J, Valentine L, Martin M, Mistry R, von Both U, Kolberg L, Zwerenz M, Buschbeck J, Bidlingmaier C, Binder V, Danhauser K, Haas N, Griese M, Feuchtinger T, Keil J, Kappler M, Lurz E, Muench G, Reiter K, Schoen C, Mallet F, Brengel-Pesce K, Pachot A, Mommert M, Pokorn M, Kolnik M, Vincek K, Srovin TP, Bahovec N, Prunk P, Osterman V, Avramoska T, Kuijpers T, Jongerius I, van den Berg JM, Schonenberg D, Barendregt AM, Pajkrt D, van der Kuip M, van Furth AM, Sprenkeler E, Zandstra J, van Mierlo G, Geissler J. Correction to: Febrile illness in high-risk children: a prospective, international observational study. Eur J Pediatr 2023; 182:555-556. [PMID: 36689005 PMCID: PMC9899168 DOI: 10.1007/s00431-022-04788-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/24/2023]
Affiliation(s)
- Fabian J. S. van der Velden
- grid.459561.a0000 0004 4904 7256Paediatric Immunology, Infectious Diseases & Allergy, Great North Children’s Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK ,grid.1006.70000 0001 0462 7212Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK
| | - Gabriella de Vries
- grid.459561.a0000 0004 4904 7256Paediatric Immunology, Infectious Diseases & Allergy, Great North Children’s Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK ,grid.416135.40000 0004 0649 0805Department of General Paediatrics, Erasmus MC-Sophia Children’s Hospital, Rotterdam, The Netherlands
| | - Alexander Martin
- grid.459561.a0000 0004 4904 7256Paediatric Immunology, Infectious Diseases & Allergy, Great North Children’s Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK ,grid.1006.70000 0001 0462 7212Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK
| | - Emma Lim
- grid.459561.a0000 0004 4904 7256Paediatric Immunology, Infectious Diseases & Allergy, Great North Children’s Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK ,grid.1006.70000 0001 0462 7212Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK
| | - Ulrich von Both
- grid.5252.00000 0004 1936 973XDivision Paediatric Infectious Diseases, Dr. Von Hauner Children’s Hospital, University Hospital LMU Munich, Munich, Germany
| | - Laura Kolberg
- grid.5252.00000 0004 1936 973XDivision Paediatric Infectious Diseases, Dr. Von Hauner Children’s Hospital, University Hospital LMU Munich, Munich, Germany
| | - Enitan D. Carrol
- grid.10025.360000 0004 1936 8470Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK ,grid.417858.70000 0004 0421 1374Alder Hey Children’s NHS Foundation Trust, Liverpool, UK
| | - Aakash Khanijau
- grid.10025.360000 0004 1936 8470Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK ,grid.417858.70000 0004 0421 1374Alder Hey Children’s NHS Foundation Trust, Liverpool, UK
| | - Jethro A. Herberg
- grid.7445.20000 0001 2113 8111Section of Paediatric Infectious Disease, Wright-Fleming Institute, Imperial College London, London, UK
| | - Tisham De
- grid.7445.20000 0001 2113 8111Section of Paediatric Infectious Disease, Wright-Fleming Institute, Imperial College London, London, UK
| | - Rachel Galassini
- grid.7445.20000 0001 2113 8111Section of Paediatric Infectious Disease, Wright-Fleming Institute, Imperial College London, London, UK
| | - Taco W. Kuijpers
- grid.7177.60000000084992262Department of Pediatric Immunology, Rheumatology and Infectious Diseases, Amsterdam University Medical Center, Location Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
| | - Federico Martinón-Torres
- grid.411048.80000 0000 8816 6945Pediatrics Department, Translational Pediatrics and Infectious Diseases, Hospital Clínico Universitario de Santiago, Santiago de Compostela, Spain ,grid.11794.3a0000000109410645Grupo de Genetica, Vacunas, Infecciones y Pediatria, Instituto de Investigacion Sanitaria de Santiago, Universidad de Santiago, Santiago de Compostela, Spain ,grid.512891.6Consorcio Centro de Investigacion Biomedicaen Red de Enfermedades Respiratorias (CIBERES), Madrid, Spain
| | - Irene Rivero-Calle
- grid.411048.80000 0000 8816 6945Pediatrics Department, Translational Pediatrics and Infectious Diseases, Hospital Clínico Universitario de Santiago, Santiago de Compostela, Spain
| | - Clementien L. Vermont
- grid.416135.40000 0004 0649 0805Department of Pediatrics, Division of Pediatric Infectious Diseases & Immunology, Erasmus MC-Sophia Children’s Hospital, Rotterdam, The Netherlands
| | - Nienke N. Hagedoorn
- grid.416135.40000 0004 0649 0805Department of General Paediatrics, Erasmus MC-Sophia Children’s Hospital, Rotterdam, The Netherlands
| | - Marko Pokorn
- grid.29524.380000 0004 0571 7705University Children’s Hospital, University Medical Centre Ljubljana, Ljubljana, Slovenia
| | - Andrew J. Pollard
- grid.4991.50000 0004 1936 8948Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK
| | - Luregn J. Schlapbach
- grid.412341.10000 0001 0726 4330Neonatal and Pediatric Intensive Care Unit, Children’s Research Center, University Children’s Hospital Zürich, University of Zürich, Zurich, Switzerland
| | - Maria Tsolia
- grid.5216.00000 0001 2155 08002nd Department of Pediatrics, National and Kapodistrian University of Athens, Children’s Hospital ‘P, and A. Kyriakou’, Athens, Greece
| | - Irini Elefhteriou
- grid.5216.00000 0001 2155 08002nd Department of Pediatrics, National and Kapodistrian University of Athens, Children’s Hospital ‘P, and A. Kyriakou’, Athens, Greece
| | - Shunmay Yeung
- grid.8991.90000 0004 0425 469XClinical Research Department, Faculty of Infectious and Tropical Disease, London School of Hygiene and Tropical Medicine, London, UK
| | - Dace Zavadska
- grid.17330.360000 0001 2173 9398Department of Pediatrics, Rīgas Stradina Universitāte, Children’s Clinical University Hospital, Riga, Latvia
| | - Colin Fink
- grid.7372.10000 0000 8809 1613Micropathology Ltd, University of Warwick, Warwick, UK
| | - Marie Voice
- grid.7372.10000 0000 8809 1613Micropathology Ltd, University of Warwick, Warwick, UK
| | - Werner Zenz
- grid.11598.340000 0000 8988 2476Department of Pediatrics and Adolescent Medicine, Division of General Pediatrics, Medical University of Graz, Graz, Austria
| | - Benno Kohlmaier
- grid.11598.340000 0000 8988 2476Department of Pediatrics and Adolescent Medicine, Division of General Pediatrics, Medical University of Graz, Graz, Austria
| | - Philipp K. A. Agyeman
- grid.5734.50000 0001 0726 5157Department of Pediatrics, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
| | - Effua Usuf
- grid.415063.50000 0004 0606 294XMedical Research Council Unit, Serrekunda, The Gambia
| | - Fatou Secka
- grid.415063.50000 0004 0606 294XMedical Research Council Unit, Serrekunda, The Gambia
| | - Ronald de Groot
- grid.461578.9Pediatric Infectious Diseases and Immunology, Amalia Children’s Hospital, Radboud University Medical Center, Nijmegen, The Netherlands
| | - Michael Levin
- grid.7445.20000 0001 2113 8111Section of Paediatric Infectious Disease, Wright-Fleming Institute, Imperial College London, London, UK
| | - Michiel van der Flier
- grid.461578.9Pediatric Infectious Diseases and Immunology, Amalia Children’s Hospital, Radboud University Medical Center, Nijmegen, The Netherlands ,grid.7692.a0000000090126352Pediatric Infectious Diseases and Immunology, Wilhelmina Children’s Hospital University Medical Center Utrecht, Utrecht, The Netherlands
| | - Marieke Emonts
- Paediatric Immunology, Infectious Diseases & Allergy, Great North Children's Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK. .,Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK. .,NIHR Newcastle Biomedical Research Centre, Newcastle upon Tyne Hospitals NHS Trust and Newcastle University, Newcastle upon Tyne, UK.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
5
|
Abud AA, Abi B, Acciarri R, Acero MA, Adames MR, Adamov G, Adamowski M, Adams D, Adinolfi M, Aduszkiewicz A, Aguilar J, Ahmad Z, Ahmed J, Aimard B, Ali-Mohammadzadeh B, Alion T, Allison K, Monsalve SA, AlRashed M, Alt C, Alton A, Alvarez R, Amedo P, Anderson J, Andreopoulos C, Andreotti M, Andrews M, Andrianala F, Andringa S, Anfimov N, Ankowski A, Antoniassi M, Antonova M, Antoshkin A, Antusch S, Aranda-Fernandez A, Arellano L, Arnold LO, Arroyave MA, Asaadi J, Asquith L, Aurisano A, Aushev V, Autiero D, Lara VA, Ayala-Torres M, Azfar F, Back A, Back H, Back JJ, Backhouse C, Bagaturia I, Bagby L, Balashov N, Balasubramanian S, Baldi P, Baller B, Bambah B, Barao F, Barenboim G, Alzas PB, Barker G, Barkhouse W, Barnes C, Barr G, Monarca JB, Barros A, Barros N, Barrow JL, Basharina-Freshville A, Bashyal A, Basque V, Batchelor C, Chagas EBD, Battat JBR, Battisti F, Bay F, Bazetto MCQ, Alba JLLB, Beacom JF, Bechetoille E, Behera B, Beigbeder C, Bellantoni L, Bellettini G, Bellini V, Beltramello O, Benekos N, Montiel CB, Neves FB, Berger J, Berkman S, Bernardini P, Berner RM, Bersani A, Bertolucci S, Betancourt M, Rodríguez AB, Bevan A, Bezawada Y, Bezerra TJC, Bhardwaj A, Bhatnagar V, Bhattacharjee M, Bhattarai D, Bhuller S, Bhuyan B, Biagi S, Bian J, Biassoni M, Biery K, Bilki B, Bishai M, Bitadze A, Blake A, Blaszczyk F, Blazey GC, Blucher E, Boissevain J, Bolognesi S, Bolton T, Bomben L, Bonesini M, Bongrand M, Bonilla-Diaz C, Bonini F, Booth A, Boran F, Bordoni S, Borkum A, Bostan N, Bour P, Bourgeois C, Boyden D, Bracinik J, Braga D, Brailsford D, Branca A, Brandt A, Bremer J, Breton D, Brew C, Brice SJ, Brizzolari C, Bromberg C, Brooke J, Bross A, Brunetti G, Brunetti M, Buchanan N, Budd H, Butorov I, Cagnoli I, Cai T, Caiulo D, Calabrese R, Calafiura P, Calcutt J, Calin M, Calvez S, Calvo E, Caminata A, Campanelli M, Caratelli D, Carber D, Carceller JC, Carini G, Carlus B, Carneiro MF, Carniti P, Terrazas IC, Carranza H, Carroll T, Forero JFC, Castillo A, Castromonte C, Catano-Mur E, Cattadori C, Cavalier F, Cavallaro G, Cavanna F, Centro S, Cerati G, Cervelli A, Villanueva AC, Chalifour M, Chappell A, Chardonnet E, Charitonidis N, Chatterjee A, Chattopadhyay S, Neyra MSSC, Chen H, Chen M, Chen Y, Chen Z, Chen-Wishart Z, Cheon Y, Cherdack D, Chi C, Childress S, Chirco R, Chiriacescu A, Chisnall G, Cho K, Choate S, Chokheli D, Chong PS, Christensen A, Christian D, Christodoulou G, Chukanov A, Chung M, Church E, Cicero V, Clarke P, Cline G, Coan TE, Cocco AG, Coelho JAB, Colton N, Conley E, Conley R, Conrad J, Convery M, Copello S, Cova P, Cremaldi L, Cremonesi L, Crespo-Anadón JI, Crisler M, Cristaldo E, Crnkovic J, Cross R, Cudd A, Cuesta C, Cui Y, Cussans D, Dalager O, da Motta H, Da Silva Peres L, David C, David Q, Davies GS, Davini S, Dawson J, De K, De S, Debbins P, De Bonis I, Decowski MP, De Gouvêa A, De Holanda PC, De Icaza Astiz IL, Deisting A, De Jong P, Delbart A, Delepine D, Delgado M, Dell’Acqua A, Delmonte N, De Lurgio P, de Mello Neto JRT, DeMuth DM, Dennis S, Densham C, Deptuch GW, De Roeck A, De Romeri V, De Souza G, Devi R, Dharmapalan R, Dias M, Diaz F, Díaz JS, Domizio SD, Giulio LD, Ding P, Noto LD, Dirkx G, Distefano C, Diurba R, Diwan M, Djurcic Z, Doering D, Dolan S, Dolek F, Dolinski M, Domine L, Donon Y, Douglas D, Douillet D, Dragone A, Drake G, Drielsma F, Duarte L, Duchesneau D, Duffy K, Dunne P, Dutta B, Duyang H, Dvornikov O, Dwyer D, Dyshkant A, Eads M, Earle A, Edmunds D, Eisch J, Emberger L, Emery S, Englezos P, Ereditato A, Erjavec T, Escobar C, Eurin G, Evans JJ, Ewart E, Ezeribe AC, Fahey K, Falcone A, Fani’ M, Farnese C, Farzan Y, Fedoseev D, Felix J, Feng Y, Fernandez-Martinez E, Menendez PF, Morales MF, Ferraro F, Fields L, Filip P, Filthaut F, Fiorini M, Fischer V, Fitzpatrick RS, Flanagan W, Fleming B, Flight R, Fogarty S, Foreman W, Fowler J, Fox W, Franc J, Francis K, Franco D, Freeman J, Freestone J, Fried J, Friedland A, Robayo FF, Fuess S, Furic IK, Furman K, Furmanski AP, Gabrielli A, Gago A, Gallagher H, Gallas A, Gallego-Ros A, Gallice N, Galymov V, Gamberini E, Gamble T, Ganacim F, Gandhi R, Gandrajula R, Gao F, Gao S, Garcia-Gamez D, García-Peris MÁ, Gardiner S, Gastler D, Gauvreau J, Ge G, Geffroy N, Gelli B, Gendotti A, Gent S, Ghorbani-Moghaddam Z, Giammaria P, Giammaria T, Giangiacomi N, Gibin D, Gil-Botella I, Gilligan S, Girerd C, Giri AK, Gnani D, Gogota O, Gold M, Gollapinni S, Gollwitzer K, Gomes RA, Bermeo LVG, Fajardo LSG, Gonnella F, Gonzalez-Diaz D, Gonzalez-Lopez M, Goodman MC, Goodwin O, Goswami S, Gotti C, Goudzovski E, Grace C, Gran R, Granados E, Granger P, Grant A, Grant C, Gratieri D, Green P, Greenler L, Greer J, Grenard J, Griffith WC, Groh M, Grudzinski J, Grzelak K, Gu W, Guardincerri E, Guarino V, Guarise M, Guenette R, Guerard E, Guerzoni M, Guffanti D, Guglielmi A, Guo B, Gupta A, Gupta V, Guthikonda KK, Gutierrez R, Guzowski P, Guzzo MM, Gwon S, Ha C, Haaf K, Habig A, Hadavand H, Haenni R, Hahn A, Haiston J, Hamacher-Baumann P, Hamernik T, Hamilton P, Han J, Harris DA, Hartnell J, Hartnett T, Harton J, Hasegawa T, Hasnip C, Hatcher R, Hatfield KW, Hatzikoutelis A, Hayes C, Hayrapetyan K, Hays J, Hazen E, He M, Heavey A, Heeger KM, Heise J, Henry S, Morquecho MAH, Herner K, Hewes J, Hilgenberg C, Hill T, Hillier SJ, Himmel A, Hinkle E, Hirsch LR, Ho J, Hoff J, Holin A, Hoppe E, Horton-Smith GA, Hostert M, Hourlier A, Howard B, Howell R, Hoyos J, Hristova I, Hronek MS, Huang J, Hulcher Z, Iles G, Ilic N, Iliescu AM, Illingworth R, Ingratta G, Ioannisian A, Irwin B, Isenhower L, Itay R, Jackson CM, Jain V, James E, Jang W, Jargowsky B, Jediny F, Jena D, Jeong YS, Jesús-Valls C, Ji X, Jiang L, Jiménez S, Jipa A, Johnson R, Johnson W, Johnston N, Jones B, Jones S, Judah M, Jung CK, Junk T, Jwa Y, Kabirnezhad M, Kaboth A, Kadenko I, Kakorin I, Kalitkina A, Kalra D, Kamiya F, Kaneshige N, Kaplan DM, Karagiorgi G, Karaman G, Karcher A, Karolak M, Karyotakis Y, Kasai S, Kasetti SP, Kashur L, Kazaryan N, Kearns E, Keener P, Kelly KJ, Kemp E, Kemularia O, Ketchum W, Kettell SH, Khabibullin M, Khotjantsev A, Khvedelidze A, Kim D, King B, Kirby B, Kirby M, Klein J, Klustova A, Kobilarcik T, Koehler K, Koerner LW, Koh DH, Kohn S, Koller PP, Kolupaeva L, Korablev D, Kordosky M, Kosc T, Kose U, Kostelecký VA, Kothekar K, Kralik R, Kreczko L, Krennrich F, Kreslo I, Kropp W, Kroupova T, Kubota S, Kudenko Y, Kudryavtsev VA, Kulagin S, Kumar J, Kumar P, Kunze P, Kurita N, Kuruppu C, Kus V, Kutter T, Kvasnicka J, Kwak D, Lambert A, Land B, Lane CE, Lang K, Langford T, Langstaff M, Larkin J, Lasorak P, Last D, Laundrie A, Laurenti G, Lawrence A, Lazanu I, LaZur R, Lazzaroni M, Le T, Leardini S, Learned J, LeBrun P, LeCompte T, Lee C, Lee SY, Miotto GL, Lehnert R, de Oliveira MAL, Leitner M, Lepin LM, Li SW, Li Y, Liao H, Lin CS, Lin Q, Lin S, Lineros RA, Ling J, Lister A, Littlejohn BR, Liu J, Liu Y, Lockwitz S, Loew T, Lokajicek M, Lomidze I, Long K, Lord T, LoSecco JM, Louis WC, Lu XG, Luk KB, Lunday B, Luo X, Luppi E, Lux T, Luzio VP, Maalmi J, MacFarlane D, Machado AA, Machado P, Macias CT, Macier JR, Maddalena A, Madera A, Madigan P, Magill S, Mahn K, Maio A, Major A, Maloney JA, Mandrioli G, Mandujano RC, Maneira J, Manenti L, Manly S, Mann A, Manolopoulos K, Plata MM, Manyam VN, Manzanillas L, Marchan M, Marchionni A, Marciano W, Marfatia D, Mariani C, Maricic J, Marie R, Marinho F, Marino AD, Marsden D, Marshak M, Marshall C, Marshall J, Marteau J, Martín-Albo J, Martinez N, Caicedo DAM, Miravé PM, Martynenko S, Mascagna V, Mason K, Mastbaum A, Matichard F, Matsuno S, Matthews J, Mauger C, Mauri N, Mavrokoridis K, Mawby I, Mazza R, Mazzacane A, Mazzucato E, McAskill T, McCluskey E, McConkey N, McFarland KS, McGrew C, McNab A, Mefodiev A, Mehta P, Melas P, Mena O, Mendez H, Mendez P, Méndez DP, Menegolli A, Meng G, Messier MD, Metcalf W, Mettler T, Mewes M, Meyer H, Miao T, Michna G, Miedema T, Mikola V, Milincic R, Miller G, Miller W, Mills J, Mineev O, Minotti A, Miranda OG, Miryala S, Mishra CS, Mishra SR, Mislivec A, Mitchell M, Mladenov D, Mocioiu I, Moffat K, Moggi N, Mohanta R, Mohayai TA, Mokhov N, Molina J, Bueno LM, Montagna E, Montanari A, Montanari C, Montanari D, Zetina LMM, Moon SH, Mooney M, Moor AF, Moreno D, Moretti D, Morris C, Mossey C, Mote M, Motuk E, Moura CA, Mousseau J, Mouster G, Mu W, Mualem L, Mueller J, Muether M, Mufson S, Muheim F, Muir A, Mulhearn M, Munford D, Muramatsu H, Murphy S, Musser J, Nachtman J, Nagu S, Nalbandyan M, Nandakumar R, Naples D, Narita S, Nath A, Navrer-Agasson A, Nayak N, Nebot-Guinot M, Negishi K, Nelson JK, Nesbit J, Nessi M, Newbold D, Newcomer M, Newton H, Nichol R, Nicolas-Arnaldos F, Nikolica A, Niner E, Nishimura K, Norman A, Norrick A, Northrop R, Novella P, Nowak JA, Oberling M, Ochoa-Ricoux J, Olivier A, Olshevskiy A, Onel Y, Onishchuk Y, Ott J, Pagani L, Palacio G, Palamara O, Palestini S, Paley JM, Pallavicini M, Palomares C, Vazquez WP, Pantic E, Paolone V, Papadimitriou V, Papaleo R, Papanestis A, Paramesvaran S, Parke S, Parozzi E, Parsa Z, Parvu M, Pascoli S, Pasqualini L, Pasternak J, Pater J, Patrick C, Patrizii L, Patterson RB, Patton SJ, Patzak T, Paudel A, Paulos B, Paulucci L, Pavlovic Z, Pawloski G, Payne D, Pec V, Peeters SJM, Perez AP, Pennacchio E, Penzo A, Peres OLG, Perry J, Pershey D, Pessina G, Petrillo G, Petta C, Petti R, Pia V, Piastra F, Pickering L, Pietropaolo F, Pimentel VL, Pinaroli G, Plows K, Plunkett R, Poling R, Pompa F, Pons X, Poonthottathil N, Poppi F, Pordes S, Porter J, Potekhin M, Potenza R, Potukuchi BVKS, Pozimski J, Pozzato M, Prakash S, Prakash T, Prest M, Prince S, Psihas F, Pugnere D, Qian X, Raaf JL, Radeka V, Rademacker J, Radics B, Rafique A, Raguzin E, Rai M, Rajaoalisoa M, Rakhno I, Rakotonandrasana A, Rakotondravohitra L, Rameika R, Delgado MAR, Ramson B, Rappoldi A, Raselli G, Ratoff P, Raut S, Razakamiandra RF, Rea EM, Real JS, Rebel B, Rechenmacher R, Reggiani-Guzzo M, Reichenbacher J, Reitzner SD, Sfar HR, Renshaw A, Rescia S, Resnati F, Ribas M, Riboldi S, Riccio C, Riccobene G, Rice LCJ, Ricol JS, Rigamonti A, Rigaut Y, Rincón EV, Ritchie-Yates H, Rivera D, Robert A, Rochester L, Roda M, Rodrigues P, Alonso MJR, Bonilla ER, Rondon JR, Rosauro-Alcaraz S, Rosenberg M, Rosier P, Roskovec B, Rossella M, Rossi M, Rout J, Roy P, Rubbia A, Rubbia C, Russell B, Ruterbories D, Rybnikov A, Saa-Hernandez A, Saakyan R, Sacerdoti S, Safford T, Sahu N, Sakashita K, Sala P, Samios N, Samoylov O, Sanchez MC, Sandberg V, Sanders DA, Sankey D, Santana S, Santos-Maldonado M, Saoulidou N, Sapienza P, Sarasty C, Sarcevic I, Savage G, Savinov V, Scaramelli A, Scarff A, Scarpelli A, Schefke T, Schellman H, Schifano S, Schlabach P, Schmitz D, Schneider AW, Scholberg K, Schukraft A, Segreto E, Selyunin A, Senise CR, Sensenig J, Sergi A, Sgalaberna D, Shaevitz MH, Shafaq S, Shaker F, Shamma M, Sharankova R, Sharma HR, Sharma R, Sharma RK, Shaw T, Shchablo K, Shepherd-Themistocleous C, Sheshukov A, Shin S, Shoemaker I, Shooltz D, Shrock R, Siegel H, Simard L, Sinclair J, Sinev G, Singh J, Singh J, Singh L, Singh P, Singh V, Sipos R, Sippach FW, Sirri G, Sitraka A, Siyeon K, Skarpaas K, Smith A, Smith E, Smith P, Smolik J, Smy M, Snider E, Snopok P, Snowden-Ifft D, Nunes MS, Sobel H, Soderberg M, Sokolov S, Salinas CJS, Söldner-Rembold S, Soleti SR, Solomey N, Solovov V, Sondheim WE, Sorel M, Sotnikov A, Soto-Oton J, Ugaldi FAS, Sousa A, Soustruznik K, Spagliardi F, Spanu M, Spitz J, Spooner NJC, Spurgeon K, Stancari M, Stanco L, Stanford C, Stein R, Steiner HM, Lisbôa AFS, Stewart J, Stillwell B, Stock J, Stocker F, Stokes T, Strait M, Strauss T, Strigari L, Stuart A, Suarez JG, Sunción JMS, Sullivan H, Summers D, Surdo A, Susic V, Suter L, Sutera CM, Svoboda R, Szczerbinska B, Szelc AM, Tanaka H, Tang S, Tapia A, Oregui BT, Tapper A, Tariq S, Tarpara E, Tata N, Tatar E, Tayloe R, Teklu AM, Tennessen P, Tenti M, Terao K, Ternes CA, Terranova F, Testera G, Thakore T, Thea A, Thompson JL, Thorn C, Timm SC, Tishchenko V, Tomassetti L, Tonazzo A, Torbunov D, Torti M, Tortola M, Tortorici F, Tosi N, Totani D, Toups M, Touramanis C, Travaglini R, Trevor J, Trilov S, Trzaska WH, Tsai Y, Tsai YT, Tsamalaidze Z, Tsang KV, Tsverava N, Tufanli S, Tull C, Tyley E, Tzanov M, Uboldi L, Uchida MA, Urheim J, Usher T, Uzunyan S, Vagins MR, Vahle P, Valder S, Valdiviesso GDA, Valencia E, Valentim R, Vallari Z, Vallazza E, Valle JWF, Vallecorsa S, Berg RV, de Water RGV, Forero DV, Vannerom D, Varanini F, Oliva DV, Varner G, Vasel J, Vasina S, Vasseur G, Vaughan N, Vaziri K, Ventura S, Verdugo A, Vergani S, Vermeulen MA, Verzocchi M, Vicenzi M, de Souza HV, Vignoli C, Vilela C, Viren B, Vrba T, Wachala T, Waldron AV, Wallbank M, Wallis C, Wang H, Wang J, Wang L, Wang MHLS, Wang X, Wang Y, Wang Y, Warburton K, Warner D, Wascko MO, Waters D, Watson A, Wawrowska K, Weatherly P, Weber A, Weber M, Wei H, Weinstein A, Wenman D, Wetstein M, White A, Whitehead LH, Whittington D, Wilking MJ, Wilkinson A, Wilkinson C, Williams Z, Wilson F, Wilson RJ, Wisniewski W, Wolcott J, Wongjirad T, Wood A, Wood K, Worcester E, Worcester M, Wresilo K, Wret C, Wu W, Wu W, Xiao Y, Xie F, Yaeggy B, Yandel E, Yang G, Yang K, Yang T, Yankelevich A, Yershov N, Yonehara K, Yoon YS, Young T, Yu B, Yu H, Yu H, Yu J, Yu Y, Yuan W, Zaki R, Zalesak J, Zambelli L, Zamorano B, Zani A, Zazueta L, Zeller GP, Zennamo J, Zeug K, Zhang C, Zhang S, Zhang Y, Zhao M, Zhivun E, Zhu G, Zimmerman ED, Zucchelli S, Zuklin J, Zutshi V, Zwaska R. Scintillation light detection in the 6-m drift-length ProtoDUNE Dual Phase liquid argon TPC. Eur Phys J C Part Fields 2022; 82:618. [PMID: 35859696 PMCID: PMC9288420 DOI: 10.1140/epjc/s10052-022-10549-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 03/31/2022] [Accepted: 06/24/2022] [Indexed: 06/15/2023]
Abstract
DUNE is a dual-site experiment for long-baseline neutrino oscillation studies, neutrino astrophysics and nucleon decay searches. ProtoDUNE Dual Phase (DP) is a 6 × 6 × 6 m 3 liquid argon time-projection-chamber (LArTPC) that recorded cosmic-muon data at the CERN Neutrino Platform in 2019-2020 as a prototype of the DUNE Far Detector. Charged particles propagating through the LArTPC produce ionization and scintillation light. The scintillation light signal in these detectors can provide the trigger for non-beam events. In addition, it adds precise timing capabilities and improves the calorimetry measurements. In ProtoDUNE-DP, scintillation and electroluminescence light produced by cosmic muons in the LArTPC is collected by photomultiplier tubes placed up to 7 m away from the ionizing track. In this paper, the ProtoDUNE-DP photon detection system performance is evaluated with a particular focus on the different wavelength shifters, such as PEN and TPB, and the use of Xe-doped LAr, considering its future use in giant LArTPCs. The scintillation light production and propagation processes are analyzed and a comparison of simulation to data is performed, improving understanding of the liquid argon properties.
Collapse
Affiliation(s)
- A. Abed Abud
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
- University of Liverpool, Liverpool, L69 7ZE UK
| | - B. Abi
- University of Oxford, Oxford, OX1 3RH UK
| | - R. Acciarri
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - M. A. Acero
- Universidad del Atlántico, Barranquilla, Atlántico Colombia
| | - M. R. Adames
- Universidade Tecnológica Federal do Paraná, Curitiba, Brazil
| | - G. Adamov
- Georgian Technical University, Tbilisi, Georgia
| | - M. Adamowski
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - D. Adams
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | | | | | - J. Aguilar
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720 USA
| | - Z. Ahmad
- Variable Energy Cyclotron Centre, Kolkata, West Bengal 700 064 India
| | - J. Ahmed
- University of Warwick, Coventry, CV4 7AL UK
| | - B. Aimard
- Laboratoire d’Annecy de Physique des Particules, Univ. Grenoble Alpes, Univ. Savoie Mont Blanc, CNRS, LAPP-IN2P3, 74000 Annecy, France
| | - B. Ali-Mohammadzadeh
- Università di Catania, 2, 95131 Catania, Italy
- Istituto Nazionale di Fisica Nucleare Sezione di Catania, 95123 Catania, Italy
| | - T. Alion
- University of Sussex, Brighton, BN1 9RH UK
| | - K. Allison
- University of Colorado Boulder, Boulder, CO 80309 USA
| | - S. Alonso Monsalve
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
- ETH Zurich, Zurich, Switzerland
| | - M. AlRashed
- Kansas State University, Manhattan, KS 66506 USA
| | - C. Alt
- ETH Zurich, Zurich, Switzerland
| | - A. Alton
- Augustana University, Sioux Falls, SD 57197 USA
| | - R. Alvarez
- CIEMAT, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, 28040 Madrid, Spain
| | - P. Amedo
- Instituto Galego de Fisica de Altas Enerxias, A Coruña, Spain
| | - J. Anderson
- Argonne National Laboratory, Argonne, IL 60439 USA
| | - C. Andreopoulos
- University of Liverpool, Liverpool, L69 7ZE UK
- STFC Rutherford Appleton Laboratory, Didcot, OX11 0QX UK
| | - M. Andreotti
- University of Ferrara, Ferrara, Italy
- Istituto Nazionale di Fisica Nucleare Sezione di Ferrara, 44122 Ferrara, Italy
| | - M. Andrews
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - F. Andrianala
- University of Antananarivo, 101 Antananarivo, Madagascar
| | - S. Andringa
- Laboratório de Instrumentação e Física Experimental de Partículas, 1649-003 Lisboa, 3004-516 Coimbra, Portugal
| | - N. Anfimov
- Joint Institute for Nuclear Research, Dzhelepov Laboratory of Nuclear Problems 6 Joliot-Curie, Dubna, Moscow Region 141980 Russia
| | - A. Ankowski
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025 USA
| | - M. Antoniassi
- Universidade Tecnológica Federal do Paraná, Curitiba, Brazil
| | - M. Antonova
- Instituto de Física Corpuscular, CSIC and Universitat de València, 46980 Paterna, Valencia Spain
| | - A. Antoshkin
- Joint Institute for Nuclear Research, Dzhelepov Laboratory of Nuclear Problems 6 Joliot-Curie, Dubna, Moscow Region 141980 Russia
| | - S. Antusch
- University of Basel, 4056 Basel, Switzerland
| | | | - L. Arellano
- University of Manchester, Manchester, M13 9PL UK
| | | | | | - J. Asaadi
- University of Texas at Arlington, Arlington, TX 76019 USA
| | - L. Asquith
- University of Sussex, Brighton, BN1 9RH UK
| | - A. Aurisano
- University of Cincinnati, Cincinnati, OH 45221 USA
| | - V. Aushev
- Taras Shevchenko National University of Kyiv, Kyiv, 01601 Ukraine
| | - D. Autiero
- Institut de Physique des 2 Infinis de Lyon, 69622 Villeurbanne, France
| | | | - M. Ayala-Torres
- Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (Cinvestav), Mexico City, Mexico
| | - F. Azfar
- University of Oxford, Oxford, OX1 3RH UK
| | - A. Back
- Indiana University, Bloomington, IN 47405 USA
| | - H. Back
- Pacific Northwest National Laboratory, Richland, WA 99352 USA
| | - J. J. Back
- University of Warwick, Coventry, CV4 7AL UK
| | | | | | - L. Bagby
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - N. Balashov
- Joint Institute for Nuclear Research, Dzhelepov Laboratory of Nuclear Problems 6 Joliot-Curie, Dubna, Moscow Region 141980 Russia
| | | | - P. Baldi
- University of California Irvine, Irvine, CA 92697 USA
| | - B. Baller
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - B. Bambah
- University of Hyderabad, Gachibowli, Hyderabad, 500 046 India
| | - F. Barao
- Instituto Superior Técnico-IST, Universidade de Lisboa, 1049-001 Lisbon, Portugal
- Laboratório de Instrumentação e Física Experimental de Partículas, 1649-003 Lisboa, 3004-516 Coimbra, Portugal
| | - G. Barenboim
- Instituto de Física Corpuscular, CSIC and Universitat de València, 46980 Paterna, Valencia Spain
| | - P. Barham Alzas
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | - G. Barker
- University of Warwick, Coventry, CV4 7AL UK
| | - W. Barkhouse
- University of North Dakota, Grand Forks, ND 58202-8357 USA
| | - C. Barnes
- University of Michigan, Ann Arbor, MI 48109 USA
| | - G. Barr
- University of Oxford, Oxford, OX1 3RH UK
| | | | - A. Barros
- Universidade Tecnológica Federal do Paraná, Curitiba, Brazil
| | - N. Barros
- Faculdade de Ciências da Universidade de Lisboa-FCUL, 1749-016 Lisbon, Portugal
- Laboratório de Instrumentação e Física Experimental de Partículas, 1649-003 Lisboa, 3004-516 Coimbra, Portugal
| | - J. L. Barrow
- Massachusetts Institute of Technology, Cambridge, MA 02139 USA
| | | | - A. Bashyal
- Argonne National Laboratory, Argonne, IL 60439 USA
| | - V. Basque
- University of Manchester, Manchester, M13 9PL UK
| | | | | | | | | | - F. Bay
- Antalya Bilim University, 07190 Döşemealti/Antalya, Turkey
| | - M. C. Q. Bazetto
- Universidade Estadual de Campinas, Campinas, SP 13083-970 Brazil
| | | | | | - E. Bechetoille
- Institut de Physique des 2 Infinis de Lyon, 69622 Villeurbanne, France
| | - B. Behera
- Colorado State University, Fort Collins, CO 80523 USA
| | - C. Beigbeder
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - L. Bellantoni
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | | | - V. Bellini
- Università di Catania, 2, 95131 Catania, Italy
- Istituto Nazionale di Fisica Nucleare Sezione di Catania, 95123 Catania, Italy
| | - O. Beltramello
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | - N. Benekos
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | | | - F. Bento Neves
- Laboratório de Instrumentação e Física Experimental de Partículas, 1649-003 Lisboa, 3004-516 Coimbra, Portugal
| | - J. Berger
- Colorado State University, Fort Collins, CO 80523 USA
| | - S. Berkman
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - P. Bernardini
- Istituto Nazionale di Fisica Nucleare Sezione di Lecce, 73100 Lecce, Italy
- Università del Salento, 73100 Lecce, Italy
| | | | - A. Bersani
- Istituto Nazionale di Fisica Nucleare Sezione di Genova, 16146 Genoa, GE Italy
| | - S. Bertolucci
- Università del Bologna, 40127 Bologna, Italy
- Istituto Nazionale di Fisica Nucleare Sezione di Bologna, 40127 Bologna, BO Italy
| | - M. Betancourt
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | | | - A. Bevan
- Queen Mary University of London, London, E1 4NS UK
| | - Y. Bezawada
- University of California Davis, Davis, CA 95616 USA
| | | | - A. Bhardwaj
- Louisiana State University, Baton Rouge, LA 70803 USA
| | - V. Bhatnagar
- Panjab University, Chandigarh, U.T. 160014 India
| | - M. Bhattacharjee
- Indian Institute of Technology Guwahati, Guwahati, 781 039 India
| | - D. Bhattarai
- University of Mississippi, University, MS 38677 USA
| | - S. Bhuller
- University of Bristol, Bristol, BS8 1TL UK
| | - B. Bhuyan
- Indian Institute of Technology Guwahati, Guwahati, 781 039 India
| | - S. Biagi
- Istituto Nazionale di Fisica Nucleare Laboratori Nazionali del Sud, 95123 Catania, Italy
| | - J. Bian
- University of California Irvine, Irvine, CA 92697 USA
| | - M. Biassoni
- Istituto Nazionale di Fisica Nucleare Sezione di Milano Bicocca, 3, 20126 Milan, Italy
| | - K. Biery
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - B. Bilki
- Beykent University, Istanbul, Turkey
- University of Iowa, Iowa City, IA 52242 USA
| | - M. Bishai
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - A. Bitadze
- University of Manchester, Manchester, M13 9PL UK
| | - A. Blake
- Lancaster University, Lancaster, LA1 4YB UK
| | - F. Blaszczyk
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - G. C. Blazey
- Northern Illinois University, DeKalb, IL 60115 USA
| | - E. Blucher
- University of Chicago, Chicago, IL 60637 USA
| | - J. Boissevain
- Los Alamos National Laboratory, Los Alamos, NM 87545 USA
| | - S. Bolognesi
- IRFU, CEA, Université Paris-Saclay, 91191 Gif-sur-Yvette, France
| | - T. Bolton
- Kansas State University, Manhattan, KS 66506 USA
| | - L. Bomben
- Istituto Nazionale di Fisica Nucleare Sezione di Milano Bicocca, 3, 20126 Milan, Italy
- University of Insubria, Via Ravasi, 2, 21100 Varese, VA Italy
| | - M. Bonesini
- Istituto Nazionale di Fisica Nucleare Sezione di Milano Bicocca, 3, 20126 Milan, Italy
- Università del Milano-Bicocca, 20126 Milan, Italy
| | - M. Bongrand
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | | | - F. Bonini
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - A. Booth
- Queen Mary University of London, London, E1 4NS UK
| | - F. Boran
- Beykent University, Istanbul, Turkey
| | - S. Bordoni
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | - A. Borkum
- University of Sussex, Brighton, BN1 9RH UK
| | - N. Bostan
- University of Notre Dame, Notre Dame, IN 46556 USA
| | - P. Bour
- Czech Technical University, 115 19 Prague 1, Czech Republic
| | - C. Bourgeois
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - D. Boyden
- Northern Illinois University, DeKalb, IL 60115 USA
| | - J. Bracinik
- University of Birmingham, Birmingham, B15 2TT UK
| | - D. Braga
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | | | - A. Branca
- Istituto Nazionale di Fisica Nucleare Sezione di Milano Bicocca, 3, 20126 Milan, Italy
| | - A. Brandt
- University of Texas at Arlington, Arlington, TX 76019 USA
| | - J. Bremer
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | - D. Breton
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - C. Brew
- STFC Rutherford Appleton Laboratory, Didcot, OX11 0QX UK
| | - S. J. Brice
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - C. Brizzolari
- Istituto Nazionale di Fisica Nucleare Sezione di Milano Bicocca, 3, 20126 Milan, Italy
- Università del Milano-Bicocca, 20126 Milan, Italy
| | - C. Bromberg
- Michigan State University, East Lansing, MI 48824 USA
| | - J. Brooke
- University of Bristol, Bristol, BS8 1TL UK
| | - A. Bross
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - G. Brunetti
- Istituto Nazionale di Fisica Nucleare Sezione di Milano Bicocca, 3, 20126 Milan, Italy
- Università del Milano-Bicocca, 20126 Milan, Italy
| | | | - N. Buchanan
- Colorado State University, Fort Collins, CO 80523 USA
| | - H. Budd
- University of Rochester, Rochester, NY 14627 USA
| | - I. Butorov
- Joint Institute for Nuclear Research, Dzhelepov Laboratory of Nuclear Problems 6 Joliot-Curie, Dubna, Moscow Region 141980 Russia
| | - I. Cagnoli
- Università del Bologna, 40127 Bologna, Italy
- Istituto Nazionale di Fisica Nucleare Sezione di Bologna, 40127 Bologna, BO Italy
| | - T. Cai
- York University, Toronto, M3J 1P3 Canada
| | - D. Caiulo
- Institut de Physique des 2 Infinis de Lyon, 69622 Villeurbanne, France
| | - R. Calabrese
- University of Ferrara, Ferrara, Italy
- Istituto Nazionale di Fisica Nucleare Sezione di Ferrara, 44122 Ferrara, Italy
| | - P. Calafiura
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720 USA
| | - J. Calcutt
- Oregon State University, Corvallis, OR 97331 USA
| | - M. Calin
- University of Bucharest, Bucharest, Romania
| | - S. Calvez
- Colorado State University, Fort Collins, CO 80523 USA
| | - E. Calvo
- CIEMAT, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, 28040 Madrid, Spain
| | - A. Caminata
- Istituto Nazionale di Fisica Nucleare Sezione di Genova, 16146 Genoa, GE Italy
| | | | - D. Caratelli
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - D. Carber
- Colorado State University, Fort Collins, CO 80523 USA
| | | | - G. Carini
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - B. Carlus
- Institut de Physique des 2 Infinis de Lyon, 69622 Villeurbanne, France
| | | | - P. Carniti
- Istituto Nazionale di Fisica Nucleare Sezione di Milano Bicocca, 3, 20126 Milan, Italy
| | | | - H. Carranza
- University of Texas at Arlington, Arlington, TX 76019 USA
| | - T. Carroll
- University of Wisconsin Madison, Madison, WI 53706 USA
| | | | - A. Castillo
- Universidad Sergio Arboleda, 11022 Bogotá, Colombia
| | | | - E. Catano-Mur
- College of William and Mary, Williamsburg, VA 23187 USA
| | - C. Cattadori
- Istituto Nazionale di Fisica Nucleare Sezione di Milano Bicocca, 3, 20126 Milan, Italy
| | - F. Cavalier
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - G. Cavallaro
- Istituto Nazionale di Fisica Nucleare Sezione di Milano Bicocca, 3, 20126 Milan, Italy
| | - F. Cavanna
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - S. Centro
- Istituto Nazionale di Fisica Nucleare Sezione di Padova, 35131 Padua, Italy
- Universtà degli Studi di Padova, 35131 Padua, Italy
| | - G. Cerati
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - A. Cervelli
- Istituto Nazionale di Fisica Nucleare Sezione di Bologna, 40127 Bologna, BO Italy
| | - A. Cervera Villanueva
- Instituto de Física Corpuscular, CSIC and Universitat de València, 46980 Paterna, Valencia Spain
| | - M. Chalifour
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | | | - E. Chardonnet
- Université de Paris, CNRS, Astroparticule et Cosmologie, 75006 Paris, France
| | - N. Charitonidis
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | | | - S. Chattopadhyay
- Variable Energy Cyclotron Centre, Kolkata, West Bengal 700 064 India
| | | | - H. Chen
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - M. Chen
- University of California Irvine, Irvine, CA 92697 USA
| | - Y. Chen
- University of Bern, 3012 Bern, Switzerland
| | - Z. Chen
- Stony Brook University, SUNY, Stony Brook, NY 11794 USA
| | | | - Y. Cheon
- Ulsan National Institute of Science and Technology, Ulsan, 689-798 South Korea
| | - D. Cherdack
- University of Houston, Houston, TX 77204 USA
| | - C. Chi
- Columbia University, New York, NY 10027 USA
| | - S. Childress
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - R. Chirco
- Illinois Institute of Technology, Chicago, IL 60616 USA
| | | | | | - K. Cho
- Korea Institute of Science and Technology Information, Daejeon, 34141 South Korea
| | - S. Choate
- Northern Illinois University, DeKalb, IL 60115 USA
| | - D. Chokheli
- Georgian Technical University, Tbilisi, Georgia
| | - P. S. Chong
- University of Pennsylvania, Philadelphia, PA 19104 USA
| | | | - D. Christian
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - G. Christodoulou
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | - A. Chukanov
- Joint Institute for Nuclear Research, Dzhelepov Laboratory of Nuclear Problems 6 Joliot-Curie, Dubna, Moscow Region 141980 Russia
| | - M. Chung
- Ulsan National Institute of Science and Technology, Ulsan, 689-798 South Korea
| | - E. Church
- Pacific Northwest National Laboratory, Richland, WA 99352 USA
| | - V. Cicero
- Università del Bologna, 40127 Bologna, Italy
- Istituto Nazionale di Fisica Nucleare Sezione di Bologna, 40127 Bologna, BO Italy
| | - P. Clarke
- University of Edinburgh, Edinburgh, EH8 9YL UK
| | - G. Cline
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720 USA
| | - T. E. Coan
- Southern Methodist University, Dallas, TX 75275 USA
| | - A. G. Cocco
- Istituto Nazionale di Fisica Nucleare Sezione di Napoli, 80126 Naples, Italy
| | - J. A. B. Coelho
- Université de Paris, CNRS, Astroparticule et Cosmologie, 75006 Paris, France
| | - N. Colton
- Colorado State University, Fort Collins, CO 80523 USA
| | - E. Conley
- Duke University, Durham, NC 27708 USA
| | - R. Conley
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025 USA
| | - J. Conrad
- Massachusetts Institute of Technology, Cambridge, MA 02139 USA
| | - M. Convery
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025 USA
| | - S. Copello
- Istituto Nazionale di Fisica Nucleare Sezione di Genova, 16146 Genoa, GE Italy
| | - P. Cova
- Istituto Nazionale di Fisica Nucleare Sezione di Milano, 20133 Milan, Italy
- University of Parma, 43121 Parma, PR Italy
| | - L. Cremaldi
- University of Mississippi, University, MS 38677 USA
| | - L. Cremonesi
- Queen Mary University of London, London, E1 4NS UK
| | - J. I. Crespo-Anadón
- CIEMAT, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, 28040 Madrid, Spain
| | - M. Crisler
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - E. Cristaldo
- Universidad Nacional de Asunción, San Lorenzo, Paraguay
| | - J. Crnkovic
- University of Mississippi, University, MS 38677 USA
| | - R. Cross
- Lancaster University, Lancaster, LA1 4YB UK
| | - A. Cudd
- University of Colorado Boulder, Boulder, CO 80309 USA
| | - C. Cuesta
- CIEMAT, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, 28040 Madrid, Spain
| | - Y. Cui
- University of California Riverside, Riverside, CA 92521 USA
| | - D. Cussans
- University of Bristol, Bristol, BS8 1TL UK
| | - O. Dalager
- University of California Irvine, Irvine, CA 92697 USA
| | - H. da Motta
- Centro Brasileiro de Pesquisas Físicas, Rio de Janeiro, RJ 22290-180 Brazil
| | - L. Da Silva Peres
- Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ 21941-901 Brazil
| | - C. David
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
- York University, Toronto, M3J 1P3 Canada
| | - Q. David
- Institut de Physique des 2 Infinis de Lyon, 69622 Villeurbanne, France
| | - G. S. Davies
- University of Mississippi, University, MS 38677 USA
| | - S. Davini
- Istituto Nazionale di Fisica Nucleare Sezione di Genova, 16146 Genoa, GE Italy
| | - J. Dawson
- Université de Paris, CNRS, Astroparticule et Cosmologie, 75006 Paris, France
| | - K. De
- University of Texas at Arlington, Arlington, TX 76019 USA
| | - S. De
- University of Albany, SUNY, Albany, NY 12222 USA
| | - P. Debbins
- University of Iowa, Iowa City, IA 52242 USA
| | - I. De Bonis
- Laboratoire d’Annecy de Physique des Particules, Univ. Grenoble Alpes, Univ. Savoie Mont Blanc, CNRS, LAPP-IN2P3, 74000 Annecy, France
| | - M. P. Decowski
- University of Amsterdam, 1098 XG Amsterdam, The Netherlands
- Nikhef National Institute of Subatomic Physics, 1098 XG Amsterdam, The Netherlands
| | | | - P. C. De Holanda
- Universidade Estadual de Campinas, Campinas, SP 13083-970 Brazil
| | | | | | - P. De Jong
- University of Amsterdam, 1098 XG Amsterdam, The Netherlands
- Nikhef National Institute of Subatomic Physics, 1098 XG Amsterdam, The Netherlands
| | - A. Delbart
- IRFU, CEA, Université Paris-Saclay, 91191 Gif-sur-Yvette, France
| | - D. Delepine
- Universidad de Guanajuato, C.P. 37000 Guanajuato, Mexico
| | - M. Delgado
- Istituto Nazionale di Fisica Nucleare Sezione di Milano Bicocca, 3, 20126 Milan, Italy
- Università del Milano-Bicocca, 20126 Milan, Italy
| | - A. Dell’Acqua
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | - N. Delmonte
- Istituto Nazionale di Fisica Nucleare Sezione di Milano, 20133 Milan, Italy
- University of Parma, 43121 Parma, PR Italy
| | - P. De Lurgio
- Argonne National Laboratory, Argonne, IL 60439 USA
| | | | - D. M. DeMuth
- Valley City State University, Valley City, ND 58072 USA
| | - S. Dennis
- University of Cambridge, Cambridge, CB3 0HE UK
| | - C. Densham
- STFC Rutherford Appleton Laboratory, Didcot, OX11 0QX UK
| | | | - A. De Roeck
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | - V. De Romeri
- Instituto de Física Corpuscular, CSIC and Universitat de València, 46980 Paterna, Valencia Spain
| | - G. De Souza
- Universidade Estadual de Campinas, Campinas, SP 13083-970 Brazil
| | - R. Devi
- University of Jammu, Jammu, 180006 India
| | | | - M. Dias
- Universidade Federal de São Paulo, São Paulo, 09913-030 Brazil
| | - F. Diaz
- Pontificia Universidad Católica del Perú, Lima, Peru
| | - J. S. Díaz
- Indiana University, Bloomington, IN 47405 USA
| | - S. Di Domizio
- Università degli Studi di Genova, Genoa, Italy
- Istituto Nazionale di Fisica Nucleare Sezione di Genova, 16146 Genoa, GE Italy
| | - L. Di Giulio
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | - P. Ding
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - L. Di Noto
- Università degli Studi di Genova, Genoa, Italy
- Istituto Nazionale di Fisica Nucleare Sezione di Genova, 16146 Genoa, GE Italy
| | - G. Dirkx
- Imperial College of Science Technology and Medicine, London, SW7 2BZ UK
| | - C. Distefano
- Istituto Nazionale di Fisica Nucleare Laboratori Nazionali del Sud, 95123 Catania, Italy
| | - R. Diurba
- University of Minnesota Twin Cities, Minneapolis, MN 55455 USA
| | - M. Diwan
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - Z. Djurcic
- Argonne National Laboratory, Argonne, IL 60439 USA
| | - D. Doering
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025 USA
| | - S. Dolan
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | - F. Dolek
- Beykent University, Istanbul, Turkey
| | - M. Dolinski
- Drexel University, Philadelphia, PA 19104 USA
| | - L. Domine
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025 USA
| | - Y. Donon
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | - D. Douglas
- Michigan State University, East Lansing, MI 48824 USA
| | - D. Douillet
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - A. Dragone
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025 USA
| | - G. Drake
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - F. Drielsma
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025 USA
| | - L. Duarte
- Universidade Federal de São Paulo, São Paulo, 09913-030 Brazil
| | - D. Duchesneau
- Laboratoire d’Annecy de Physique des Particules, Univ. Grenoble Alpes, Univ. Savoie Mont Blanc, CNRS, LAPP-IN2P3, 74000 Annecy, France
| | - K. Duffy
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - P. Dunne
- Imperial College of Science Technology and Medicine, London, SW7 2BZ UK
| | - B. Dutta
- Texas A &M University, College Station, 77840 USA
| | - H. Duyang
- University of South Carolina, Columbia, SC 29208 USA
| | | | - D. Dwyer
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720 USA
| | - A. Dyshkant
- Northern Illinois University, DeKalb, IL 60115 USA
| | - M. Eads
- Northern Illinois University, DeKalb, IL 60115 USA
| | - A. Earle
- University of Sussex, Brighton, BN1 9RH UK
| | - D. Edmunds
- Michigan State University, East Lansing, MI 48824 USA
| | - J. Eisch
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - L. Emberger
- University of Manchester, Manchester, M13 9PL UK
- Max-Planck-Institut, 80805 Munich, Germany
| | - S. Emery
- IRFU, CEA, Université Paris-Saclay, 91191 Gif-sur-Yvette, France
| | - P. Englezos
- Rutgers University, Piscataway, NJ 08854 USA
| | | | - T. Erjavec
- University of California Davis, Davis, CA 95616 USA
| | - C. Escobar
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - G. Eurin
- IRFU, CEA, Université Paris-Saclay, 91191 Gif-sur-Yvette, France
| | - J. J. Evans
- University of Manchester, Manchester, M13 9PL UK
| | - E. Ewart
- Indiana University, Bloomington, IN 47405 USA
| | | | - K. Fahey
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - A. Falcone
- Istituto Nazionale di Fisica Nucleare Sezione di Milano Bicocca, 3, 20126 Milan, Italy
- Università del Milano-Bicocca, 20126 Milan, Italy
| | - M. Fani’
- Los Alamos National Laboratory, Los Alamos, NM 87545 USA
| | - C. Farnese
- Istituto Nazionale di Fisica Nucleare Sezione di Padova, 35131 Padua, Italy
| | - Y. Farzan
- Institute for Research in Fundamental Sciences, Tehran, Iran
| | - D. Fedoseev
- Joint Institute for Nuclear Research, Dzhelepov Laboratory of Nuclear Problems 6 Joliot-Curie, Dubna, Moscow Region 141980 Russia
| | - J. Felix
- Universidad de Guanajuato, C.P. 37000 Guanajuato, Mexico
| | - Y. Feng
- Iowa State University, Ames, IA 50011 USA
| | | | - P. Fernandez Menendez
- Instituto de Física Corpuscular, CSIC and Universitat de València, 46980 Paterna, Valencia Spain
| | | | - F. Ferraro
- Università degli Studi di Genova, Genoa, Italy
- Istituto Nazionale di Fisica Nucleare Sezione di Genova, 16146 Genoa, GE Italy
| | - L. Fields
- University of Notre Dame, Notre Dame, IN 46556 USA
| | - P. Filip
- Institute of Physics, Czech Academy of Sciences, 182 00 Prague 8, Czech Republic
| | - F. Filthaut
- Nikhef National Institute of Subatomic Physics, 1098 XG Amsterdam, The Netherlands
- Radboud University, 6525 AJ Nijmegen, The Netherlands
| | - M. Fiorini
- University of Ferrara, Ferrara, Italy
- Istituto Nazionale di Fisica Nucleare Sezione di Ferrara, 44122 Ferrara, Italy
| | - V. Fischer
- Iowa State University, Ames, IA 50011 USA
| | | | - W. Flanagan
- University of Dallas, Irving, TX 75062-4736 USA
| | - B. Fleming
- Yale University, New Haven, CT 06520 USA
| | - R. Flight
- University of Rochester, Rochester, NY 14627 USA
| | - S. Fogarty
- Colorado State University, Fort Collins, CO 80523 USA
| | - W. Foreman
- Illinois Institute of Technology, Chicago, IL 60616 USA
| | - J. Fowler
- Duke University, Durham, NC 27708 USA
| | - W. Fox
- Indiana University, Bloomington, IN 47405 USA
| | - J. Franc
- Czech Technical University, 115 19 Prague 1, Czech Republic
| | - K. Francis
- Northern Illinois University, DeKalb, IL 60115 USA
| | - D. Franco
- Yale University, New Haven, CT 06520 USA
| | - J. Freeman
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - J. Freestone
- University of Manchester, Manchester, M13 9PL UK
| | - J. Fried
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - A. Friedland
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025 USA
| | | | - S. Fuess
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - I. K. Furic
- University of Florida, Gainesville, FL 32611-8440 USA
| | - K. Furman
- Queen Mary University of London, London, E1 4NS UK
| | - A. P. Furmanski
- University of Minnesota Twin Cities, Minneapolis, MN 55455 USA
| | - A. Gabrielli
- Istituto Nazionale di Fisica Nucleare Sezione di Bologna, 40127 Bologna, BO Italy
| | - A. Gago
- Pontificia Universidad Católica del Perú, Lima, Peru
| | | | - A. Gallas
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - A. Gallego-Ros
- CIEMAT, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, 28040 Madrid, Spain
| | - N. Gallice
- Istituto Nazionale di Fisica Nucleare Sezione di Milano, 20133 Milan, Italy
- Università degli Studi di Milano, 20133 Milan, Italy
| | - V. Galymov
- Institut de Physique des 2 Infinis de Lyon, 69622 Villeurbanne, France
| | - E. Gamberini
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | - T. Gamble
- University of Sheffield, Sheffield, S3 7RH UK
| | - F. Ganacim
- Universidade Tecnológica Federal do Paraná, Curitiba, Brazil
| | - R. Gandhi
- Harish-Chandra Research Institute, Jhunsi, Allahabad, 211 019 India
| | - R. Gandrajula
- Michigan State University, East Lansing, MI 48824 USA
| | - F. Gao
- University of Pittsburgh, Pittsburgh, PA 15260 USA
| | - S. Gao
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | | | - M. Á. García-Peris
- Instituto de Física Corpuscular, CSIC and Universitat de València, 46980 Paterna, Valencia Spain
| | - S. Gardiner
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | | | - J. Gauvreau
- Occidental College, Los Angeles, CA 90041 USA
| | - G. Ge
- Columbia University, New York, NY 10027 USA
| | - N. Geffroy
- Laboratoire d’Annecy de Physique des Particules, Univ. Grenoble Alpes, Univ. Savoie Mont Blanc, CNRS, LAPP-IN2P3, 74000 Annecy, France
| | - B. Gelli
- Universidade Estadual de Campinas, Campinas, SP 13083-970 Brazil
| | | | - S. Gent
- South Dakota State University, Brookings, SD 57007 USA
| | | | - P. Giammaria
- Universidade Estadual de Campinas, Campinas, SP 13083-970 Brazil
| | - T. Giammaria
- University of Ferrara, Ferrara, Italy
- Istituto Nazionale di Fisica Nucleare Sezione di Ferrara, 44122 Ferrara, Italy
| | | | - D. Gibin
- Istituto Nazionale di Fisica Nucleare Sezione di Padova, 35131 Padua, Italy
- Universtà degli Studi di Padova, 35131 Padua, Italy
| | - I. Gil-Botella
- CIEMAT, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, 28040 Madrid, Spain
| | - S. Gilligan
- Oregon State University, Corvallis, OR 97331 USA
| | - C. Girerd
- Institut de Physique des 2 Infinis de Lyon, 69622 Villeurbanne, France
| | - A. K. Giri
- Indian Institute of Technology Hyderabad, Hyderabad, 502285 India
| | - D. Gnani
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720 USA
| | - O. Gogota
- Taras Shevchenko National University of Kyiv, Kyiv, 01601 Ukraine
| | - M. Gold
- University of New Mexico, Albuquerque, NM 87131 USA
| | - S. Gollapinni
- Los Alamos National Laboratory, Los Alamos, NM 87545 USA
| | - K. Gollwitzer
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - R. A. Gomes
- Universidade Federal de Goias, Goiania, GO 74690-900 Brazil
| | | | | | - F. Gonnella
- University of Birmingham, Birmingham, B15 2TT UK
| | | | | | | | - O. Goodwin
- University of Manchester, Manchester, M13 9PL UK
| | - S. Goswami
- Physical Research Laboratory, Ahmedabad, 380 009 India
| | - C. Gotti
- Istituto Nazionale di Fisica Nucleare Sezione di Milano Bicocca, 3, 20126 Milan, Italy
| | | | - C. Grace
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720 USA
| | - R. Gran
- University of Minnesota Duluth, Duluth, MN 55812 USA
| | - E. Granados
- Universidad de Guanajuato, C.P. 37000 Guanajuato, Mexico
| | - P. Granger
- IRFU, CEA, Université Paris-Saclay, 91191 Gif-sur-Yvette, France
| | - A. Grant
- Daresbury Laboratory, Cheshire, WA4 4AD UK
| | - C. Grant
- Boston University, Boston, MA 02215 USA
| | - D. Gratieri
- Fluminense Federal University, 9 Icaraí, Niterói, RJ 24220-900 Brazil
| | - P. Green
- University of Manchester, Manchester, M13 9PL UK
| | - L. Greenler
- University of Wisconsin Madison, Madison, WI 53706 USA
| | - J. Greer
- University of Bristol, Bristol, BS8 1TL UK
| | - J. Grenard
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | | | - M. Groh
- Colorado State University, Fort Collins, CO 80523 USA
| | | | - K. Grzelak
- University of Warsaw, 02-093 Warsaw, Poland
| | - W. Gu
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | | | - V. Guarino
- Argonne National Laboratory, Argonne, IL 60439 USA
| | - M. Guarise
- University of Ferrara, Ferrara, Italy
- Istituto Nazionale di Fisica Nucleare Sezione di Ferrara, 44122 Ferrara, Italy
| | | | - E. Guerard
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - M. Guerzoni
- Istituto Nazionale di Fisica Nucleare Sezione di Bologna, 40127 Bologna, BO Italy
| | - D. Guffanti
- Istituto Nazionale di Fisica Nucleare Sezione di Milano, 20133 Milan, Italy
| | - A. Guglielmi
- Istituto Nazionale di Fisica Nucleare Sezione di Padova, 35131 Padua, Italy
| | - B. Guo
- University of South Carolina, Columbia, SC 29208 USA
| | - A. Gupta
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025 USA
| | - V. Gupta
- Nikhef National Institute of Subatomic Physics, 1098 XG Amsterdam, The Netherlands
| | | | | | - P. Guzowski
- University of Manchester, Manchester, M13 9PL UK
| | - M. M. Guzzo
- Universidade Estadual de Campinas, Campinas, SP 13083-970 Brazil
| | - S. Gwon
- Chung-Ang University, Seoul, 06974 South Korea
| | - C. Ha
- Chung-Ang University, Seoul, 06974 South Korea
| | - K. Haaf
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - A. Habig
- University of Minnesota Duluth, Duluth, MN 55812 USA
| | - H. Hadavand
- University of Texas at Arlington, Arlington, TX 76019 USA
| | - R. Haenni
- University of Bern, 3012 Bern, Switzerland
| | - A. Hahn
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - J. Haiston
- South Dakota School of Mines and Technology, Rapid City, SD 57701 USA
| | | | - T. Hamernik
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - P. Hamilton
- Imperial College of Science Technology and Medicine, London, SW7 2BZ UK
| | - J. Han
- University of Pittsburgh, Pittsburgh, PA 15260 USA
| | - D. A. Harris
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
- York University, Toronto, M3J 1P3 Canada
| | | | - T. Hartnett
- STFC Rutherford Appleton Laboratory, Didcot, OX11 0QX UK
| | - J. Harton
- Colorado State University, Fort Collins, CO 80523 USA
| | - T. Hasegawa
- High Energy Accelerator Research Organization (KEK), Ibaraki, 305-0801 Japan
| | - C. Hasnip
- University of Oxford, Oxford, OX1 3RH UK
| | - R. Hatcher
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | | | | | - C. Hayes
- Indiana University, Bloomington, IN 47405 USA
| | | | - J. Hays
- Queen Mary University of London, London, E1 4NS UK
| | - E. Hazen
- Boston University, Boston, MA 02215 USA
| | - M. He
- University of Houston, Houston, TX 77204 USA
| | - A. Heavey
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | | | - J. Heise
- Sanford Underground Research Facility, Lead, SD 57754 USA
| | - S. Henry
- University of Rochester, Rochester, NY 14627 USA
| | | | - K. Herner
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - J. Hewes
- University of Cincinnati, Cincinnati, OH 45221 USA
| | - C. Hilgenberg
- University of Minnesota Twin Cities, Minneapolis, MN 55455 USA
| | - T. Hill
- Idaho State University, Pocatello, ID 83209 USA
| | | | - A. Himmel
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - E. Hinkle
- University of Chicago, Chicago, IL 60637 USA
| | - L. R. Hirsch
- Universidade Tecnológica Federal do Paraná, Curitiba, Brazil
| | - J. Ho
- Harvard University, Cambridge, MA 02138 USA
| | - J. Hoff
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - A. Holin
- STFC Rutherford Appleton Laboratory, Didcot, OX11 0QX UK
| | - E. Hoppe
- Pacific Northwest National Laboratory, Richland, WA 99352 USA
| | | | - M. Hostert
- University of Minnesota Twin Cities, Minneapolis, MN 55455 USA
| | - A. Hourlier
- Massachusetts Institute of Technology, Cambridge, MA 02139 USA
| | - B. Howard
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - R. Howell
- University of Rochester, Rochester, NY 14627 USA
| | - J. Hoyos
- University of Medellín, Medellín, 050026 Colombia
| | - I. Hristova
- STFC Rutherford Appleton Laboratory, Didcot, OX11 0QX UK
| | - M. S. Hronek
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - J. Huang
- University of California Davis, Davis, CA 95616 USA
| | - Z. Hulcher
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025 USA
| | - G. Iles
- Imperial College of Science Technology and Medicine, London, SW7 2BZ UK
| | - N. Ilic
- University of Toronto, Toronto, ON M5S 1A1 Canada
| | - A. M. Iliescu
- Istituto Nazionale di Fisica Nucleare Sezione di Bologna, 40127 Bologna, BO Italy
| | - R. Illingworth
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - G. Ingratta
- Università del Bologna, 40127 Bologna, Italy
- Istituto Nazionale di Fisica Nucleare Sezione di Bologna, 40127 Bologna, BO Italy
| | - A. Ioannisian
- Yerevan Institute for Theoretical Physics and Modeling, Yerevan, 0036 Armenia
| | - B. Irwin
- University of Minnesota Twin Cities, Minneapolis, MN 55455 USA
| | - L. Isenhower
- Abilene Christian University, Abilene, TX 79601 USA
| | - R. Itay
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025 USA
| | - C. M. Jackson
- Pacific Northwest National Laboratory, Richland, WA 99352 USA
| | - V. Jain
- University of Albany, SUNY, Albany, NY 12222 USA
| | - E. James
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - W. Jang
- University of Texas at Arlington, Arlington, TX 76019 USA
| | - B. Jargowsky
- University of California Irvine, Irvine, CA 92697 USA
| | - F. Jediny
- Czech Technical University, 115 19 Prague 1, Czech Republic
| | - D. Jena
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - Y. S. Jeong
- Chung-Ang University, Seoul, 06974 South Korea
- University of Iowa, Iowa City, IA 52242 USA
| | - C. Jesús-Valls
- Institut de Física d’Altes Energies (IFAE)-Barcelona Institute of Science and Technology (BIST), Barcelona, Spain
| | - X. Ji
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - L. Jiang
- Virginia Tech, Blacksburg, VA 24060 USA
| | - S. Jiménez
- CIEMAT, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, 28040 Madrid, Spain
| | - A. Jipa
- University of Bucharest, Bucharest, Romania
| | - R. Johnson
- University of Cincinnati, Cincinnati, OH 45221 USA
| | - W. Johnson
- South Dakota School of Mines and Technology, Rapid City, SD 57701 USA
| | - N. Johnston
- Indiana University, Bloomington, IN 47405 USA
| | - B. Jones
- University of Texas at Arlington, Arlington, TX 76019 USA
| | - S. Jones
- University College London, London, WC1E 6BT UK
| | - M. Judah
- University of Pittsburgh, Pittsburgh, PA 15260 USA
| | - C. K. Jung
- Stony Brook University, SUNY, Stony Brook, NY 11794 USA
| | - T. Junk
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - Y. Jwa
- Columbia University, New York, NY 10027 USA
| | | | - A. Kaboth
- Royal Holloway College, London, TW20 0EX UK
- STFC Rutherford Appleton Laboratory, Didcot, OX11 0QX UK
| | - I. Kadenko
- Taras Shevchenko National University of Kyiv, Kyiv, 01601 Ukraine
| | - I. Kakorin
- Joint Institute for Nuclear Research, Dzhelepov Laboratory of Nuclear Problems 6 Joliot-Curie, Dubna, Moscow Region 141980 Russia
| | - A. Kalitkina
- Joint Institute for Nuclear Research, Dzhelepov Laboratory of Nuclear Problems 6 Joliot-Curie, Dubna, Moscow Region 141980 Russia
| | - D. Kalra
- Columbia University, New York, NY 10027 USA
| | - F. Kamiya
- Universidade Federal do ABC, Santo André, SP 09210-580 Brazil
| | - N. Kaneshige
- University of California Santa Barbara, Santa Barbara, CA 93106 USA
| | - D. M. Kaplan
- Illinois Institute of Technology, Chicago, IL 60616 USA
| | | | - G. Karaman
- University of Iowa, Iowa City, IA 52242 USA
| | - A. Karcher
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720 USA
| | - M. Karolak
- IRFU, CEA, Université Paris-Saclay, 91191 Gif-sur-Yvette, France
| | - Y. Karyotakis
- Laboratoire d’Annecy de Physique des Particules, Univ. Grenoble Alpes, Univ. Savoie Mont Blanc, CNRS, LAPP-IN2P3, 74000 Annecy, France
| | - S. Kasai
- National Institute of Technology, Kure College, Hiroshima, 737-8506 Japan
| | - S. P. Kasetti
- Louisiana State University, Baton Rouge, LA 70803 USA
| | - L. Kashur
- Colorado State University, Fort Collins, CO 80523 USA
| | - N. Kazaryan
- Yerevan Institute for Theoretical Physics and Modeling, Yerevan, 0036 Armenia
| | - E. Kearns
- Boston University, Boston, MA 02215 USA
| | - P. Keener
- University of Pennsylvania, Philadelphia, PA 19104 USA
| | - K. J. Kelly
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | - E. Kemp
- Universidade Estadual de Campinas, Campinas, SP 13083-970 Brazil
| | | | - W. Ketchum
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | | | - M. Khabibullin
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow, 117312 Russia
| | - A. Khotjantsev
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow, 117312 Russia
| | | | - D. Kim
- Texas A &M University, College Station, 77840 USA
| | - B. King
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - B. Kirby
- Columbia University, New York, NY 10027 USA
| | - M. Kirby
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - J. Klein
- University of Pennsylvania, Philadelphia, PA 19104 USA
| | - A. Klustova
- Imperial College of Science Technology and Medicine, London, SW7 2BZ UK
| | - T. Kobilarcik
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - K. Koehler
- University of Wisconsin Madison, Madison, WI 53706 USA
| | | | - D. H. Koh
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025 USA
| | - S. Kohn
- University of California Berkeley, Berkeley, CA 94720 USA
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720 USA
| | | | - L. Kolupaeva
- Joint Institute for Nuclear Research, Dzhelepov Laboratory of Nuclear Problems 6 Joliot-Curie, Dubna, Moscow Region 141980 Russia
| | - D. Korablev
- Joint Institute for Nuclear Research, Dzhelepov Laboratory of Nuclear Problems 6 Joliot-Curie, Dubna, Moscow Region 141980 Russia
| | - M. Kordosky
- College of William and Mary, Williamsburg, VA 23187 USA
| | - T. Kosc
- University Grenoble Alpes, CNRS, Grenoble INP, LPSC-IN2P3, 38000 Grenoble, France
| | - U. Kose
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | | | | | - R. Kralik
- University of Sussex, Brighton, BN1 9RH UK
| | - L. Kreczko
- University of Bristol, Bristol, BS8 1TL UK
| | | | - I. Kreslo
- University of Bern, 3012 Bern, Switzerland
| | - W. Kropp
- University of California Irvine, Irvine, CA 92697 USA
| | - T. Kroupova
- University of Pennsylvania, Philadelphia, PA 19104 USA
| | - S. Kubota
- Harvard University, Cambridge, MA 02138 USA
| | - Y. Kudenko
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow, 117312 Russia
| | | | - S. Kulagin
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow, 117312 Russia
| | - J. Kumar
- University of Hawaii, Honolulu, HI 96822 USA
| | - P. Kumar
- University of Sheffield, Sheffield, S3 7RH UK
| | - P. Kunze
- Laboratoire d’Annecy de Physique des Particules, Univ. Grenoble Alpes, Univ. Savoie Mont Blanc, CNRS, LAPP-IN2P3, 74000 Annecy, France
| | - N. Kurita
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025 USA
| | - C. Kuruppu
- University of South Carolina, Columbia, SC 29208 USA
| | - V. Kus
- Czech Technical University, 115 19 Prague 1, Czech Republic
| | - T. Kutter
- Louisiana State University, Baton Rouge, LA 70803 USA
| | - J. Kvasnicka
- Institute of Physics, Czech Academy of Sciences, 182 00 Prague 8, Czech Republic
| | - D. Kwak
- Ulsan National Institute of Science and Technology, Ulsan, 689-798 South Korea
| | - A. Lambert
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720 USA
| | - B. Land
- University of Pennsylvania, Philadelphia, PA 19104 USA
| | - C. E. Lane
- Drexel University, Philadelphia, PA 19104 USA
| | - K. Lang
- University of Texas at Austin, Austin, TX 78712 USA
| | | | - M. Langstaff
- University of Manchester, Manchester, M13 9PL UK
| | - J. Larkin
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - P. Lasorak
- University of Sussex, Brighton, BN1 9RH UK
| | - D. Last
- University of Pennsylvania, Philadelphia, PA 19104 USA
| | - A. Laundrie
- University of Wisconsin Madison, Madison, WI 53706 USA
| | - G. Laurenti
- Istituto Nazionale di Fisica Nucleare Sezione di Bologna, 40127 Bologna, BO Italy
| | - A. Lawrence
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720 USA
| | - I. Lazanu
- University of Bucharest, Bucharest, Romania
| | - R. LaZur
- Colorado State University, Fort Collins, CO 80523 USA
| | - M. Lazzaroni
- Istituto Nazionale di Fisica Nucleare Sezione di Milano, 20133 Milan, Italy
- Università degli Studi di Milano, 20133 Milan, Italy
| | - T. Le
- Tufts University, Medford, MA 02155 USA
| | - S. Leardini
- Instituto Galego de Fisica de Altas Enerxias, A Coruña, Spain
| | - J. Learned
- University of Hawaii, Honolulu, HI 96822 USA
| | - P. LeBrun
- Institut de Physique des 2 Infinis de Lyon, 69622 Villeurbanne, France
| | - T. LeCompte
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025 USA
| | - C. Lee
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - S. Y. Lee
- Jeonbuk National University, Jeonrabuk-do, 54896 South Korea
| | - G. Lehmann Miotto
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | - R. Lehnert
- Indiana University, Bloomington, IN 47405 USA
| | | | - M. Leitner
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720 USA
| | - L. M. Lepin
- University of Manchester, Manchester, M13 9PL UK
| | - S. W. Li
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025 USA
| | - Y. Li
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - H. Liao
- Kansas State University, Manhattan, KS 66506 USA
| | - C. S. Lin
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720 USA
| | - Q. Lin
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025 USA
| | - S. Lin
- Louisiana State University, Baton Rouge, LA 70803 USA
| | | | - J. Ling
- Sun Yat-Sen University, Guangzhou, 510275 China
| | - A. Lister
- University of Wisconsin Madison, Madison, WI 53706 USA
| | | | - J. Liu
- University of California Irvine, Irvine, CA 92697 USA
| | - Y. Liu
- University of Chicago, Chicago, IL 60637 USA
| | - S. Lockwitz
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - T. Loew
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720 USA
| | - M. Lokajicek
- Institute of Physics, Czech Academy of Sciences, 182 00 Prague 8, Czech Republic
| | - I. Lomidze
- Georgian Technical University, Tbilisi, Georgia
| | - K. Long
- Imperial College of Science Technology and Medicine, London, SW7 2BZ UK
| | - T. Lord
- University of Warwick, Coventry, CV4 7AL UK
| | | | - W. C. Louis
- Los Alamos National Laboratory, Los Alamos, NM 87545 USA
| | - X.-G. Lu
- University of Warwick, Coventry, CV4 7AL UK
| | - K. B. Luk
- University of California Berkeley, Berkeley, CA 94720 USA
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720 USA
| | - B. Lunday
- University of Pennsylvania, Philadelphia, PA 19104 USA
| | - X. Luo
- University of California Santa Barbara, Santa Barbara, CA 93106 USA
| | - E. Luppi
- University of Ferrara, Ferrara, Italy
- Istituto Nazionale di Fisica Nucleare Sezione di Ferrara, 44122 Ferrara, Italy
| | - T. Lux
- Institut de Física d’Altes Energies (IFAE)-Barcelona Institute of Science and Technology (BIST), Barcelona, Spain
| | - V. P. Luzio
- Universidade Federal do ABC, Santo André, SP 09210-580 Brazil
| | - J. Maalmi
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - D. MacFarlane
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025 USA
| | - A. A. Machado
- Universidade Estadual de Campinas, Campinas, SP 13083-970 Brazil
| | - P. Machado
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | | | - J. R. Macier
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - A. Maddalena
- Laboratori Nazionali del Gran Sasso, L’Aquila, AQ Italy
| | - A. Madera
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | - P. Madigan
- University of California Berkeley, Berkeley, CA 94720 USA
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720 USA
| | - S. Magill
- Argonne National Laboratory, Argonne, IL 60439 USA
| | - K. Mahn
- Michigan State University, East Lansing, MI 48824 USA
| | - A. Maio
- Faculdade de Ciências da Universidade de Lisboa-FCUL, 1749-016 Lisbon, Portugal
- Laboratório de Instrumentação e Física Experimental de Partículas, 1649-003 Lisboa, 3004-516 Coimbra, Portugal
| | - A. Major
- Duke University, Durham, NC 27708 USA
| | | | - G. Mandrioli
- Istituto Nazionale di Fisica Nucleare Sezione di Bologna, 40127 Bologna, BO Italy
| | | | - J. Maneira
- Faculdade de Ciências da Universidade de Lisboa-FCUL, 1749-016 Lisbon, Portugal
- Laboratório de Instrumentação e Física Experimental de Partículas, 1649-003 Lisboa, 3004-516 Coimbra, Portugal
| | - L. Manenti
- University College London, London, WC1E 6BT UK
| | - S. Manly
- University of Rochester, Rochester, NY 14627 USA
| | - A. Mann
- Tufts University, Medford, MA 02155 USA
| | | | | | - V. N. Manyam
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - L. Manzanillas
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - M. Marchan
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - A. Marchionni
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - W. Marciano
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - D. Marfatia
- University of Hawaii, Honolulu, HI 96822 USA
| | | | - J. Maricic
- University of Hawaii, Honolulu, HI 96822 USA
| | - R. Marie
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - F. Marinho
- Universidade Federal de São Carlos, Araras, SP 13604-900 Brazil
| | - A. D. Marino
- University of Colorado Boulder, Boulder, CO 80309 USA
| | - D. Marsden
- University of Manchester, Manchester, M13 9PL UK
| | - M. Marshak
- University of Minnesota Twin Cities, Minneapolis, MN 55455 USA
| | - C. Marshall
- University of Rochester, Rochester, NY 14627 USA
| | | | - J. Marteau
- Institut de Physique des 2 Infinis de Lyon, 69622 Villeurbanne, France
| | - J. Martín-Albo
- Instituto de Física Corpuscular, CSIC and Universitat de València, 46980 Paterna, Valencia Spain
| | - N. Martinez
- Kansas State University, Manhattan, KS 66506 USA
| | | | - P. Martínez Miravé
- Instituto de Física Corpuscular, CSIC and Universitat de València, 46980 Paterna, Valencia Spain
| | - S. Martynenko
- Stony Brook University, SUNY, Stony Brook, NY 11794 USA
| | - V. Mascagna
- Istituto Nazionale di Fisica Nucleare Sezione di Milano Bicocca, 3, 20126 Milan, Italy
- University of Insubria, Via Ravasi, 2, 21100 Varese, VA Italy
| | - K. Mason
- Tufts University, Medford, MA 02155 USA
| | - A. Mastbaum
- Rutgers University, Piscataway, NJ 08854 USA
| | - F. Matichard
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720 USA
| | - S. Matsuno
- University of Hawaii, Honolulu, HI 96822 USA
| | - J. Matthews
- Louisiana State University, Baton Rouge, LA 70803 USA
| | - C. Mauger
- University of Pennsylvania, Philadelphia, PA 19104 USA
| | - N. Mauri
- Università del Bologna, 40127 Bologna, Italy
- Istituto Nazionale di Fisica Nucleare Sezione di Bologna, 40127 Bologna, BO Italy
| | | | - I. Mawby
- University of Warwick, Coventry, CV4 7AL UK
| | - R. Mazza
- Istituto Nazionale di Fisica Nucleare Sezione di Milano Bicocca, 3, 20126 Milan, Italy
| | - A. Mazzacane
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - E. Mazzucato
- IRFU, CEA, Université Paris-Saclay, 91191 Gif-sur-Yvette, France
| | | | - E. McCluskey
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - N. McConkey
- University of Manchester, Manchester, M13 9PL UK
| | | | - C. McGrew
- Stony Brook University, SUNY, Stony Brook, NY 11794 USA
| | - A. McNab
- University of Manchester, Manchester, M13 9PL UK
| | - A. Mefodiev
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow, 117312 Russia
| | - P. Mehta
- Jawaharlal Nehru University, New Delhi, 110067 India
| | - P. Melas
- University of Athens, 157 84 Zografou, Greece
| | - O. Mena
- Instituto de Física Corpuscular, CSIC and Universitat de València, 46980 Paterna, Valencia Spain
| | - H. Mendez
- University of Puerto Rico, Mayaguez, PR 00681 USA
| | - P. Mendez
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | - D. P. Méndez
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - A. Menegolli
- Istituto Nazionale di Fisica Nucleare Sezione di Pavia, 27100 Pavia, Italy
- Università degli Studi di Pavia, 27100 Pavia, PV Italy
| | - G. Meng
- Istituto Nazionale di Fisica Nucleare Sezione di Padova, 35131 Padua, Italy
| | | | - W. Metcalf
- Louisiana State University, Baton Rouge, LA 70803 USA
| | - T. Mettler
- University of Bern, 3012 Bern, Switzerland
| | - M. Mewes
- Indiana University, Bloomington, IN 47405 USA
| | - H. Meyer
- Wichita State University, Wichita, KS 67260 USA
| | - T. Miao
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - G. Michna
- South Dakota State University, Brookings, SD 57007 USA
| | - T. Miedema
- Nikhef National Institute of Subatomic Physics, 1098 XG Amsterdam, The Netherlands
- Radboud University, 6525 AJ Nijmegen, The Netherlands
| | - V. Mikola
- University College London, London, WC1E 6BT UK
| | - R. Milincic
- University of Hawaii, Honolulu, HI 96822 USA
| | - G. Miller
- University of Manchester, Manchester, M13 9PL UK
| | - W. Miller
- University of Minnesota Twin Cities, Minneapolis, MN 55455 USA
| | - J. Mills
- Tufts University, Medford, MA 02155 USA
| | - O. Mineev
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow, 117312 Russia
| | - A. Minotti
- Istituto Nazionale di Fisica Nucleare Sezione di Milano, 20133 Milan, Italy
- Università del Milano-Bicocca, 20126 Milan, Italy
| | - O. G. Miranda
- Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (Cinvestav), Mexico City, Mexico
| | - S. Miryala
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - C. S. Mishra
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - S. R. Mishra
- University of South Carolina, Columbia, SC 29208 USA
| | - A. Mislivec
- University of Minnesota Twin Cities, Minneapolis, MN 55455 USA
| | - M. Mitchell
- Louisiana State University, Baton Rouge, LA 70803 USA
| | - D. Mladenov
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | - I. Mocioiu
- Pennsylvania State University, University Park, PA 16802 USA
| | - K. Moffat
- Durham University, Durham, DH1 3LE UK
| | - N. Moggi
- Università del Bologna, 40127 Bologna, Italy
- Istituto Nazionale di Fisica Nucleare Sezione di Bologna, 40127 Bologna, BO Italy
| | - R. Mohanta
- University of Hyderabad, Gachibowli, Hyderabad, 500 046 India
| | - T. A. Mohayai
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - N. Mokhov
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - J. Molina
- Universidad Nacional de Asunción, San Lorenzo, Paraguay
| | - L. Molina Bueno
- Instituto de Física Corpuscular, CSIC and Universitat de València, 46980 Paterna, Valencia Spain
| | - E. Montagna
- Università del Bologna, 40127 Bologna, Italy
- Istituto Nazionale di Fisica Nucleare Sezione di Bologna, 40127 Bologna, BO Italy
| | - A. Montanari
- Istituto Nazionale di Fisica Nucleare Sezione di Bologna, 40127 Bologna, BO Italy
| | - C. Montanari
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
- Istituto Nazionale di Fisica Nucleare Sezione di Pavia, 27100 Pavia, Italy
- Università degli Studi di Pavia, 27100 Pavia, PV Italy
| | - D. Montanari
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - L. M. Montañno Zetina
- Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (Cinvestav), Mexico City, Mexico
| | - S. H. Moon
- Ulsan National Institute of Science and Technology, Ulsan, 689-798 South Korea
| | - M. Mooney
- Colorado State University, Fort Collins, CO 80523 USA
| | - A. F. Moor
- University of Cambridge, Cambridge, CB3 0HE UK
| | - D. Moreno
- Universidad Antonio Nariño, Bogotá, Colombia
| | - D. Moretti
- Istituto Nazionale di Fisica Nucleare Sezione di Milano Bicocca, 3, 20126 Milan, Italy
| | - C. Morris
- University of Houston, Houston, TX 77204 USA
| | - C. Mossey
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - M. Mote
- Louisiana State University, Baton Rouge, LA 70803 USA
| | - E. Motuk
- University College London, London, WC1E 6BT UK
| | - C. A. Moura
- Universidade Federal do ABC, Santo André, SP 09210-580 Brazil
| | - J. Mousseau
- University of Michigan, Ann Arbor, MI 48109 USA
| | - G. Mouster
- Lancaster University, Lancaster, LA1 4YB UK
| | - W. Mu
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - L. Mualem
- California Institute of Technology, Pasadena, CA 91125 USA
| | - J. Mueller
- Colorado State University, Fort Collins, CO 80523 USA
| | - M. Muether
- Wichita State University, Wichita, KS 67260 USA
| | - S. Mufson
- Indiana University, Bloomington, IN 47405 USA
| | - F. Muheim
- University of Edinburgh, Edinburgh, EH8 9YL UK
| | - A. Muir
- Daresbury Laboratory, Cheshire, WA4 4AD UK
| | - M. Mulhearn
- University of California Davis, Davis, CA 95616 USA
| | - D. Munford
- University of Houston, Houston, TX 77204 USA
| | - H. Muramatsu
- University of Minnesota Twin Cities, Minneapolis, MN 55455 USA
| | | | - J. Musser
- Indiana University, Bloomington, IN 47405 USA
| | | | - S. Nagu
- University of Lucknow, Lucknow, Uttar Pradesh 226007 India
| | - M. Nalbandyan
- Yerevan Institute for Theoretical Physics and Modeling, Yerevan, 0036 Armenia
| | - R. Nandakumar
- STFC Rutherford Appleton Laboratory, Didcot, OX11 0QX UK
| | - D. Naples
- University of Pittsburgh, Pittsburgh, PA 15260 USA
| | - S. Narita
- Iwate University, Morioka, Iwate 020-8551 Japan
| | - A. Nath
- Indian Institute of Technology Guwahati, Guwahati, 781 039 India
| | | | - N. Nayak
- University of California Irvine, Irvine, CA 92697 USA
| | | | - K. Negishi
- Iwate University, Morioka, Iwate 020-8551 Japan
| | - J. K. Nelson
- College of William and Mary, Williamsburg, VA 23187 USA
| | - J. Nesbit
- University of Wisconsin Madison, Madison, WI 53706 USA
| | - M. Nessi
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | - D. Newbold
- STFC Rutherford Appleton Laboratory, Didcot, OX11 0QX UK
| | - M. Newcomer
- University of Pennsylvania, Philadelphia, PA 19104 USA
| | - H. Newton
- Daresbury Laboratory, Cheshire, WA4 4AD UK
| | - R. Nichol
- University College London, London, WC1E 6BT UK
| | | | - A. Nikolica
- University of Pennsylvania, Philadelphia, PA 19104 USA
| | - E. Niner
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | | | - A. Norman
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - A. Norrick
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - R. Northrop
- University of Chicago, Chicago, IL 60637 USA
| | - P. Novella
- Instituto de Física Corpuscular, CSIC and Universitat de València, 46980 Paterna, Valencia Spain
| | | | - M. Oberling
- Argonne National Laboratory, Argonne, IL 60439 USA
| | | | - A. Olivier
- University of Rochester, Rochester, NY 14627 USA
| | - A. Olshevskiy
- Joint Institute for Nuclear Research, Dzhelepov Laboratory of Nuclear Problems 6 Joliot-Curie, Dubna, Moscow Region 141980 Russia
| | - Y. Onel
- University of Iowa, Iowa City, IA 52242 USA
| | - Y. Onishchuk
- Taras Shevchenko National University of Kyiv, Kyiv, 01601 Ukraine
| | - J. Ott
- University of California Irvine, Irvine, CA 92697 USA
| | - L. Pagani
- University of California Davis, Davis, CA 95616 USA
| | - G. Palacio
- Universidad EIA, Envigado, Antioquia, Colombia
| | - O. Palamara
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - S. Palestini
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | - J. M. Paley
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - M. Pallavicini
- Università degli Studi di Genova, Genoa, Italy
- Istituto Nazionale di Fisica Nucleare Sezione di Genova, 16146 Genoa, GE Italy
| | - C. Palomares
- CIEMAT, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, 28040 Madrid, Spain
| | | | - E. Pantic
- University of California Davis, Davis, CA 95616 USA
| | - V. Paolone
- University of Pittsburgh, Pittsburgh, PA 15260 USA
| | | | - R. Papaleo
- Istituto Nazionale di Fisica Nucleare Laboratori Nazionali del Sud, 95123 Catania, Italy
| | - A. Papanestis
- STFC Rutherford Appleton Laboratory, Didcot, OX11 0QX UK
| | | | - S. Parke
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - E. Parozzi
- Istituto Nazionale di Fisica Nucleare Sezione di Milano Bicocca, 3, 20126 Milan, Italy
- Università del Milano-Bicocca, 20126 Milan, Italy
| | - Z. Parsa
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - M. Parvu
- University of Bucharest, Bucharest, Romania
| | - S. Pascoli
- Università del Bologna, 40127 Bologna, Italy
- Durham University, Durham, DH1 3LE UK
| | - L. Pasqualini
- Università del Bologna, 40127 Bologna, Italy
- Istituto Nazionale di Fisica Nucleare Sezione di Bologna, 40127 Bologna, BO Italy
| | - J. Pasternak
- Imperial College of Science Technology and Medicine, London, SW7 2BZ UK
| | - J. Pater
- University of Manchester, Manchester, M13 9PL UK
| | - C. Patrick
- University College London, London, WC1E 6BT UK
| | - L. Patrizii
- Istituto Nazionale di Fisica Nucleare Sezione di Bologna, 40127 Bologna, BO Italy
| | | | - S. J. Patton
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720 USA
| | - T. Patzak
- Université de Paris, CNRS, Astroparticule et Cosmologie, 75006 Paris, France
| | - A. Paudel
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - B. Paulos
- University of Wisconsin Madison, Madison, WI 53706 USA
| | - L. Paulucci
- Universidade Federal do ABC, Santo André, SP 09210-580 Brazil
| | - Z. Pavlovic
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - G. Pawloski
- University of Minnesota Twin Cities, Minneapolis, MN 55455 USA
| | - D. Payne
- University of Liverpool, Liverpool, L69 7ZE UK
| | - V. Pec
- Institute of Physics, Czech Academy of Sciences, 182 00 Prague 8, Czech Republic
| | | | - A. Pena Perez
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025 USA
| | - E. Pennacchio
- Institut de Physique des 2 Infinis de Lyon, 69622 Villeurbanne, France
| | - A. Penzo
- University of Iowa, Iowa City, IA 52242 USA
| | - O. L. G. Peres
- Universidade Estadual de Campinas, Campinas, SP 13083-970 Brazil
| | - J. Perry
- University of Edinburgh, Edinburgh, EH8 9YL UK
| | | | - G. Pessina
- Istituto Nazionale di Fisica Nucleare Sezione di Milano Bicocca, 3, 20126 Milan, Italy
| | - G. Petrillo
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025 USA
| | - C. Petta
- Università di Catania, 2, 95131 Catania, Italy
- Istituto Nazionale di Fisica Nucleare Sezione di Catania, 95123 Catania, Italy
| | - R. Petti
- University of South Carolina, Columbia, SC 29208 USA
| | - V. Pia
- Università del Bologna, 40127 Bologna, Italy
- Istituto Nazionale di Fisica Nucleare Sezione di Bologna, 40127 Bologna, BO Italy
| | - F. Piastra
- University of Bern, 3012 Bern, Switzerland
| | - L. Pickering
- Michigan State University, East Lansing, MI 48824 USA
| | - F. Pietropaolo
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
- Istituto Nazionale di Fisica Nucleare Sezione di Padova, 35131 Padua, Italy
| | - V. L. Pimentel
- Universidade Estadual de Campinas, Campinas, SP 13083-970 Brazil
- Centro de Tecnologia da Informacao Renato Archer, Amarais, Campinas, SP CEP 13069-901 Brazil
| | - G. Pinaroli
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - K. Plows
- University of Oxford, Oxford, OX1 3RH UK
| | - R. Plunkett
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - R. Poling
- University of Minnesota Twin Cities, Minneapolis, MN 55455 USA
| | - F. Pompa
- Instituto de Física Corpuscular, CSIC and Universitat de València, 46980 Paterna, Valencia Spain
| | - X. Pons
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | | | - F. Poppi
- Università del Bologna, 40127 Bologna, Italy
- Istituto Nazionale di Fisica Nucleare Sezione di Bologna, 40127 Bologna, BO Italy
| | - S. Pordes
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - J. Porter
- University of Sussex, Brighton, BN1 9RH UK
| | - M. Potekhin
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - R. Potenza
- Università di Catania, 2, 95131 Catania, Italy
- Istituto Nazionale di Fisica Nucleare Sezione di Catania, 95123 Catania, Italy
| | | | - J. Pozimski
- Imperial College of Science Technology and Medicine, London, SW7 2BZ UK
| | - M. Pozzato
- Università del Bologna, 40127 Bologna, Italy
- Istituto Nazionale di Fisica Nucleare Sezione di Bologna, 40127 Bologna, BO Italy
| | - S. Prakash
- Universidade Estadual de Campinas, Campinas, SP 13083-970 Brazil
| | - T. Prakash
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720 USA
| | - M. Prest
- Istituto Nazionale di Fisica Nucleare Sezione di Milano Bicocca, 3, 20126 Milan, Italy
| | - S. Prince
- Harvard University, Cambridge, MA 02138 USA
| | - F. Psihas
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - D. Pugnere
- Institut de Physique des 2 Infinis de Lyon, 69622 Villeurbanne, France
| | - X. Qian
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - J. L. Raaf
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - V. Radeka
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | | | | | - A. Rafique
- Argonne National Laboratory, Argonne, IL 60439 USA
| | - E. Raguzin
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - M. Rai
- University of Warwick, Coventry, CV4 7AL UK
| | | | - I. Rakhno
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | | | | | - R. Rameika
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | | | - B. Ramson
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - A. Rappoldi
- Istituto Nazionale di Fisica Nucleare Sezione di Pavia, 27100 Pavia, Italy
- Università degli Studi di Pavia, 27100 Pavia, PV Italy
| | - G. Raselli
- Istituto Nazionale di Fisica Nucleare Sezione di Pavia, 27100 Pavia, Italy
- Università degli Studi di Pavia, 27100 Pavia, PV Italy
| | - P. Ratoff
- Lancaster University, Lancaster, LA1 4YB UK
| | - S. Raut
- Stony Brook University, SUNY, Stony Brook, NY 11794 USA
| | | | - E. M. Rea
- University of Minnesota Twin Cities, Minneapolis, MN 55455 USA
| | - J. S. Real
- University Grenoble Alpes, CNRS, Grenoble INP, LPSC-IN2P3, 38000 Grenoble, France
| | - B. Rebel
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
- University of Wisconsin Madison, Madison, WI 53706 USA
| | - R. Rechenmacher
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | | | - J. Reichenbacher
- South Dakota School of Mines and Technology, Rapid City, SD 57701 USA
| | - S. D. Reitzner
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - H. Rejeb Sfar
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | - A. Renshaw
- University of Houston, Houston, TX 77204 USA
| | - S. Rescia
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - F. Resnati
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | - M. Ribas
- Universidade Tecnológica Federal do Paraná, Curitiba, Brazil
| | - S. Riboldi
- Istituto Nazionale di Fisica Nucleare Sezione di Milano, 20133 Milan, Italy
| | - C. Riccio
- Stony Brook University, SUNY, Stony Brook, NY 11794 USA
| | - G. Riccobene
- Istituto Nazionale di Fisica Nucleare Laboratori Nazionali del Sud, 95123 Catania, Italy
| | | | - J. S. Ricol
- University Grenoble Alpes, CNRS, Grenoble INP, LPSC-IN2P3, 38000 Grenoble, France
| | - A. Rigamonti
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | | | | | | | - D. Rivera
- Los Alamos National Laboratory, Los Alamos, NM 87545 USA
| | - A. Robert
- University Grenoble Alpes, CNRS, Grenoble INP, LPSC-IN2P3, 38000 Grenoble, France
| | - L. Rochester
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025 USA
| | - M. Roda
- University of Liverpool, Liverpool, L69 7ZE UK
| | | | | | | | | | | | - M. Rosenberg
- University of Pittsburgh, Pittsburgh, PA 15260 USA
| | - P. Rosier
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - B. Roskovec
- University of California Irvine, Irvine, CA 92697 USA
| | - M. Rossella
- Istituto Nazionale di Fisica Nucleare Sezione di Pavia, 27100 Pavia, Italy
- Università degli Studi di Pavia, 27100 Pavia, PV Italy
| | - M. Rossi
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | - J. Rout
- Jawaharlal Nehru University, New Delhi, 110067 India
| | - P. Roy
- Wichita State University, Wichita, KS 67260 USA
| | | | - C. Rubbia
- Gran Sasso Science Institute, L’Aquila, Italy
| | - B. Russell
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720 USA
| | | | - A. Rybnikov
- Joint Institute for Nuclear Research, Dzhelepov Laboratory of Nuclear Problems 6 Joliot-Curie, Dubna, Moscow Region 141980 Russia
| | | | - R. Saakyan
- University College London, London, WC1E 6BT UK
| | - S. Sacerdoti
- Université de Paris, CNRS, Astroparticule et Cosmologie, 75006 Paris, France
| | - T. Safford
- Michigan State University, East Lansing, MI 48824 USA
| | - N. Sahu
- Indian Institute of Technology Hyderabad, Hyderabad, 502285 India
| | - K. Sakashita
- High Energy Accelerator Research Organization (KEK), Ibaraki, 305-0801 Japan
| | - P. Sala
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
- Istituto Nazionale di Fisica Nucleare Sezione di Milano, 20133 Milan, Italy
| | - N. Samios
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - O. Samoylov
- Joint Institute for Nuclear Research, Dzhelepov Laboratory of Nuclear Problems 6 Joliot-Curie, Dubna, Moscow Region 141980 Russia
| | | | - V. Sandberg
- Los Alamos National Laboratory, Los Alamos, NM 87545 USA
| | | | - D. Sankey
- STFC Rutherford Appleton Laboratory, Didcot, OX11 0QX UK
| | - S. Santana
- University of Puerto Rico, Mayaguez, PR 00681 USA
| | | | | | - P. Sapienza
- Istituto Nazionale di Fisica Nucleare Laboratori Nazionali del Sud, 95123 Catania, Italy
| | - C. Sarasty
- University of Cincinnati, Cincinnati, OH 45221 USA
| | | | - G. Savage
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - V. Savinov
- University of Pittsburgh, Pittsburgh, PA 15260 USA
| | - A. Scaramelli
- Istituto Nazionale di Fisica Nucleare Sezione di Pavia, 27100 Pavia, Italy
| | - A. Scarff
- University of Sheffield, Sheffield, S3 7RH UK
| | - A. Scarpelli
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - T. Schefke
- Louisiana State University, Baton Rouge, LA 70803 USA
| | - H. Schellman
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
- Oregon State University, Corvallis, OR 97331 USA
| | - S. Schifano
- University of Ferrara, Ferrara, Italy
- Istituto Nazionale di Fisica Nucleare Sezione di Ferrara, 44122 Ferrara, Italy
| | - P. Schlabach
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - D. Schmitz
- University of Chicago, Chicago, IL 60637 USA
| | - A. W. Schneider
- Massachusetts Institute of Technology, Cambridge, MA 02139 USA
| | | | - A. Schukraft
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - E. Segreto
- Universidade Estadual de Campinas, Campinas, SP 13083-970 Brazil
| | - A. Selyunin
- Joint Institute for Nuclear Research, Dzhelepov Laboratory of Nuclear Problems 6 Joliot-Curie, Dubna, Moscow Region 141980 Russia
| | - C. R. Senise
- Universidade Federal de São Paulo, São Paulo, 09913-030 Brazil
| | - J. Sensenig
- University of Pennsylvania, Philadelphia, PA 19104 USA
| | - A. Sergi
- University of Birmingham, Birmingham, B15 2TT UK
| | | | | | - S. Shafaq
- Jawaharlal Nehru University, New Delhi, 110067 India
| | - F. Shaker
- York University, Toronto, M3J 1P3 Canada
| | - M. Shamma
- University of California Riverside, Riverside, CA 92521 USA
| | | | | | - R. Sharma
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - R. K. Sharma
- Punjab Agricultural University, Ludhiana, 141004 India
| | - T. Shaw
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - K. Shchablo
- Institut de Physique des 2 Infinis de Lyon, 69622 Villeurbanne, France
| | | | - A. Sheshukov
- Joint Institute for Nuclear Research, Dzhelepov Laboratory of Nuclear Problems 6 Joliot-Curie, Dubna, Moscow Region 141980 Russia
| | - S. Shin
- Jeonbuk National University, Jeonrabuk-do, 54896 South Korea
| | | | - D. Shooltz
- Michigan State University, East Lansing, MI 48824 USA
| | - R. Shrock
- Stony Brook University, SUNY, Stony Brook, NY 11794 USA
| | - H. Siegel
- Columbia University, New York, NY 10027 USA
| | - L. Simard
- Université Paris-Saclay, CNRS/IN2P3, IJCLab, 91405 Orsay, France
| | - J. Sinclair
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025 USA
| | - G. Sinev
- South Dakota School of Mines and Technology, Rapid City, SD 57701 USA
| | - J. Singh
- University of Lucknow, Lucknow, Uttar Pradesh 226007 India
| | - J. Singh
- University of Lucknow, Lucknow, Uttar Pradesh 226007 India
| | - L. Singh
- Central University of South Bihar, Gaya, 824236 India
| | - P. Singh
- Queen Mary University of London, London, E1 4NS UK
| | - V. Singh
- Banaras Hindu University, Varanasi, 221 005 India
- Central University of South Bihar, Gaya, 824236 India
| | - R. Sipos
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | | | - G. Sirri
- Istituto Nazionale di Fisica Nucleare Sezione di Bologna, 40127 Bologna, BO Italy
| | - A. Sitraka
- South Dakota School of Mines and Technology, Rapid City, SD 57701 USA
| | - K. Siyeon
- Chung-Ang University, Seoul, 06974 South Korea
| | - K. Skarpaas
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025 USA
| | - A. Smith
- University of Cambridge, Cambridge, CB3 0HE UK
| | - E. Smith
- Indiana University, Bloomington, IN 47405 USA
| | - P. Smith
- Indiana University, Bloomington, IN 47405 USA
| | - J. Smolik
- Czech Technical University, 115 19 Prague 1, Czech Republic
| | - M. Smy
- University of California Irvine, Irvine, CA 92697 USA
| | - E. Snider
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - P. Snopok
- Illinois Institute of Technology, Chicago, IL 60616 USA
| | | | | | - H. Sobel
- University of California Irvine, Irvine, CA 92697 USA
| | | | - S. Sokolov
- Joint Institute for Nuclear Research, Dzhelepov Laboratory of Nuclear Problems 6 Joliot-Curie, Dubna, Moscow Region 141980 Russia
| | | | | | - S. R. Soleti
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720 USA
| | - N. Solomey
- Wichita State University, Wichita, KS 67260 USA
| | - V. Solovov
- Laboratório de Instrumentação e Física Experimental de Partículas, 1649-003 Lisboa, 3004-516 Coimbra, Portugal
| | - W. E. Sondheim
- Los Alamos National Laboratory, Los Alamos, NM 87545 USA
| | - M. Sorel
- Instituto de Física Corpuscular, CSIC and Universitat de València, 46980 Paterna, Valencia Spain
| | - A. Sotnikov
- Joint Institute for Nuclear Research, Dzhelepov Laboratory of Nuclear Problems 6 Joliot-Curie, Dubna, Moscow Region 141980 Russia
| | - J. Soto-Oton
- CIEMAT, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, 28040 Madrid, Spain
| | | | - A. Sousa
- University of Cincinnati, Cincinnati, OH 45221 USA
| | - K. Soustruznik
- Institute of Particle and Nuclear Physics of the Faculty of Mathematics and Physics of the Charles University, 180 00 Prague 8, Czech Republic
| | | | - M. Spanu
- Istituto Nazionale di Fisica Nucleare Sezione di Milano Bicocca, 3, 20126 Milan, Italy
- Università del Milano-Bicocca, 20126 Milan, Italy
| | - J. Spitz
- University of Michigan, Ann Arbor, MI 48109 USA
| | | | | | - M. Stancari
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - L. Stanco
- Istituto Nazionale di Fisica Nucleare Sezione di Padova, 35131 Padua, Italy
- Universtà degli Studi di Padova, 35131 Padua, Italy
| | | | - R. Stein
- University of Bristol, Bristol, BS8 1TL UK
| | - H. M. Steiner
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720 USA
| | | | - J. Stewart
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | | | - J. Stock
- South Dakota School of Mines and Technology, Rapid City, SD 57701 USA
| | - F. Stocker
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | - T. Stokes
- Louisiana State University, Baton Rouge, LA 70803 USA
| | - M. Strait
- University of Minnesota Twin Cities, Minneapolis, MN 55455 USA
| | - T. Strauss
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - L. Strigari
- Texas A &M University, College Station, 77840 USA
| | - A. Stuart
- Universidad de Colima, Colima, Mexico
| | | | | | - H. Sullivan
- University of Texas at Arlington, Arlington, TX 76019 USA
| | - D. Summers
- University of Mississippi, University, MS 38677 USA
| | - A. Surdo
- Istituto Nazionale di Fisica Nucleare Sezione di Lecce, 73100 Lecce, Italy
| | - V. Susic
- University of Basel, 4056 Basel, Switzerland
| | - L. Suter
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - C. M. Sutera
- Università di Catania, 2, 95131 Catania, Italy
- Istituto Nazionale di Fisica Nucleare Sezione di Catania, 95123 Catania, Italy
| | - R. Svoboda
- University of California Davis, Davis, CA 95616 USA
| | - B. Szczerbinska
- Texas A &M University-Corpus Christi, Corpus Christi, TX 78412 USA
| | - A. M. Szelc
- University of Edinburgh, Edinburgh, EH8 9YL UK
| | - H. Tanaka
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025 USA
| | - S. Tang
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - A. Tapia
- University of Medellín, Medellín, 050026 Colombia
| | | | - A. Tapper
- Imperial College of Science Technology and Medicine, London, SW7 2BZ UK
| | - S. Tariq
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - E. Tarpara
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - N. Tata
- Harvard University, Cambridge, MA 02138 USA
| | - E. Tatar
- Idaho State University, Pocatello, ID 83209 USA
| | - R. Tayloe
- Indiana University, Bloomington, IN 47405 USA
| | - A. M. Teklu
- Stony Brook University, SUNY, Stony Brook, NY 11794 USA
| | - P. Tennessen
- Antalya Bilim University, 07190 Döşemealti/Antalya, Turkey
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720 USA
| | - M. Tenti
- Istituto Nazionale di Fisica Nucleare Sezione di Bologna, 40127 Bologna, BO Italy
| | - K. Terao
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025 USA
| | - C. A. Ternes
- Instituto de Física Corpuscular, CSIC and Universitat de València, 46980 Paterna, Valencia Spain
| | - F. Terranova
- Istituto Nazionale di Fisica Nucleare Sezione di Milano Bicocca, 3, 20126 Milan, Italy
- Università del Milano-Bicocca, 20126 Milan, Italy
| | - G. Testera
- Istituto Nazionale di Fisica Nucleare Sezione di Genova, 16146 Genoa, GE Italy
| | - T. Thakore
- University of Cincinnati, Cincinnati, OH 45221 USA
| | - A. Thea
- STFC Rutherford Appleton Laboratory, Didcot, OX11 0QX UK
| | | | - C. Thorn
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - S. C. Timm
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | | | - L. Tomassetti
- University of Ferrara, Ferrara, Italy
- Istituto Nazionale di Fisica Nucleare Sezione di Ferrara, 44122 Ferrara, Italy
| | - A. Tonazzo
- Université de Paris, CNRS, Astroparticule et Cosmologie, 75006 Paris, France
| | - D. Torbunov
- University of Minnesota Twin Cities, Minneapolis, MN 55455 USA
| | - M. Torti
- Istituto Nazionale di Fisica Nucleare Sezione di Milano Bicocca, 3, 20126 Milan, Italy
- Università del Milano-Bicocca, 20126 Milan, Italy
| | - M. Tortola
- Instituto de Física Corpuscular, CSIC and Universitat de València, 46980 Paterna, Valencia Spain
| | - F. Tortorici
- Università di Catania, 2, 95131 Catania, Italy
- Istituto Nazionale di Fisica Nucleare Sezione di Catania, 95123 Catania, Italy
| | - N. Tosi
- Istituto Nazionale di Fisica Nucleare Sezione di Bologna, 40127 Bologna, BO Italy
| | - D. Totani
- University of California Santa Barbara, Santa Barbara, CA 93106 USA
| | - M. Toups
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | | | - R. Travaglini
- Istituto Nazionale di Fisica Nucleare Sezione di Bologna, 40127 Bologna, BO Italy
| | - J. Trevor
- California Institute of Technology, Pasadena, CA 91125 USA
| | - S. Trilov
- University of Bristol, Bristol, BS8 1TL UK
| | | | - Y. Tsai
- University of California Irvine, Irvine, CA 92697 USA
| | - Y.-T. Tsai
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025 USA
| | | | - K. V. Tsang
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025 USA
| | - N. Tsverava
- Georgian Technical University, Tbilisi, Georgia
| | - S. Tufanli
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | - C. Tull
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720 USA
| | - E. Tyley
- University of Sheffield, Sheffield, S3 7RH UK
| | - M. Tzanov
- Louisiana State University, Baton Rouge, LA 70803 USA
| | - L. Uboldi
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | | | - J. Urheim
- Indiana University, Bloomington, IN 47405 USA
| | - T. Usher
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025 USA
| | - S. Uzunyan
- Northern Illinois University, DeKalb, IL 60115 USA
| | - M. R. Vagins
- Kavli Institute for the Physics and Mathematics of the Universe, Kashiwa, Chiba 277-8583 Japan
| | - P. Vahle
- College of William and Mary, Williamsburg, VA 23187 USA
| | - S. Valder
- University of Sussex, Brighton, BN1 9RH UK
| | | | - E. Valencia
- Universidad de Guanajuato, C.P. 37000 Guanajuato, Mexico
| | - R. Valentim
- Universidade Federal de São Paulo, São Paulo, 09913-030 Brazil
| | - Z. Vallari
- California Institute of Technology, Pasadena, CA 91125 USA
| | - E. Vallazza
- Istituto Nazionale di Fisica Nucleare Sezione di Milano Bicocca, 3, 20126 Milan, Italy
| | - J. W. F. Valle
- Instituto de Física Corpuscular, CSIC and Universitat de València, 46980 Paterna, Valencia Spain
| | - S. Vallecorsa
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | - R. Van Berg
- University of Pennsylvania, Philadelphia, PA 19104 USA
| | | | | | - D. Vannerom
- Massachusetts Institute of Technology, Cambridge, MA 02139 USA
| | - F. Varanini
- Istituto Nazionale di Fisica Nucleare Sezione di Padova, 35131 Padua, Italy
| | - D. Vargas Oliva
- Institut de Física d’Altes Energies (IFAE)-Barcelona Institute of Science and Technology (BIST), Barcelona, Spain
| | - G. Varner
- University of Hawaii, Honolulu, HI 96822 USA
| | - J. Vasel
- Indiana University, Bloomington, IN 47405 USA
| | - S. Vasina
- Joint Institute for Nuclear Research, Dzhelepov Laboratory of Nuclear Problems 6 Joliot-Curie, Dubna, Moscow Region 141980 Russia
| | - G. Vasseur
- IRFU, CEA, Université Paris-Saclay, 91191 Gif-sur-Yvette, France
| | - N. Vaughan
- Oregon State University, Corvallis, OR 97331 USA
| | - K. Vaziri
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - S. Ventura
- Istituto Nazionale di Fisica Nucleare Sezione di Padova, 35131 Padua, Italy
| | - A. Verdugo
- CIEMAT, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, 28040 Madrid, Spain
| | - S. Vergani
- University of Cambridge, Cambridge, CB3 0HE UK
| | - M. A. Vermeulen
- Nikhef National Institute of Subatomic Physics, 1098 XG Amsterdam, The Netherlands
| | - M. Verzocchi
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - M. Vicenzi
- Università degli Studi di Genova, Genoa, Italy
- Istituto Nazionale di Fisica Nucleare Sezione di Genova, 16146 Genoa, GE Italy
| | - H. Vieira de Souza
- Université de Paris, CNRS, Astroparticule et Cosmologie, 75006 Paris, France
| | - C. Vignoli
- Laboratori Nazionali del Gran Sasso, L’Aquila, AQ Italy
| | - C. Vilela
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | - B. Viren
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - T. Vrba
- Czech Technical University, 115 19 Prague 1, Czech Republic
| | - T. Wachala
- H. Niewodniczański Institute of Nuclear Physics, Polish Academy of Sciences, Kraków, Poland
| | - A. V. Waldron
- Imperial College of Science Technology and Medicine, London, SW7 2BZ UK
| | - M. Wallbank
- University of Cincinnati, Cincinnati, OH 45221 USA
| | - C. Wallis
- Colorado State University, Fort Collins, CO 80523 USA
| | - H. Wang
- University of California Los Angeles, Los Angeles, CA 90095 USA
| | - J. Wang
- South Dakota School of Mines and Technology, Rapid City, SD 57701 USA
| | - L. Wang
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720 USA
| | | | - X. Wang
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - Y. Wang
- University of California Los Angeles, Los Angeles, CA 90095 USA
| | - Y. Wang
- Stony Brook University, SUNY, Stony Brook, NY 11794 USA
| | | | - D. Warner
- Colorado State University, Fort Collins, CO 80523 USA
| | - M. O. Wascko
- Imperial College of Science Technology and Medicine, London, SW7 2BZ UK
| | - D. Waters
- University College London, London, WC1E 6BT UK
| | - A. Watson
- University of Birmingham, Birmingham, B15 2TT UK
| | - K. Wawrowska
- STFC Rutherford Appleton Laboratory, Didcot, OX11 0QX UK
- University of Sussex, Brighton, BN1 9RH UK
| | | | - A. Weber
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
- Johannes Gutenberg-Universität Mainz, 55122 Mainz, Germany
| | - M. Weber
- University of Bern, 3012 Bern, Switzerland
| | - H. Wei
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | | | - D. Wenman
- University of Wisconsin Madison, Madison, WI 53706 USA
| | | | - A. White
- University of Texas at Arlington, Arlington, TX 76019 USA
| | | | | | - M. J. Wilking
- Stony Brook University, SUNY, Stony Brook, NY 11794 USA
| | | | - C. Wilkinson
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720 USA
| | - Z. Williams
- University of Texas at Arlington, Arlington, TX 76019 USA
| | - F. Wilson
- STFC Rutherford Appleton Laboratory, Didcot, OX11 0QX UK
| | - R. J. Wilson
- Colorado State University, Fort Collins, CO 80523 USA
| | - W. Wisniewski
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025 USA
| | | | | | - A. Wood
- University of Houston, Houston, TX 77204 USA
| | - K. Wood
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720 USA
| | - E. Worcester
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - M. Worcester
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - K. Wresilo
- University of Cambridge, Cambridge, CB3 0HE UK
| | - C. Wret
- University of Rochester, Rochester, NY 14627 USA
| | - W. Wu
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - W. Wu
- University of California Irvine, Irvine, CA 92697 USA
| | - Y. Xiao
- University of California Irvine, Irvine, CA 92697 USA
| | - F. Xie
- University of Sussex, Brighton, BN1 9RH UK
| | - B. Yaeggy
- University of Cincinnati, Cincinnati, OH 45221 USA
| | - E. Yandel
- University of California Santa Barbara, Santa Barbara, CA 93106 USA
| | - G. Yang
- Stony Brook University, SUNY, Stony Brook, NY 11794 USA
| | - K. Yang
- University of Oxford, Oxford, OX1 3RH UK
| | - T. Yang
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | | | - N. Yershov
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow, 117312 Russia
| | - K. Yonehara
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - Y. S. Yoon
- Chung-Ang University, Seoul, 06974 South Korea
| | - T. Young
- University of North Dakota, Grand Forks, ND 58202-8357 USA
| | - B. Yu
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - H. Yu
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - H. Yu
- Sun Yat-Sen University, Guangzhou, 510275 China
| | - J. Yu
- University of Texas at Arlington, Arlington, TX 76019 USA
| | - Y. Yu
- Illinois Institute of Technology, Chicago, IL 60616 USA
| | - W. Yuan
- University of Edinburgh, Edinburgh, EH8 9YL UK
| | - R. Zaki
- York University, Toronto, M3J 1P3 Canada
| | - J. Zalesak
- Institute of Physics, Czech Academy of Sciences, 182 00 Prague 8, Czech Republic
| | - L. Zambelli
- Laboratoire d’Annecy de Physique des Particules, Univ. Grenoble Alpes, Univ. Savoie Mont Blanc, CNRS, LAPP-IN2P3, 74000 Annecy, France
| | - B. Zamorano
- University of Granada & CAFPE, 18002 Granada, Spain
| | - A. Zani
- Istituto Nazionale di Fisica Nucleare Sezione di Milano, 20133 Milan, Italy
| | - L. Zazueta
- College of William and Mary, Williamsburg, VA 23187 USA
| | - G. P. Zeller
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - J. Zennamo
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - K. Zeug
- University of Wisconsin Madison, Madison, WI 53706 USA
| | - C. Zhang
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - S. Zhang
- Indiana University, Bloomington, IN 47405 USA
| | - Y. Zhang
- University of Pittsburgh, Pittsburgh, PA 15260 USA
| | - M. Zhao
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - E. Zhivun
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - G. Zhu
- Ohio State University, Columbus, OH 43210 USA
| | | | - S. Zucchelli
- Università del Bologna, 40127 Bologna, Italy
- Istituto Nazionale di Fisica Nucleare Sezione di Bologna, 40127 Bologna, BO Italy
| | - J. Zuklin
- Institute of Physics, Czech Academy of Sciences, 182 00 Prague 8, Czech Republic
| | - V. Zutshi
- Northern Illinois University, DeKalb, IL 60115 USA
| | - R. Zwaska
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | | |
Collapse
|
6
|
Abi B, Acciarri R, Acero MA, Adamov G, Adams D, Adinolfi M, Ahmad Z, Ahmed J, Alion T, Monsalve SA, Alt C, Anderson J, Andreopoulos C, Andrews MP, Andrianala F, Andringa S, Ankowski A, Antonova M, Antusch S, Aranda-Fernandez A, Ariga A, Arnold LO, Arroyave MA, Asaadi J, Aurisano A, Aushev V, Autiero D, Azfar F, Back H, Back JJ, Backhouse C, Baesso P, Bagby L, Bajou R, Balasubramanian S, Baldi P, Bambah B, Barao F, Barenboim G, Barker GJ, Barkhouse W, Barnes C, Barr G, Monarca JB, Barros N, Barrow JL, Bashyal A, Basque V, Bay F, Alba JLB, Beacom JF, Bechetoille E, Behera B, Bellantoni L, Bellettini G, Bellini V, Beltramello O, Belver D, Benekos N, Neves FB, Berger J, Berkman S, Bernardini P, Berner RM, Berns H, Bertolucci S, Betancourt M, Bezawada Y, Bhattacharjee M, Bhuyan B, Biagi S, Bian J, Biassoni M, Biery K, Bilki B, Bishai M, Bitadze A, Blake A, Siffert BB, Blaszczyk FDM, Blazey GC, Blucher E, Boissevain J, Bolognesi S, Bolton T, Bonesini M, Bongrand M, Bonini F, Booth A, Booth C, Bordoni S, Borkum A, Boschi T, Bostan N, Bour P, Boyd SB, Boyden D, Bracinik J, Braga D, Brailsford D, Brandt A, Bremer J, Brew C, Brianne E, Brice SJ, Brizzolari C, Bromberg C, Brooijmans G, Brooke J, Bross A, Brunetti G, Buchanan N, Budd H, Caiulo D, Calafiura P, Calcutt J, Calin M, Calvez S, Calvo E, Camilleri L, Caminata A, Campanelli M, Caratelli D, Carini G, Carlus B, Carniti P, Terrazas IC, Carranza H, Castillo A, Castromonte C, Cattadori C, Cavalier F, Cavanna F, Centro S, Cerati G, Cervelli A, Villanueva AC, Chalifour M, Chang C, Chardonnet E, Chatterjee A, Chattopadhyay S, Chaves J, Chen H, Chen M, Chen Y, Cherdack D, Chi C, Childress S, Chiriacescu A, Cho K, Choubey S, Christensen A, Christian D, Christodoulou G, Church E, Clarke P, Coan TE, Cocco AG, Coelho JAB, Conley E, Conrad JM, Convery M, Corwin L, Cotte P, Cremaldi L, Cremonesi L, Crespo-Anadón JI, Cristaldo E, Cross R, Cuesta C, Cui Y, Cussans D, Dabrowski M, da Motta H, Peres LDS, David C, David Q, Davies GS, Davini S, Dawson J, De K, De Almeida RM, Debbins P, De Bonis I, Decowski MP, de Gouvêa A, De Holanda PC, De Icaza Astiz IL, Deisting A, De Jong P, Delbart A, Delepine D, Delgado M, Dell’Acqua A, De Lurgio P, de Mello Neto JRT, DeMuth DM, Dennis S, Densham C, Deptuch G, De Roeck A, De Romeri V, De Vries JJ, Dharmapalan R, Dias M, Diaz F, Díaz JS, Di Domizio S, Di Giulio L, Ding P, Di Noto L, Distefano C, Diurba R, Diwan M, Djurcic Z, Dokania N, Dolinski MJ, Domine L, Douglas D, Drielsma F, Duchesneau D, Duffy K, Dunne P, Durkin T, Duyang H, Dvornikov O, Dwyer DA, Dyshkant AS, Eads M, Edmunds D, Eisch J, Emery S, Ereditato A, Escobar CO, Sanchez LE, Evans JJ, Ewart E, Ezeribe AC, Fahey K, Falcone A, Farnese C, Farzan Y, Felix J, Fernandez-Martinez E, Fernandez Menendez P, Ferraro F, Fields L, Filkins A, Filthaut F, Fitzpatrick RS, Flanagan W, Fleming B, Flight R, Fowler J, Fox W, Franc J, Francis K, Franco D, Freeman J, Freestone J, Fried J, Friedland A, Fuess S, Furic I, Furmanski AP, Gago A, Gallagher H, Gallego-Ros A, Gallice N, Galymov V, Gamberini E, Gamble T, Gandhi R, Gandrajula R, Gao S, Garcia-Gamez D, García-Peris MÁ, Gardiner S, Gastler D, Ge G, Gelli B, Gendotti A, Gent S, Ghorbani-Moghaddam Z, Gibin D, Gil-Botella I, Girerd C, Giri AK, Gnani D, Gogota O, Gold M, Gollapinni S, Gollwitzer K, Gomes RA, Bermeo LVG, Fajardo LSG, Gonnella F, Gonzalez-Cuevas JA, Goodman MC, Goodwin O, Goswami S, Gotti C, Goudzovski E, Grace C, Graham M, Gramellini E, Gran R, Granados E, Grant A, Grant C, Gratieri D, Green P, Green S, Greenler L, Greenwood M, Greer J, Griffith WC, Groh M, Grudzinski J, Grzelak K, Gu W, Guarino V, Guenette R, Guglielmi A, Guo B, Guthikonda KK, Gutierrez R, Guzowski P, Guzzo MM, Gwon S, Habig A, Hackenburg A, Hadavand H, Haenni R, Hahn A, Haigh J, Haiston J, Hamernik T, Hamilton P, Han J, Harder K, Harris DA, Hartnell J, Hasegawa T, Hatcher R, Hazen E, Heavey A, Heeger KM, Heise J, Hennessy K, Henry S, Morquecho MAH, Herner K, Hertel L, Hesam AS, Hewes J, Higuera A, Hill T, Hillier SJ, Himmel A, Hoff J, Hohl C, Holin A, Hoppe E, Horton-Smith GA, Hostert M, Hourlier A, Howard B, Howell R, Huang J, Huang J, Hugon J, Iles G, Ilic N, Iliescu AM, Illingworth R, Ioannisian A, Itay R, Izmaylov A, James E, Jargowsky B, Jediny F, Jesùs-Valls C, Ji X, Jiang L, Jiménez S, Jipa A, Joglekar A, Johnson C, Johnson R, Jones B, Jones S, Jung CK, Junk T, Jwa Y, Kabirnezhad M, Kaboth A, Kadenko I, Kamiya F, Karagiorgi G, Karcher A, Karolak M, Karyotakis Y, Kasai S, Kasetti SP, Kashur L, Kazaryan N, Kearns E, Keener P, Kelly KJ, Kemp E, Ketchum W, Kettell SH, Khabibullin M, Khotjantsev A, Khvedelidze A, Kim D, King B, Kirby B, Kirby M, Klein J, Koehler K, Koerner LW, Kohn S, Koller PP, Kordosky M, Kosc T, Kose U, Kostelecký VA, Kothekar K, Krennrich F, Kreslo I, Kudenko Y, Kudryavtsev VA, Kulagin S, Kumar J, Kumar R, Kuruppu C, Kus V, Kutter T, Lambert A, Lande K, Lane CE, Lang K, Langford T, Lasorak P, Last D, Lastoria C, Laundrie A, Lawrence A, Lazanu I, LaZur R, Le T, Learned J, LeBrun P, Miotto GL, Lehnert R, de Oliveira MAL, Leitner M, Leyton M, Li L, Li S, Li SW, Li T, Li Y, Liao H, Lin CS, Lin S, Lister A, Littlejohn BR, Liu J, Lockwitz S, Loew T, Lokajicek M, Lomidze I, Long K, Loo K, Lorca D, Lord T, LoSecco JM, Louis WC, Luk KB, Luo X, Lurkin N, Lux T, Luzio VP, MacFarland D, Machado AA, Machado P, Macias CT, Macier JR, Maddalena A, Madigan P, Magill S, Mahn K, Maio A, Maloney JA, Mandrioli G, Maneira J, Manenti L, Manly S, Mann A, Manolopoulos K, Plata MM, Marchionni A, Marciano W, Marfatia D, Mariani C, Maricic J, Marinho F, Marino AD, Marshak M, Marshall C, Marshall J, Marteau J, Martin-Albo J, Martinez N, Caicedo DAM, Martynenko S, Mason K, Mastbaum A, Masud M, Matsuno S, Matthews J, Mauger C, Mauri N, Mavrokoridis K, Mazza R, Mazzacane A, Mazzucato E, McCluskey E, McConkey N, McFarland KS, McGrew C, McNab A, Mefodiev A, Mehta P, Melas P, Mellinato M, Mena O, Menary S, Mendez H, Menegolli A, Meng G, Messier MD, Metcalf W, Mewes M, Meyer H, Miao T, Michna G, Miedema T, Migenda J, Milincic R, Miller W, Mills J, Milne C, Mineev O, Miranda OG, Miryala S, Mishra CS, Mishra SR, Mislivec A, Mladenov D, Mocioiu I, Moffat K, Moggi N, Mohanta R, Mohayai TA, Mokhov N, Molina J, Bueno LM, Montanari A, Montanari C, Montanari D, Zetina LMM, Moon J, Mooney M, Moor A, Moreno D, Morgan B, Morris C, Mossey C, Motuk E, Moura CA, Mousseau J, Mu W, Mualem L, Mueller J, Muether M, Mufson S, Muheim F, Muir A, Mulhearn M, Muramatsu H, Murphy S, Musser J, Nachtman J, Nagu S, Nalbandyan M, Nandakumar R, Naples D, Narita S, Navas-Nicolás D, Nayak N, Nebot-Guinot M, Necib L, Negishi K, Nelson JK, Nesbit J, Nessi M, Newbold D, Newcomer M, Newhart D, Nichol R, Niner E, Nishimura K, Norman A, Norrick A, Northrop R, Novella P, Nowak JA, Oberling M, Del Campo AO, Olivier A, Onel Y, Onishchuk Y, Ott J, Pagani L, Pakvasa S, Palamara O, Palestini S, Paley JM, Pallavicini M, Palomares C, Pantic E, Paolone V, Papadimitriou V, Papaleo R, Papanestis A, Paramesvaran S, Park JC, Parke S, Parsa Z, Parvu M, Pascoli S, Pasqualini L, Pasternak J, Pater J, Patrick C, Patrizii L, Patterson RB, Patton SJ, Patzak T, Paudel A, Paulos B, Paulucci L, Pavlovic Z, Pawloski G, Payne D, Pec V, Peeters SJM, Penichot Y, Pennacchio E, Penzo A, Peres OLG, Perry J, Pershey D, Pessina G, Petrillo G, Petta C, Petti R, Piastra F, Pickering L, Pietropaolo F, Pillow J, Pinzino J, Plunkett R, Poling R, Pons X, Poonthottathil N, Pordes S, Potekhin M, Potenza R, Potukuchi BVKS, Pozimski J, Pozzato M, Prakash S, Prakash T, Prince S, Prior G, Pugnere D, Qi K, Qian X, Raaf JL, Raboanary R, Radeka V, Rademacker J, Radics B, Rafique A, Raguzin E, Rai M, Rajaoalisoa M, Rakhno I, Rakotondramanana HT, Rakotondravohitra L, Ramachers YA, Rameika R, Delgado MAR, Ramson B, Rappoldi A, Raselli G, Ratoff P, Ravat S, Razafinime H, Real JS, Rebel B, Redondo D, Reggiani-Guzzo M, Rehak T, Reichenbacher J, Reitzner SD, Renshaw A, Rescia S, Resnati F, Reynolds A, Riccobene G, Rice LCJ, Rielage K, Rigaut Y, Rivera D, Rochester L, Roda M, Rodrigues P, Alonso MJR, Rondon JR, Roeth AJ, Rogers H, Rosauro-Alcaraz S, Rossella M, Rout J, Roy S, Rubbia A, Rubbia C, Russell B, Russell J, Ruterbories D, Saakyan R, Sacerdoti S, Safford T, Sahu N, Sala P, Samios N, Sanchez MC, Sanders DA, Sankey D, Santana S, Santos-Maldonado M, Saoulidou N, Sapienza P, Sarasty C, Sarcevic I, Savage G, Savinov V, Scaramelli A, Scarff A, Scarpelli A, Schaffer T, Schellman H, Schlabach P, Schmitz D, Scholberg K, Schukraft A, Segreto E, Sensenig J, Seong I, Sergi A, Sergiampietri F, Sgalaberna D, Shaevitz MH, Shafaq S, Shamma M, Sharma HR, Sharma R, Shaw T, Shepherd-Themistocleous C, Shin S, Shooltz D, Shrock R, Simard L, Simos N, Sinclair J, Sinev G, Singh J, Singh J, Singh V, Sipos R, Sippach FW, Sirri G, Sitraka A, Siyeon K, Smargianaki D, Smith A, Smith A, Smith E, Smith P, Smolik J, Smy M, Snopok P, Nunes MS, Sobel H, Soderberg M, Salinas CJS, Söldner-Rembold S, Solomey N, Solovov V, Sondheim WE, Sorel M, Soto-Oton J, Sousa A, Soustruznik K, Spagliardi F, Spanu M, Spitz J, Spooner NJC, Spurgeon K, Staley R, Stancari M, Stanco L, Steiner HM, Stewart J, Stillwell B, Stock J, Stocker F, Stocks D, Stokes T, Strait M, Strauss T, Striganov S, Stuart A, Summers D, Surdo A, Susic V, Suter L, Sutera CM, Svoboda R, Szczerbinska B, Szelc AM, Talaga R, Tanaka HA, Oregui BT, Tapper A, Tariq S, Tatar E, Tayloe R, Teklu AM, Tenti M, Terao K, Ternes CA, Terranova F, Testera G, Thea A, Thompson JL, Thorn C, Timm SC, Todd J, Tonazzo A, Torti M, Tortola M, Tortorici F, Totani D, Toups M, Touramanis C, Trevor J, Trzaska WH, Tsai YT, Tsamalaidze Z, Tsang KV, Tsverava N, Tufanli S, Tull C, Tyley E, Tzanov M, Uchida MA, Urheim J, Usher T, Vagins MR, Vahle P, Valdiviesso GA, Valencia E, Vallari Z, Valle JWF, Vallecorsa S, Berg RV, de Water RGV, Forero DV, Varanini F, Vargas D, Varner G, Vasel J, Vasseur G, Vaziri K, Ventura S, Verdugo A, Vergani S, Vermeulen MA, Verzocchi M, de Souza HV, Vignoli C, Vilela C, Viren B, Vrba T, Wachala T, Waldron AV, Wallbank M, Wang H, Wang J, Wang Y, Wang Y, Warburton K, Warner D, Wascko M, Waters D, Watson A, Weatherly P, Weber A, Weber M, Wei H, Weinstein A, Wenman D, Wetstein M, While MR, White A, Whitehead LH, Whittington D, Wilking MJ, Wilkinson C, Williams Z, Wilson F, Wilson RJ, Wolcott J, Wongjirad T, Wood K, Wood L, Worcester E, Worcester M, Wret C, Wu W, Wu W, Xiao Y, Yang G, Yang T, Yershov N, Yonehara K, Young T, Yu B, Yu J, Zaki R, Zalesak J, Zambelli L, Zamorano B, Zani A, Zazueta L, Zeller GP, Zennamo J, Zeug K, Zhang C, Zhao M, Zhao Y, Zhivun E, Zhu G, Zimmerman ED, Zito M, Zucchelli S, Zuklin J, Zutshi V, Zwaska R. Prospects for beyond the Standard Model physics searches at the Deep Underground Neutrino Experiment: DUNE Collaboration. Eur Phys J C Part Fields 2021; 81:322. [PMID: 34720713 PMCID: PMC8550327 DOI: 10.1140/epjc/s10052-021-09007-w] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 11/10/2020] [Accepted: 02/23/2021] [Indexed: 06/13/2023]
Abstract
The Deep Underground Neutrino Experiment (DUNE) will be a powerful tool for a variety of physics topics. The high-intensity proton beams provide a large neutrino flux, sampled by a near detector system consisting of a combination of capable precision detectors, and by the massive far detector system located deep underground. This configuration sets up DUNE as a machine for discovery, as it enables opportunities not only to perform precision neutrino measurements that may uncover deviations from the present three-flavor mixing paradigm, but also to discover new particles and unveil new interactions and symmetries beyond those predicted in the Standard Model (SM). Of the many potential beyond the Standard Model (BSM) topics DUNE will probe, this paper presents a selection of studies quantifying DUNE's sensitivities to sterile neutrino mixing, heavy neutral leptons, non-standard interactions, CPT symmetry violation, Lorentz invariance violation, neutrino trident production, dark matter from both beam induced and cosmogenic sources, baryon number violation, and other new physics topics that complement those at high-energy colliders and significantly extend the present reach.
Collapse
Grants
- MR/T019530/1 Medical Research Council
- MR/T041323/1 Medical Research Council
- MSMT, Czech Republic
- NRF, South Korea
- Canadian Network for Research and Innovation in Machining Technology, Natural Sciences and Engineering Research Council of Canada
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- SERI, Switzerland
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- U.S. Department of Energy
- CERN
- Türkiye Bilimsel ve Teknolojik Arastirma Kurumu
- The Royal Society, United Kingdom
- Canada Foundation for Innovation
- U.S. NSF
- FCT, Portugal
- CEA, France
- CNRS/IN2P3, France
- European Regional Development Fund
- Science and Technology Facilities Council
- H2020-EU, European Union
- IPP, Canada
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
- CAM, Spain
- MSCA, European Union
- Instituto Nazionale di Fisica Nucleare
- Fundacção de Amparo à Pesquisa do Estado de Goiás
- Ministerio de Ciencia e Innovación
- Fundacion “La Caixa” Spain
Collapse
Affiliation(s)
- B. Abi
- University of Oxford, Oxford, OX1 3RH UK
| | - R. Acciarri
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - M. A. Acero
- Universidad del Atlántico, Barranquilla, Atlántico Colombia
| | - G. Adamov
- Georgian Technical University, Tbilisi, Georgia
| | - D. Adams
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | | | - Z. Ahmad
- Variable Energy Cyclotron Centre, Kolkata, West Bengal 700 064 India
| | - J. Ahmed
- University of Warwick, Coventry, CV4 7AL UK
| | - T. Alion
- University of Sussex, Brighton, BN1 9RH UK
| | - S. Alonso Monsalve
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | - C. Alt
- ETH Zurich, Zurich, Switzerland
| | - J. Anderson
- Argonne National Laboratory, Argonne, IL 60439 USA
| | - C. Andreopoulos
- University of Liverpool, Liverpool, L69 7ZE UK
- STFC Rutherford Appleton Laboratory, Didcot, OX11 0QX UK
| | - M. P. Andrews
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - F. Andrianala
- University of Antananarivo, 101 Antananarivo, Madagascar
| | - S. Andringa
- Laboratório de Instrumentação e Física Experimental de Partículas, 1649-003, Lisbon and, 3004-516 Coimbra, Portugal
| | - A. Ankowski
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025 USA
| | - M. Antonova
- Instituto de Fisica Corpuscular, 46980 Paterna, Valencia Spain
| | - S. Antusch
- University of Basel, 4056 Basel, Switzerland
| | | | - A. Ariga
- University of Bern, 3012 Bern, Switzerland
| | | | | | - J. Asaadi
- University of Texas at Arlington, Arlington, TX 76019 USA
| | - A. Aurisano
- University of Cincinnati, Cincinnati, OH 45221 USA
| | - V. Aushev
- Kyiv National University, Kiev, 01601 Ukraine
| | - D. Autiero
- Institut de Physique des 2 Infinis de Lyon, 69622 Villeurbanne, France
| | - F. Azfar
- University of Oxford, Oxford, OX1 3RH UK
| | - H. Back
- Pacific Northwest National Laboratory, Richland, WA 99352 USA
| | - J. J. Back
- University of Warwick, Coventry, CV4 7AL UK
| | | | - P. Baesso
- University of Bristol, Bristol, BS8 1TL UK
| | - L. Bagby
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - R. Bajou
- Université de Paris, CNRS, Astroparticule et Cosmologie, 75006 Paris, France
| | | | - P. Baldi
- University of California Irvine, Irvine, CA 92697 USA
| | - B. Bambah
- University of Hyderabad, Gachibowli, Hyderabad, 500 046 India
| | - F. Barao
- Instituto Superior Técnico-IST, Universidade de Lisboa, Lisbon, Portugal
- Laboratório de Instrumentação e Física Experimental de Partículas, 1649-003, Lisbon and, 3004-516 Coimbra, Portugal
| | - G. Barenboim
- Instituto de Fisica Corpuscular, 46980 Paterna, Valencia Spain
| | | | - W. Barkhouse
- University of North Dakota, Grand Forks, ND 58202-8357 USA
| | - C. Barnes
- University of Michigan, Ann Arbor, MI 48109 USA
| | - G. Barr
- University of Oxford, Oxford, OX1 3RH UK
| | | | - N. Barros
- Faculdade de Ciências da Universidade de Lisboa-FCUL, 1749-016 Lisbon, Portugal
- Laboratório de Instrumentação e Física Experimental de Partículas, 1649-003, Lisbon and, 3004-516 Coimbra, Portugal
| | - J. L. Barrow
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
- University of Tennessee at Knoxville, Knoxville, TN 37996 USA
| | - A. Bashyal
- Oregon State University, Corvallis, OR 97331 USA
| | - V. Basque
- University of Manchester, Manchester, M13 9PL UK
| | - F. Bay
- Nikhef National Institute of Subatomic Physics, 1098 XG Amsterdam, The Netherlands
| | | | | | - E. Bechetoille
- Institut de Physique des 2 Infinis de Lyon, 69622 Villeurbanne, France
| | - B. Behera
- Colorado State University, Fort Collins, CO 80523 USA
| | - L. Bellantoni
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | | | - V. Bellini
- Università di Catania, 2, 95131 Catania, Italy
- Istituto Nazionale di Fisica Nucleare Sezione di Catania, 95123 Catania, Italy
| | - O. Beltramello
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | - D. Belver
- CIEMAT, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, 28040 Madrid, Spain
| | - N. Benekos
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | - F. Bento Neves
- Laboratório de Instrumentação e Física Experimental de Partículas, 1649-003, Lisbon and, 3004-516 Coimbra, Portugal
| | - J. Berger
- University of Pittsburgh, Pittsburgh, PA 15260 USA
| | - S. Berkman
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - P. Bernardini
- Istituto Nazionale di Fisica Nucleare Sezione di Lecce, 73100 Lecce, Italy
- Università del Salento, 73100 Lecce, Italy
| | | | - H. Berns
- University of California Davis, Davis, CA 95616 USA
| | - S. Bertolucci
- Università del Bologna, 40127 Bologna, Italy
- Istituto Nazionale di Fisica Nucleare Sezione di Bologna, 40127 Bologna, BO Italy
| | - M. Betancourt
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - Y. Bezawada
- University of California Davis, Davis, CA 95616 USA
| | - M. Bhattacharjee
- Indian Institute of Technology Guwahati, Guwahati, 781 039 India
| | - B. Bhuyan
- Indian Institute of Technology Guwahati, Guwahati, 781 039 India
| | - S. Biagi
- Istituto Nazionale di Fisica Nucleare Laboratori Nazionali del Sud, 95123 Catania, Italy
| | - J. Bian
- University of California Irvine, Irvine, CA 92697 USA
| | - M. Biassoni
- Istituto Nazionale di Fisica Nucleare Sezione di Milano Bicocca, 3, 20126 Milan, Italy
| | - K. Biery
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - B. Bilki
- Beykent University, Istanbul, Turkey
- University of Iowa, Iowa City, IA 52242 USA
| | - M. Bishai
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - A. Bitadze
- University of Manchester, Manchester, M13 9PL UK
| | - A. Blake
- Lancaster University, Lancaster, LA1 4YB UK
| | - B. Blanco Siffert
- Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ 21941-901 Brazil
| | | | - G. C. Blazey
- Northern Illinois University, DeKalb, IL 60115 USA
| | - E. Blucher
- University of Chicago, Chicago, IL 60637 USA
| | - J. Boissevain
- Los Alamos National Laboratory, Los Alamos, NM 87545 USA
| | - S. Bolognesi
- CEA/Saclay, IRFU Institut de Recherche sur les Lois Fondamentales de l’Univers, 91191 Gif-sur-Yvette Cedex, France
| | - T. Bolton
- Kansas State University, Manhattan, KS 66506 USA
| | - M. Bonesini
- Istituto Nazionale di Fisica Nucleare Sezione di Milano Bicocca, 3, 20126 Milan, Italy
- Università del Milano-Bicocca, 20126 Milan, Italy
| | - M. Bongrand
- Laboratoire de l’Accélérateur Linéaire, 91440 Orsay, France
| | - F. Bonini
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - A. Booth
- University of Sussex, Brighton, BN1 9RH UK
| | - C. Booth
- University of Sheffield, Sheffield, S3 7RH UK
| | - S. Bordoni
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | - A. Borkum
- University of Sussex, Brighton, BN1 9RH UK
| | - T. Boschi
- Durham University, Durham, DH1 3LE UK
| | - N. Bostan
- University of Iowa, Iowa City, IA 52242 USA
| | - P. Bour
- Czech Technical University, 115 19 Prague 1, Czech Republic
| | - S. B. Boyd
- University of Warwick, Coventry, CV4 7AL UK
| | - D. Boyden
- Northern Illinois University, DeKalb, IL 60115 USA
| | - J. Bracinik
- University of Birmingham, Birmingham, B15 2TT UK
| | - D. Braga
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | | | - A. Brandt
- University of Texas at Arlington, Arlington, TX 76019 USA
| | - J. Bremer
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | - C. Brew
- STFC Rutherford Appleton Laboratory, Didcot, OX11 0QX UK
| | - E. Brianne
- University of Manchester, Manchester, M13 9PL UK
| | - S. J. Brice
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - C. Brizzolari
- Istituto Nazionale di Fisica Nucleare Sezione di Milano Bicocca, 3, 20126 Milan, Italy
- Università del Milano-Bicocca, 20126 Milan, Italy
| | - C. Bromberg
- Michigan State University, East Lansing, MI 48824 USA
| | | | - J. Brooke
- University of Bristol, Bristol, BS8 1TL UK
| | - A. Bross
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - G. Brunetti
- Istituto Nazionale di Fisica Nucleare Sezione di Padova, 35131 Padua, Italy
| | - N. Buchanan
- Colorado State University, Fort Collins, CO 80523 USA
| | - H. Budd
- University of Rochester, Rochester, NY 14627 USA
| | - D. Caiulo
- Institut de Physique des 2 Infinis de Lyon, 69622 Villeurbanne, France
| | - P. Calafiura
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720 USA
| | - J. Calcutt
- Michigan State University, East Lansing, MI 48824 USA
| | - M. Calin
- University of Bucharest, Bucharest, Romania
| | - S. Calvez
- Colorado State University, Fort Collins, CO 80523 USA
| | - E. Calvo
- CIEMAT, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, 28040 Madrid, Spain
| | | | - A. Caminata
- Istituto Nazionale di Fisica Nucleare Sezione di Genova, 16146 Genoa, GE Italy
| | | | - D. Caratelli
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - G. Carini
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - B. Carlus
- Institut de Physique des 2 Infinis de Lyon, 69622 Villeurbanne, France
| | - P. Carniti
- Istituto Nazionale di Fisica Nucleare Sezione di Milano Bicocca, 3, 20126 Milan, Italy
| | | | - H. Carranza
- University of Texas at Arlington, Arlington, TX 76019 USA
| | - A. Castillo
- Universidad Sergio Arboleda, Bogotá, 11022 Colombia
| | | | - C. Cattadori
- Istituto Nazionale di Fisica Nucleare Sezione di Milano Bicocca, 3, 20126 Milan, Italy
| | - F. Cavalier
- Laboratoire de l’Accélérateur Linéaire, 91440 Orsay, France
| | - F. Cavanna
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - S. Centro
- Universtà degli Studi di Padova, 35131 Padua, Italy
| | - G. Cerati
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - A. Cervelli
- Istituto Nazionale di Fisica Nucleare Sezione di Bologna, 40127 Bologna, BO Italy
| | | | - M. Chalifour
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | - C. Chang
- University of California Riverside, Riverside, CA 92521 USA
| | - E. Chardonnet
- Université de Paris, CNRS, Astroparticule et Cosmologie, 75006 Paris, France
| | | | - S. Chattopadhyay
- Variable Energy Cyclotron Centre, Kolkata, West Bengal 700 064 India
| | - J. Chaves
- University of Pennsylvania, Philadelphia, PA 19104 USA
| | - H. Chen
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - M. Chen
- University of California Irvine, Irvine, CA 92697 USA
| | - Y. Chen
- University of Bern, 3012 Bern, Switzerland
| | - D. Cherdack
- University of Houston, Houston, TX 77204 USA
| | - C. Chi
- Columbia University, New York, NY 10027 USA
| | - S. Childress
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | | | - K. Cho
- Korea Institute of Science and Technology Information, Daejeon, 34141 South Korea
| | - S. Choubey
- Harish-Chandra Research Institute, Jhunsi, Allahabad, 211 019 India
| | | | - D. Christian
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - G. Christodoulou
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | - E. Church
- Pacific Northwest National Laboratory, Richland, WA 99352 USA
| | - P. Clarke
- University of Edinburgh, Edinburgh, EH8 9YL UK
| | - T. E. Coan
- Southern Methodist University, Dallas, TX 75275 USA
| | - A. G. Cocco
- Istituto Nazionale di Fisica Nucleare Sezione di Napoli, 80126 Naples, Italy
| | | | - E. Conley
- Duke University, Durham, NC 27708 USA
| | - J. M. Conrad
- Massachusetts Institute of Technology, Cambridge, MA 02139 USA
| | - M. Convery
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025 USA
| | - L. Corwin
- South Dakota School of Mines and Technology, Rapid City, SD 57701 USA
| | - P. Cotte
- CEA/Saclay, IRFU Institut de Recherche sur les Lois Fondamentales de l’Univers, 91191 Gif-sur-Yvette Cedex, France
| | - L. Cremaldi
- University of Mississippi, University, MS 38677 USA
| | | | - J. I. Crespo-Anadón
- CIEMAT, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, 28040 Madrid, Spain
| | - E. Cristaldo
- Universidad Nacional de Asunción, San Lorenzo, Paraguay
| | - R. Cross
- Lancaster University, Lancaster, LA1 4YB UK
| | - C. Cuesta
- CIEMAT, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, 28040 Madrid, Spain
| | - Y. Cui
- University of California Riverside, Riverside, CA 92521 USA
| | - D. Cussans
- University of Bristol, Bristol, BS8 1TL UK
| | - M. Dabrowski
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - H. da Motta
- Centro Brasileiro de Pesquisas Físicas, Rio de Janeiro, RJ 22290-180 Brazil
| | - L. Da Silva Peres
- Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ 21941-901 Brazil
| | - C. David
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
- York University, Toronto, M3J 1P3 Canada
| | - Q. David
- Institut de Physique des 2 Infinis de Lyon, 69622 Villeurbanne, France
| | - G. S. Davies
- University of Mississippi, University, MS 38677 USA
| | - S. Davini
- Istituto Nazionale di Fisica Nucleare Sezione di Genova, 16146 Genoa, GE Italy
| | - J. Dawson
- Université de Paris, CNRS, Astroparticule et Cosmologie, 75006 Paris, France
| | - K. De
- University of Texas at Arlington, Arlington, TX 76019 USA
| | - R. M. De Almeida
- Fluminense Federal University, 9 Icaraí, Niterói, RJ 24220-900 Brazil
| | - P. Debbins
- University of Iowa, Iowa City, IA 52242 USA
| | - I. De Bonis
- Laboratoire d’Annecy-le-Vieux de Physique des Particules, CNRS/IN2P3 and Université Savoie Mont Blanc, 74941 Annecy-le-Vieux, France
| | - M. P. Decowski
- University of Amsterdam, 1098 XG Amsterdam, The Netherlands
- Nikhef National Institute of Subatomic Physics, 1098 XG Amsterdam, The Netherlands
| | | | - P. C. De Holanda
- Universidade Estadual de Campinas, Campinas, SP 13083-970 Brazil
| | | | | | - P. De Jong
- University of Amsterdam, 1098 XG Amsterdam, The Netherlands
- Nikhef National Institute of Subatomic Physics, 1098 XG Amsterdam, The Netherlands
| | - A. Delbart
- CEA/Saclay, IRFU Institut de Recherche sur les Lois Fondamentales de l’Univers, 91191 Gif-sur-Yvette Cedex, France
| | - D. Delepine
- Universidad de Guanajuato, C.P. 37000 Guanajuato, Mexico
| | - M. Delgado
- Universidad Antonio Nariño, Bogotá, Colombia
| | - A. Dell’Acqua
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | - P. De Lurgio
- Argonne National Laboratory, Argonne, IL 60439 USA
| | | | - D. M. DeMuth
- Valley City State University, Valley City, ND 58072 USA
| | - S. Dennis
- University of Cambridge, Cambridge, CB3 0HE UK
| | - C. Densham
- STFC Rutherford Appleton Laboratory, Didcot, OX11 0QX UK
| | - G. Deptuch
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - A. De Roeck
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | - V. De Romeri
- Instituto de Fisica Corpuscular, 46980 Paterna, Valencia Spain
| | | | | | - M. Dias
- Universidade Federal de São Paulo, São Paulo, 09913-030 Brazil
| | - F. Diaz
- Pontificia Universidad Católica del Perú, Lima, Peru
| | - J. S. Díaz
- Indiana University, Bloomington, IN 47405 USA
| | - S. Di Domizio
- Università degli Studi di Genova, Genoa, Italy
- Istituto Nazionale di Fisica Nucleare Sezione di Genova, 16146 Genoa, GE Italy
| | - L. Di Giulio
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | - P. Ding
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - L. Di Noto
- Università degli Studi di Genova, Genoa, Italy
- Istituto Nazionale di Fisica Nucleare Sezione di Genova, 16146 Genoa, GE Italy
| | - C. Distefano
- Istituto Nazionale di Fisica Nucleare Laboratori Nazionali del Sud, 95123 Catania, Italy
| | - R. Diurba
- University of Minnesota Twin Cities, Minneapolis, MN 55455 USA
| | - M. Diwan
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - Z. Djurcic
- Argonne National Laboratory, Argonne, IL 60439 USA
| | - N. Dokania
- Stony Brook University, SUNY, Stony Brook, NY 11794 USA
| | | | - L. Domine
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025 USA
| | - D. Douglas
- Michigan State University, East Lansing, MI 48824 USA
| | - F. Drielsma
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025 USA
| | - D. Duchesneau
- Laboratoire d’Annecy-le-Vieux de Physique des Particules, CNRS/IN2P3 and Université Savoie Mont Blanc, 74941 Annecy-le-Vieux, France
| | - K. Duffy
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - P. Dunne
- Imperial College of Science Technology and Medicine, London, SW7 2BZ UK
| | - T. Durkin
- STFC Rutherford Appleton Laboratory, Didcot, OX11 0QX UK
| | - H. Duyang
- University of South Carolina, Columbia, SC 29208 USA
| | | | - D. A. Dwyer
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720 USA
| | | | - M. Eads
- Northern Illinois University, DeKalb, IL 60115 USA
| | - D. Edmunds
- Michigan State University, East Lansing, MI 48824 USA
| | - J. Eisch
- Iowa State University, Ames, IA 50011 USA
| | - S. Emery
- CEA/Saclay, IRFU Institut de Recherche sur les Lois Fondamentales de l’Univers, 91191 Gif-sur-Yvette Cedex, France
| | | | - C. O. Escobar
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | | | - J. J. Evans
- University of Manchester, Manchester, M13 9PL UK
| | - E. Ewart
- Indiana University, Bloomington, IN 47405 USA
| | | | - K. Fahey
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - A. Falcone
- Istituto Nazionale di Fisica Nucleare Sezione di Milano Bicocca, 3, 20126 Milan, Italy
- Università del Milano-Bicocca, 20126 Milan, Italy
| | - C. Farnese
- Universtà degli Studi di Padova, 35131 Padua, Italy
| | - Y. Farzan
- Institute for Research in Fundamental Sciences, Tehran, Iran
| | - J. Felix
- Universidad de Guanajuato, C.P. 37000 Guanajuato, Mexico
| | | | | | - F. Ferraro
- Università degli Studi di Genova, Genoa, Italy
- Istituto Nazionale di Fisica Nucleare Sezione di Genova, 16146 Genoa, GE Italy
| | - L. Fields
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - A. Filkins
- William and Mary, Williamsburg, VA 23187 USA
| | - F. Filthaut
- Nikhef National Institute of Subatomic Physics, 1098 XG Amsterdam, The Netherlands
- Radboud University, 6525 AJ Nijmegen, The Netherlands
| | | | - W. Flanagan
- University of Dallas, Irving, TX 75062-4736 USA
| | - B. Fleming
- Yale University, New Haven, CT 06520 USA
| | - R. Flight
- University of Rochester, Rochester, NY 14627 USA
| | - J. Fowler
- Duke University, Durham, NC 27708 USA
| | - W. Fox
- Indiana University, Bloomington, IN 47405 USA
| | - J. Franc
- Czech Technical University, 115 19 Prague 1, Czech Republic
| | - K. Francis
- Northern Illinois University, DeKalb, IL 60115 USA
| | - D. Franco
- Yale University, New Haven, CT 06520 USA
| | - J. Freeman
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - J. Freestone
- University of Manchester, Manchester, M13 9PL UK
| | - J. Fried
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - A. Friedland
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025 USA
| | - S. Fuess
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - I. Furic
- University of Florida, Gainesville, FL 32611-8440 USA
| | - A. P. Furmanski
- University of Minnesota Twin Cities, Minneapolis, MN 55455 USA
| | - A. Gago
- Pontificia Universidad Católica del Perú, Lima, Peru
| | | | - A. Gallego-Ros
- CIEMAT, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, 28040 Madrid, Spain
| | - N. Gallice
- Istituto Nazionale di Fisica Nucleare Sezione di Milano, 20133 Milan, Italy
- Università degli Studi di Milano, 20133 Milan, Italy
| | - V. Galymov
- Institut de Physique des 2 Infinis de Lyon, 69622 Villeurbanne, France
| | - E. Gamberini
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | - T. Gamble
- University of Sheffield, Sheffield, S3 7RH UK
| | - R. Gandhi
- Harish-Chandra Research Institute, Jhunsi, Allahabad, 211 019 India
| | - R. Gandrajula
- Michigan State University, East Lansing, MI 48824 USA
| | - S. Gao
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | | | | | - S. Gardiner
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | | | - G. Ge
- Columbia University, New York, NY 10027 USA
| | - B. Gelli
- Universidade Estadual de Campinas, Campinas, SP 13083-970 Brazil
| | | | - S. Gent
- South Dakota State University, Brookings, SD 57007 USA
| | | | - D. Gibin
- Universtà degli Studi di Padova, 35131 Padua, Italy
| | - I. Gil-Botella
- CIEMAT, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, 28040 Madrid, Spain
| | - C. Girerd
- Institut de Physique des 2 Infinis de Lyon, 69622 Villeurbanne, France
| | - A. K. Giri
- Indian Institute of Technology Hyderabad, Hyderabad, 502285 India
| | - D. Gnani
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720 USA
| | - O. Gogota
- Kyiv National University, Kiev, 01601 Ukraine
| | - M. Gold
- University of New Mexico, Albuquerque, NM 87131 USA
| | - S. Gollapinni
- Los Alamos National Laboratory, Los Alamos, NM 87545 USA
| | - K. Gollwitzer
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - R. A. Gomes
- Universidade Federal de Goias, Goiânia, GO 74690-900 Brazil
| | | | | | - F. Gonnella
- University of Birmingham, Birmingham, B15 2TT UK
| | | | | | - O. Goodwin
- University of Manchester, Manchester, M13 9PL UK
| | - S. Goswami
- Physical Research Laboratory, Ahmedabad, 380 009 India
| | - C. Gotti
- Istituto Nazionale di Fisica Nucleare Sezione di Milano Bicocca, 3, 20126 Milan, Italy
| | | | - C. Grace
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720 USA
| | - M. Graham
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025 USA
| | | | - R. Gran
- University of Minnesota Duluth, Duluth, MN 55812 USA
| | - E. Granados
- Universidad de Guanajuato, C.P. 37000 Guanajuato, Mexico
| | - A. Grant
- Daresbury Laboratory, Cheshire, WA4 4AD UK
| | - C. Grant
- Boston University, Boston, MA 02215 USA
| | - D. Gratieri
- Fluminense Federal University, 9 Icaraí, Niterói, RJ 24220-900 Brazil
| | - P. Green
- University of Manchester, Manchester, M13 9PL UK
| | - S. Green
- University of Cambridge, Cambridge, CB3 0HE UK
| | - L. Greenler
- University of Wisconsin Madison, Madison, WI 53706 USA
| | - M. Greenwood
- Oregon State University, Corvallis, OR 97331 USA
| | - J. Greer
- University of Bristol, Bristol, BS8 1TL UK
| | | | - M. Groh
- Indiana University, Bloomington, IN 47405 USA
| | | | - K. Grzelak
- University of Warsaw, 00-927 Warsaw, Poland
| | - W. Gu
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - V. Guarino
- Argonne National Laboratory, Argonne, IL 60439 USA
| | | | - A. Guglielmi
- Istituto Nazionale di Fisica Nucleare Sezione di Padova, 35131 Padua, Italy
| | - B. Guo
- University of South Carolina, Columbia, SC 29208 USA
| | | | | | - P. Guzowski
- University of Manchester, Manchester, M13 9PL UK
| | - M. M. Guzzo
- Universidade Estadual de Campinas, Campinas, SP 13083-970 Brazil
| | - S. Gwon
- Chung-Ang University, Seoul, 06974 South Korea
| | - A. Habig
- University of Minnesota Duluth, Duluth, MN 55812 USA
| | | | - H. Hadavand
- University of Texas at Arlington, Arlington, TX 76019 USA
| | - R. Haenni
- University of Bern, 3012 Bern, Switzerland
| | - A. Hahn
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - J. Haigh
- University of Warwick, Coventry, CV4 7AL UK
| | - J. Haiston
- South Dakota School of Mines and Technology, Rapid City, SD 57701 USA
| | - T. Hamernik
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - P. Hamilton
- Imperial College of Science Technology and Medicine, London, SW7 2BZ UK
| | - J. Han
- University of Pittsburgh, Pittsburgh, PA 15260 USA
| | - K. Harder
- STFC Rutherford Appleton Laboratory, Didcot, OX11 0QX UK
| | - D. A. Harris
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
- York University, Toronto, M3J 1P3 Canada
| | | | - T. Hasegawa
- High Energy Accelerator Research Organization (KEK), Tsukuba, Ibaraki 305-0801 Japan
| | - R. Hatcher
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - E. Hazen
- Boston University, Boston, MA 02215 USA
| | - A. Heavey
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | | | - J. Heise
- Sanford Underground Research Facility, Lead, SD 57754 USA
| | - K. Hennessy
- University of Liverpool, Liverpool, L69 7ZE UK
| | - S. Henry
- University of Rochester, Rochester, NY 14627 USA
| | | | - K. Herner
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - L. Hertel
- University of California Irvine, Irvine, CA 92697 USA
| | - A. S. Hesam
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | - J. Hewes
- University of Cincinnati, Cincinnati, OH 45221 USA
| | - A. Higuera
- University of Houston, Houston, TX 77204 USA
| | - T. Hill
- Idaho State University, Pocatello, ID 83209 USA
| | | | - A. Himmel
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - J. Hoff
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - C. Hohl
- University of Basel, 4056 Basel, Switzerland
| | - A. Holin
- University College London, London, WC1E 6BT UK
| | - E. Hoppe
- Pacific Northwest National Laboratory, Richland, WA 99352 USA
| | | | | | - A. Hourlier
- Massachusetts Institute of Technology, Cambridge, MA 02139 USA
| | - B. Howard
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - R. Howell
- University of Rochester, Rochester, NY 14627 USA
| | - J. Huang
- University of Texas at Austin, Austin, TX 78712 USA
| | - J. Huang
- University of California Davis, Davis, CA 95616 USA
| | - J. Hugon
- Louisiana State University, Baton Rouge, LA 70803 USA
| | - G. Iles
- Imperial College of Science Technology and Medicine, London, SW7 2BZ UK
| | - N. Ilic
- University of Toronto, Toronto, ON M5S 1A1 Canada
| | - A. M. Iliescu
- Istituto Nazionale di Fisica Nucleare Sezione di Bologna, 40127 Bologna, BO Italy
| | - R. Illingworth
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - A. Ioannisian
- Yerevan Institute for Theoretical Physics and Modeling, 0036 Yerevan, Armenia
| | - R. Itay
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025 USA
| | - A. Izmaylov
- Instituto de Fisica Corpuscular, 46980 Paterna, Valencia Spain
| | - E. James
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - B. Jargowsky
- University of California Irvine, Irvine, CA 92697 USA
| | - F. Jediny
- Czech Technical University, 115 19 Prague 1, Czech Republic
| | | | - X. Ji
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - L. Jiang
- Virginia Tech, Blacksburg, VA 24060 USA
| | - S. Jiménez
- CIEMAT, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, 28040 Madrid, Spain
| | - A. Jipa
- University of Bucharest, Bucharest, Romania
| | - A. Joglekar
- University of California Riverside, Riverside, CA 92521 USA
| | - C. Johnson
- Colorado State University, Fort Collins, CO 80523 USA
| | - R. Johnson
- University of Cincinnati, Cincinnati, OH 45221 USA
| | - B. Jones
- University of Texas at Arlington, Arlington, TX 76019 USA
| | - S. Jones
- University College London, London, WC1E 6BT UK
| | - C. K. Jung
- Stony Brook University, SUNY, Stony Brook, NY 11794 USA
| | - T. Junk
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - Y. Jwa
- Columbia University, New York, NY 10027 USA
| | | | - A. Kaboth
- STFC Rutherford Appleton Laboratory, Didcot, OX11 0QX UK
| | - I. Kadenko
- Kyiv National University, Kiev, 01601 Ukraine
| | - F. Kamiya
- Universidade Federal do ABC, Santo André, SP 09210-580 Brazil
| | | | - A. Karcher
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720 USA
| | - M. Karolak
- CEA/Saclay, IRFU Institut de Recherche sur les Lois Fondamentales de l’Univers, 91191 Gif-sur-Yvette Cedex, France
| | - Y. Karyotakis
- Laboratoire d’Annecy-le-Vieux de Physique des Particules, CNRS/IN2P3 and Université Savoie Mont Blanc, 74941 Annecy-le-Vieux, France
| | - S. Kasai
- National Institute of Technology, Kure College, Hiroshima, 737-8506 Japan
| | - S. P. Kasetti
- Louisiana State University, Baton Rouge, LA 70803 USA
| | - L. Kashur
- Colorado State University, Fort Collins, CO 80523 USA
| | - N. Kazaryan
- Yerevan Institute for Theoretical Physics and Modeling, 0036 Yerevan, Armenia
| | - E. Kearns
- Boston University, Boston, MA 02215 USA
| | - P. Keener
- University of Pennsylvania, Philadelphia, PA 19104 USA
| | - K. J. Kelly
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - E. Kemp
- Universidade Estadual de Campinas, Campinas, SP 13083-970 Brazil
| | - W. Ketchum
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | | | - M. Khabibullin
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow, 117312 Russia
| | - A. Khotjantsev
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow, 117312 Russia
| | | | - D. Kim
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | - B. King
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - B. Kirby
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - M. Kirby
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - J. Klein
- University of Pennsylvania, Philadelphia, PA 19104 USA
| | - K. Koehler
- University of Wisconsin Madison, Madison, WI 53706 USA
| | | | - S. Kohn
- University of California Berkeley, Berkeley, CA 94720 USA
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720 USA
| | | | - M. Kordosky
- William and Mary, Williamsburg, VA 23187 USA
| | - T. Kosc
- Institut de Physique des 2 Infinis de Lyon, 69622 Villeurbanne, France
| | - U. Kose
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | | | | | | | - I. Kreslo
- University of Bern, 3012 Bern, Switzerland
| | - Y. Kudenko
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow, 117312 Russia
| | | | - S. Kulagin
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow, 117312 Russia
| | - J. Kumar
- University of Hawaii, Honolulu, HI 96822 USA
| | - R. Kumar
- Punjab Agricultural University, Ludhiana, 141004 India
| | - C. Kuruppu
- University of South Carolina, Columbia, SC 29208 USA
| | - V. Kus
- Czech Technical University, 115 19 Prague 1, Czech Republic
| | - T. Kutter
- Louisiana State University, Baton Rouge, LA 70803 USA
| | - A. Lambert
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720 USA
| | - K. Lande
- University of Pennsylvania, Philadelphia, PA 19104 USA
| | - C. E. Lane
- Drexel University, Philadelphia, PA 19104 USA
| | - K. Lang
- University of Texas at Austin, Austin, TX 78712 USA
| | | | - P. Lasorak
- University of Sussex, Brighton, BN1 9RH UK
| | - D. Last
- University of Pennsylvania, Philadelphia, PA 19104 USA
| | - C. Lastoria
- CIEMAT, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, 28040 Madrid, Spain
| | - A. Laundrie
- University of Wisconsin Madison, Madison, WI 53706 USA
| | - A. Lawrence
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720 USA
| | - I. Lazanu
- University of Bucharest, Bucharest, Romania
| | - R. LaZur
- Colorado State University, Fort Collins, CO 80523 USA
| | - T. Le
- Tufts University, Medford, MA 02155 USA
| | - J. Learned
- University of Hawaii, Honolulu, HI 96822 USA
| | - P. LeBrun
- Institut de Physique des 2 Infinis de Lyon, 69622 Villeurbanne, France
| | - G. Lehmann Miotto
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | - R. Lehnert
- Indiana University, Bloomington, IN 47405 USA
| | | | - M. Leitner
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720 USA
| | - M. Leyton
- Institut de Fìsica d’Altes Energies, Barcelona, Spain
| | - L. Li
- University of California Irvine, Irvine, CA 92697 USA
| | - S. Li
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - S. W. Li
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025 USA
| | - T. Li
- University of Edinburgh, Edinburgh, EH8 9YL UK
| | - Y. Li
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - H. Liao
- Kansas State University, Manhattan, KS 66506 USA
| | - C. S. Lin
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720 USA
| | - S. Lin
- Louisiana State University, Baton Rouge, LA 70803 USA
| | - A. Lister
- University of Wisconsin Madison, Madison, WI 53706 USA
| | | | - J. Liu
- University of California Irvine, Irvine, CA 92697 USA
| | - S. Lockwitz
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - T. Loew
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720 USA
| | - M. Lokajicek
- Institute of Physics, Czech Academy of Sciences, 182 00 Prague 8, Czech Republic
| | - I. Lomidze
- Georgian Technical University, Tbilisi, Georgia
| | - K. Long
- Imperial College of Science Technology and Medicine, London, SW7 2BZ UK
| | - K. Loo
- University of Jyvaskyla, 40014 Jyväskylä, Finland
| | - D. Lorca
- University of Bern, 3012 Bern, Switzerland
| | - T. Lord
- University of Warwick, Coventry, CV4 7AL UK
| | | | - W. C. Louis
- Los Alamos National Laboratory, Los Alamos, NM 87545 USA
| | - K. B. Luk
- University of California Berkeley, Berkeley, CA 94720 USA
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720 USA
| | - X. Luo
- University of California Santa Barbara, Santa Barbara, CA 93106 USA
| | - N. Lurkin
- University of Birmingham, Birmingham, B15 2TT UK
| | - T. Lux
- Institut de Fìsica d’Altes Energies, Barcelona, Spain
| | - V. P. Luzio
- Universidade Federal do ABC, Santo André, SP 09210-580 Brazil
| | - D. MacFarland
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025 USA
| | - A. A. Machado
- Universidade Estadual de Campinas, Campinas, SP 13083-970 Brazil
| | - P. Machado
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | | | - J. R. Macier
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - A. Maddalena
- Laboratori Nazionali del Gran Sasso, L’Aquila, AQ Italy
| | - P. Madigan
- University of California Berkeley, Berkeley, CA 94720 USA
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720 USA
| | - S. Magill
- Argonne National Laboratory, Argonne, IL 60439 USA
| | - K. Mahn
- Michigan State University, East Lansing, MI 48824 USA
| | - A. Maio
- Faculdade de Ciências da Universidade de Lisboa-FCUL, 1749-016 Lisbon, Portugal
- Laboratório de Instrumentação e Física Experimental de Partículas, 1649-003, Lisbon and, 3004-516 Coimbra, Portugal
| | | | - G. Mandrioli
- Istituto Nazionale di Fisica Nucleare Sezione di Bologna, 40127 Bologna, BO Italy
| | - J. Maneira
- Faculdade de Ciências da Universidade de Lisboa-FCUL, 1749-016 Lisbon, Portugal
- Laboratório de Instrumentação e Física Experimental de Partículas, 1649-003, Lisbon and, 3004-516 Coimbra, Portugal
| | - L. Manenti
- University College London, London, WC1E 6BT UK
| | - S. Manly
- University of Rochester, Rochester, NY 14627 USA
| | - A. Mann
- Tufts University, Medford, MA 02155 USA
| | | | | | - A. Marchionni
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - W. Marciano
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - D. Marfatia
- University of Hawaii, Honolulu, HI 96822 USA
| | | | - J. Maricic
- University of Hawaii, Honolulu, HI 96822 USA
| | - F. Marinho
- Universidade Federal de São Carlos, Araras, SP 13604-900 Brazil
| | - A. D. Marino
- University of Colorado Boulder, Boulder, CO 80309 USA
| | - M. Marshak
- University of Minnesota Twin Cities, Minneapolis, MN 55455 USA
| | - C. Marshall
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720 USA
| | | | - J. Marteau
- Institut de Physique des 2 Infinis de Lyon, 69622 Villeurbanne, France
| | - J. Martin-Albo
- Instituto de Fisica Corpuscular, 46980 Paterna, Valencia Spain
| | - N. Martinez
- Kansas State University, Manhattan, KS 66506 USA
| | | | - S. Martynenko
- Stony Brook University, SUNY, Stony Brook, NY 11794 USA
| | - K. Mason
- Tufts University, Medford, MA 02155 USA
| | - A. Mastbaum
- Rutgers University, Piscataway, NJ 08854 USA
| | - M. Masud
- Instituto de Fisica Corpuscular, 46980 Paterna, Valencia Spain
| | - S. Matsuno
- University of Hawaii, Honolulu, HI 96822 USA
| | - J. Matthews
- Louisiana State University, Baton Rouge, LA 70803 USA
| | - C. Mauger
- University of Pennsylvania, Philadelphia, PA 19104 USA
| | - N. Mauri
- Università del Bologna, 40127 Bologna, Italy
- Istituto Nazionale di Fisica Nucleare Sezione di Bologna, 40127 Bologna, BO Italy
| | | | - R. Mazza
- Istituto Nazionale di Fisica Nucleare Sezione di Milano Bicocca, 3, 20126 Milan, Italy
| | - A. Mazzacane
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - E. Mazzucato
- CEA/Saclay, IRFU Institut de Recherche sur les Lois Fondamentales de l’Univers, 91191 Gif-sur-Yvette Cedex, France
| | - E. McCluskey
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - N. McConkey
- University of Manchester, Manchester, M13 9PL UK
| | | | - C. McGrew
- Stony Brook University, SUNY, Stony Brook, NY 11794 USA
| | - A. McNab
- University of Manchester, Manchester, M13 9PL UK
| | - A. Mefodiev
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow, 117312 Russia
| | - P. Mehta
- Jawaharlal Nehru University, New Delhi, 110067 India
| | - P. Melas
- University of Athens, 157 84 Zografou, Greece
| | - M. Mellinato
- Istituto Nazionale di Fisica Nucleare Sezione di Milano Bicocca, 3, 20126 Milan, Italy
- Università del Milano-Bicocca, 20126 Milan, Italy
| | - O. Mena
- Instituto de Fisica Corpuscular, 46980 Paterna, Valencia Spain
| | - S. Menary
- York University, Toronto, M3J 1P3 Canada
| | - H. Mendez
- University of Puerto Rico, Mayagüez, PR 00681 USA
| | - A. Menegolli
- Istituto Nazionale di Fisica Nucleare Sezione di Pavia, 27100 Pavia, Italy
- Università degli Studi di Pavia, 27100 Pavia, PV Italy
| | - G. Meng
- Istituto Nazionale di Fisica Nucleare Sezione di Padova, 35131 Padua, Italy
| | | | - W. Metcalf
- Louisiana State University, Baton Rouge, LA 70803 USA
| | - M. Mewes
- Indiana University, Bloomington, IN 47405 USA
| | - H. Meyer
- Wichita State University, Wichita, KS 67260 USA
| | - T. Miao
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - G. Michna
- South Dakota State University, Brookings, SD 57007 USA
| | - T. Miedema
- Nikhef National Institute of Subatomic Physics, 1098 XG Amsterdam, The Netherlands
- Radboud University, 6525 AJ Nijmegen, The Netherlands
| | - J. Migenda
- University of Sheffield, Sheffield, S3 7RH UK
| | - R. Milincic
- University of Hawaii, Honolulu, HI 96822 USA
| | - W. Miller
- University of Minnesota Twin Cities, Minneapolis, MN 55455 USA
| | - J. Mills
- Tufts University, Medford, MA 02155 USA
| | - C. Milne
- Idaho State University, Pocatello, ID 83209 USA
| | - O. Mineev
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow, 117312 Russia
| | - O. G. Miranda
- Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (Cinvestav), Mexico City, Mexico
| | - S. Miryala
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - C. S. Mishra
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - S. R. Mishra
- University of South Carolina, Columbia, SC 29208 USA
| | - A. Mislivec
- University of Minnesota Twin Cities, Minneapolis, MN 55455 USA
| | - D. Mladenov
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | - I. Mocioiu
- Pennsylvania State University, University Park, PA 16802 USA
| | - K. Moffat
- Durham University, Durham, DH1 3LE UK
| | - N. Moggi
- Università del Bologna, 40127 Bologna, Italy
- Istituto Nazionale di Fisica Nucleare Sezione di Bologna, 40127 Bologna, BO Italy
| | - R. Mohanta
- University of Hyderabad, Gachibowli, Hyderabad, 500 046 India
| | - T. A. Mohayai
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - N. Mokhov
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - J. Molina
- Universidad Nacional de Asunción, San Lorenzo, Paraguay
| | | | - A. Montanari
- Istituto Nazionale di Fisica Nucleare Sezione di Bologna, 40127 Bologna, BO Italy
| | - C. Montanari
- Istituto Nazionale di Fisica Nucleare Sezione di Pavia, 27100 Pavia, Italy
- Università degli Studi di Pavia, 27100 Pavia, PV Italy
| | - D. Montanari
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - L. M. Montano Zetina
- Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (Cinvestav), Mexico City, Mexico
| | - J. Moon
- Massachusetts Institute of Technology, Cambridge, MA 02139 USA
| | - M. Mooney
- Colorado State University, Fort Collins, CO 80523 USA
| | - A. Moor
- University of Cambridge, Cambridge, CB3 0HE UK
| | - D. Moreno
- Universidad Antonio Nariño, Bogotá, Colombia
| | - B. Morgan
- University of Warwick, Coventry, CV4 7AL UK
| | - C. Morris
- University of Houston, Houston, TX 77204 USA
| | - C. Mossey
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - E. Motuk
- University College London, London, WC1E 6BT UK
| | - C. A. Moura
- Universidade Federal do ABC, Santo André, SP 09210-580 Brazil
| | - J. Mousseau
- University of Michigan, Ann Arbor, MI 48109 USA
| | - W. Mu
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - L. Mualem
- California Institute of Technology, Pasadena, CA 91125 USA
| | - J. Mueller
- Colorado State University, Fort Collins, CO 80523 USA
| | - M. Muether
- Wichita State University, Wichita, KS 67260 USA
| | - S. Mufson
- Indiana University, Bloomington, IN 47405 USA
| | - F. Muheim
- University of Edinburgh, Edinburgh, EH8 9YL UK
| | - A. Muir
- Daresbury Laboratory, Cheshire, WA4 4AD UK
| | - M. Mulhearn
- University of California Davis, Davis, CA 95616 USA
| | - H. Muramatsu
- University of Minnesota Twin Cities, Minneapolis, MN 55455 USA
| | | | - J. Musser
- Indiana University, Bloomington, IN 47405 USA
| | | | - S. Nagu
- University of Lucknow, Lucknow, Uttar Pradesh 226007 India
| | - M. Nalbandyan
- Yerevan Institute for Theoretical Physics and Modeling, 0036 Yerevan, Armenia
| | - R. Nandakumar
- STFC Rutherford Appleton Laboratory, Didcot, OX11 0QX UK
| | - D. Naples
- University of Pittsburgh, Pittsburgh, PA 15260 USA
| | - S. Narita
- Iwate University, Morioka, Iwate 020-8551 Japan
| | - D. Navas-Nicolás
- CIEMAT, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, 28040 Madrid, Spain
| | - N. Nayak
- University of California Irvine, Irvine, CA 92697 USA
| | | | - L. Necib
- California Institute of Technology, Pasadena, CA 91125 USA
| | - K. Negishi
- Iwate University, Morioka, Iwate 020-8551 Japan
| | | | - J. Nesbit
- University of Wisconsin Madison, Madison, WI 53706 USA
| | - M. Nessi
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | - D. Newbold
- STFC Rutherford Appleton Laboratory, Didcot, OX11 0QX UK
| | - M. Newcomer
- University of Pennsylvania, Philadelphia, PA 19104 USA
| | - D. Newhart
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - R. Nichol
- University College London, London, WC1E 6BT UK
| | - E. Niner
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | | | - A. Norman
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - A. Norrick
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - R. Northrop
- University of Chicago, Chicago, IL 60637 USA
| | - P. Novella
- Instituto de Fisica Corpuscular, 46980 Paterna, Valencia Spain
| | | | - M. Oberling
- Argonne National Laboratory, Argonne, IL 60439 USA
| | | | - A. Olivier
- University of Rochester, Rochester, NY 14627 USA
| | - Y. Onel
- University of Iowa, Iowa City, IA 52242 USA
| | | | - J. Ott
- University of California Irvine, Irvine, CA 92697 USA
| | - L. Pagani
- University of California Davis, Davis, CA 95616 USA
| | - S. Pakvasa
- University of Hawaii, Honolulu, HI 96822 USA
| | - O. Palamara
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - S. Palestini
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | - J. M. Paley
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - M. Pallavicini
- Università degli Studi di Genova, Genoa, Italy
- Istituto Nazionale di Fisica Nucleare Sezione di Genova, 16146 Genoa, GE Italy
| | - C. Palomares
- CIEMAT, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, 28040 Madrid, Spain
| | - E. Pantic
- University of California Davis, Davis, CA 95616 USA
| | - V. Paolone
- University of Pittsburgh, Pittsburgh, PA 15260 USA
| | | | - R. Papaleo
- Istituto Nazionale di Fisica Nucleare Laboratori Nazionali del Sud, 95123 Catania, Italy
| | - A. Papanestis
- STFC Rutherford Appleton Laboratory, Didcot, OX11 0QX UK
| | | | - J. C. Park
- Chungnam National University, Daejeon, 34134 South Korea
| | - S. Parke
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - Z. Parsa
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - M. Parvu
- University of Bucharest, Bucharest, Romania
| | | | - L. Pasqualini
- Università del Bologna, 40127 Bologna, Italy
- Istituto Nazionale di Fisica Nucleare Sezione di Bologna, 40127 Bologna, BO Italy
| | - J. Pasternak
- Imperial College of Science Technology and Medicine, London, SW7 2BZ UK
| | - J. Pater
- University of Manchester, Manchester, M13 9PL UK
| | - C. Patrick
- University College London, London, WC1E 6BT UK
| | - L. Patrizii
- Istituto Nazionale di Fisica Nucleare Sezione di Bologna, 40127 Bologna, BO Italy
| | | | - S. J. Patton
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720 USA
| | - T. Patzak
- Université de Paris, CNRS, Astroparticule et Cosmologie, 75006 Paris, France
| | - A. Paudel
- Kansas State University, Manhattan, KS 66506 USA
| | - B. Paulos
- University of Wisconsin Madison, Madison, WI 53706 USA
| | - L. Paulucci
- Universidade Federal do ABC, Santo André, SP 09210-580 Brazil
| | - Z. Pavlovic
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - G. Pawloski
- University of Minnesota Twin Cities, Minneapolis, MN 55455 USA
| | - D. Payne
- University of Liverpool, Liverpool, L69 7ZE UK
| | - V. Pec
- University of Sheffield, Sheffield, S3 7RH UK
| | | | - Y. Penichot
- CEA/Saclay, IRFU Institut de Recherche sur les Lois Fondamentales de l’Univers, 91191 Gif-sur-Yvette Cedex, France
| | - E. Pennacchio
- Institut de Physique des 2 Infinis de Lyon, 69622 Villeurbanne, France
| | - A. Penzo
- University of Iowa, Iowa City, IA 52242 USA
| | - O. L. G. Peres
- Universidade Estadual de Campinas, Campinas, SP 13083-970 Brazil
| | - J. Perry
- University of Edinburgh, Edinburgh, EH8 9YL UK
| | | | - G. Pessina
- Istituto Nazionale di Fisica Nucleare Sezione di Milano Bicocca, 3, 20126 Milan, Italy
| | - G. Petrillo
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025 USA
| | - C. Petta
- Università di Catania, 2, 95131 Catania, Italy
- Istituto Nazionale di Fisica Nucleare Sezione di Catania, 95123 Catania, Italy
| | - R. Petti
- University of South Carolina, Columbia, SC 29208 USA
| | - F. Piastra
- University of Bern, 3012 Bern, Switzerland
| | - L. Pickering
- Michigan State University, East Lansing, MI 48824 USA
| | - F. Pietropaolo
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
- Istituto Nazionale di Fisica Nucleare Sezione di Padova, 35131 Padua, Italy
| | - J. Pillow
- University of Warwick, Coventry, CV4 7AL UK
| | - J. Pinzino
- University of Toronto, Toronto, ON M5S 1A1 Canada
| | - R. Plunkett
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - R. Poling
- University of Minnesota Twin Cities, Minneapolis, MN 55455 USA
| | - X. Pons
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | | | - S. Pordes
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - M. Potekhin
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - R. Potenza
- Università di Catania, 2, 95131 Catania, Italy
- Istituto Nazionale di Fisica Nucleare Sezione di Catania, 95123 Catania, Italy
| | | | - J. Pozimski
- Imperial College of Science Technology and Medicine, London, SW7 2BZ UK
| | - M. Pozzato
- Università del Bologna, 40127 Bologna, Italy
- Istituto Nazionale di Fisica Nucleare Sezione di Bologna, 40127 Bologna, BO Italy
| | - S. Prakash
- Universidade Estadual de Campinas, Campinas, SP 13083-970 Brazil
| | - T. Prakash
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720 USA
| | - S. Prince
- Harvard University, Cambridge, MA 02138 USA
| | - G. Prior
- Laboratório de Instrumentação e Física Experimental de Partículas, 1649-003, Lisbon and, 3004-516 Coimbra, Portugal
| | - D. Pugnere
- Institut de Physique des 2 Infinis de Lyon, 69622 Villeurbanne, France
| | - K. Qi
- Stony Brook University, SUNY, Stony Brook, NY 11794 USA
| | - X. Qian
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - J. L. Raaf
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - R. Raboanary
- University of Antananarivo, 101 Antananarivo, Madagascar
| | - V. Radeka
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | | | | | - A. Rafique
- Argonne National Laboratory, Argonne, IL 60439 USA
| | - E. Raguzin
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - M. Rai
- University of Warwick, Coventry, CV4 7AL UK
| | | | - I. Rakhno
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | | | | | | | - R. Rameika
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | | | - B. Ramson
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - A. Rappoldi
- Istituto Nazionale di Fisica Nucleare Sezione di Pavia, 27100 Pavia, Italy
- Università degli Studi di Pavia, 27100 Pavia, PV Italy
| | - G. Raselli
- Istituto Nazionale di Fisica Nucleare Sezione di Pavia, 27100 Pavia, Italy
- Università degli Studi di Pavia, 27100 Pavia, PV Italy
| | - P. Ratoff
- Lancaster University, Lancaster, LA1 4YB UK
| | - S. Ravat
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | - H. Razafinime
- University of Antananarivo, 101 Antananarivo, Madagascar
| | - J. S. Real
- University Grenoble Alpes, CNRS, Grenoble INP, LPSC-IN2P3, 38000 Grenoble, France
| | - B. Rebel
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
- University of Wisconsin Madison, Madison, WI 53706 USA
| | - D. Redondo
- CIEMAT, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, 28040 Madrid, Spain
| | | | - T. Rehak
- Drexel University, Philadelphia, PA 19104 USA
| | - J. Reichenbacher
- South Dakota School of Mines and Technology, Rapid City, SD 57701 USA
| | - S. D. Reitzner
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - A. Renshaw
- University of Houston, Houston, TX 77204 USA
| | - S. Rescia
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - F. Resnati
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | | | - G. Riccobene
- Istituto Nazionale di Fisica Nucleare Laboratori Nazionali del Sud, 95123 Catania, Italy
| | | | - K. Rielage
- Los Alamos National Laboratory, Los Alamos, NM 87545 USA
| | | | - D. Rivera
- University of Pennsylvania, Philadelphia, PA 19104 USA
| | - L. Rochester
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025 USA
| | - M. Roda
- University of Liverpool, Liverpool, L69 7ZE UK
| | | | | | | | | | - H. Rogers
- Colorado State University, Fort Collins, CO 80523 USA
| | | | - M. Rossella
- Istituto Nazionale di Fisica Nucleare Sezione di Pavia, 27100 Pavia, Italy
- Università degli Studi di Pavia, 27100 Pavia, PV Italy
| | - J. Rout
- Jawaharlal Nehru University, New Delhi, 110067 India
| | - S. Roy
- Harish-Chandra Research Institute, Jhunsi, Allahabad, 211 019 India
| | | | - C. Rubbia
- Gran Sasso Science Institute, L’Aquila, Italy
| | - B. Russell
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720 USA
| | - J. Russell
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025 USA
| | | | - R. Saakyan
- University College London, London, WC1E 6BT UK
| | - S. Sacerdoti
- Université de Paris, CNRS, Astroparticule et Cosmologie, 75006 Paris, France
| | - T. Safford
- Michigan State University, East Lansing, MI 48824 USA
| | - N. Sahu
- Indian Institute of Technology Hyderabad, Hyderabad, 502285 India
| | - P. Sala
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
- Istituto Nazionale di Fisica Nucleare Sezione di Milano, 20133 Milan, Italy
| | - N. Samios
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | | | | | - D. Sankey
- STFC Rutherford Appleton Laboratory, Didcot, OX11 0QX UK
| | - S. Santana
- University of Puerto Rico, Mayagüez, PR 00681 USA
| | | | | | - P. Sapienza
- Istituto Nazionale di Fisica Nucleare Laboratori Nazionali del Sud, 95123 Catania, Italy
| | - C. Sarasty
- University of Cincinnati, Cincinnati, OH 45221 USA
| | | | - G. Savage
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - V. Savinov
- University of Pittsburgh, Pittsburgh, PA 15260 USA
| | - A. Scaramelli
- Istituto Nazionale di Fisica Nucleare Sezione di Pavia, 27100 Pavia, Italy
| | - A. Scarff
- University of Sheffield, Sheffield, S3 7RH UK
| | - A. Scarpelli
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - T. Schaffer
- University of Minnesota Duluth, Duluth, MN 55812 USA
| | - H. Schellman
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
- Oregon State University, Corvallis, OR 97331 USA
| | - P. Schlabach
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - D. Schmitz
- University of Chicago, Chicago, IL 60637 USA
| | | | - A. Schukraft
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - E. Segreto
- Universidade Estadual de Campinas, Campinas, SP 13083-970 Brazil
| | - J. Sensenig
- University of Pennsylvania, Philadelphia, PA 19104 USA
| | - I. Seong
- University of California Irvine, Irvine, CA 92697 USA
| | - A. Sergi
- University of Birmingham, Birmingham, B15 2TT UK
| | | | | | | | - S. Shafaq
- Jawaharlal Nehru University, New Delhi, 110067 India
| | - M. Shamma
- University of California Riverside, Riverside, CA 92521 USA
| | | | - R. Sharma
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - T. Shaw
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | | | - S. Shin
- Jeonbuk National University, Jeonju, Jeonrabuk-do 54896 South Korea
| | - D. Shooltz
- Michigan State University, East Lansing, MI 48824 USA
| | - R. Shrock
- Stony Brook University, SUNY, Stony Brook, NY 11794 USA
| | - L. Simard
- Laboratoire de l’Accélérateur Linéaire, 91440 Orsay, France
| | - N. Simos
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | | | - G. Sinev
- Duke University, Durham, NC 27708 USA
| | - J. Singh
- University of Lucknow, Lucknow, Uttar Pradesh 226007 India
| | - J. Singh
- University of Lucknow, Lucknow, Uttar Pradesh 226007 India
| | - V. Singh
- Banaras Hindu University, Varanasi, 221 005 India
- Central University of South Bihar, Gaya, 824236 India
| | - R. Sipos
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | | | - G. Sirri
- Istituto Nazionale di Fisica Nucleare Sezione di Bologna, 40127 Bologna, BO Italy
| | - A. Sitraka
- South Dakota School of Mines and Technology, Rapid City, SD 57701 USA
| | - K. Siyeon
- Chung-Ang University, Seoul, 06974 South Korea
| | | | - A. Smith
- Duke University, Durham, NC 27708 USA
| | - A. Smith
- University of Cambridge, Cambridge, CB3 0HE UK
| | - E. Smith
- Indiana University, Bloomington, IN 47405 USA
| | - P. Smith
- Indiana University, Bloomington, IN 47405 USA
| | - J. Smolik
- Czech Technical University, 115 19 Prague 1, Czech Republic
| | - M. Smy
- University of California Irvine, Irvine, CA 92697 USA
| | - P. Snopok
- Illinois Institute of Technology, Chicago, IL 60616 USA
| | - M. Soares Nunes
- Universidade Estadual de Campinas, Campinas, SP 13083-970 Brazil
| | - H. Sobel
- University of California Irvine, Irvine, CA 92697 USA
| | | | | | | | - N. Solomey
- Wichita State University, Wichita, KS 67260 USA
| | - V. Solovov
- Laboratório de Instrumentação e Física Experimental de Partículas, 1649-003, Lisbon and, 3004-516 Coimbra, Portugal
| | - W. E. Sondheim
- Los Alamos National Laboratory, Los Alamos, NM 87545 USA
| | - M. Sorel
- Instituto de Fisica Corpuscular, 46980 Paterna, Valencia Spain
| | - J. Soto-Oton
- CIEMAT, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, 28040 Madrid, Spain
| | - A. Sousa
- University of Cincinnati, Cincinnati, OH 45221 USA
| | - K. Soustruznik
- Institute of Particle and Nuclear Physics of the Faculty of Mathematics and Physics of the Charles University, 180 00 Prague 8, Czech Republic
| | | | - M. Spanu
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - J. Spitz
- University of Michigan, Ann Arbor, MI 48109 USA
| | | | | | - R. Staley
- University of Birmingham, Birmingham, B15 2TT UK
| | - M. Stancari
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - L. Stanco
- Istituto Nazionale di Fisica Nucleare Sezione di Padova, 35131 Padua, Italy
| | - H. M. Steiner
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720 USA
| | - J. Stewart
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | | | - J. Stock
- South Dakota School of Mines and Technology, Rapid City, SD 57701 USA
| | - F. Stocker
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | - D. Stocks
- Stanford University, Stanford, CA 94305 USA
| | - T. Stokes
- Louisiana State University, Baton Rouge, LA 70803 USA
| | - M. Strait
- University of Minnesota Twin Cities, Minneapolis, MN 55455 USA
| | - T. Strauss
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - S. Striganov
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - A. Stuart
- Universidad de Colima, Colima, Mexico
| | - D. Summers
- University of Mississippi, University, MS 38677 USA
| | - A. Surdo
- Istituto Nazionale di Fisica Nucleare Sezione di Lecce, 73100 Lecce, Italy
| | - V. Susic
- University of Basel, 4056 Basel, Switzerland
| | - L. Suter
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - C. M. Sutera
- Università di Catania, 2, 95131 Catania, Italy
- Istituto Nazionale di Fisica Nucleare Sezione di Catania, 95123 Catania, Italy
| | - R. Svoboda
- University of California Davis, Davis, CA 95616 USA
| | - B. Szczerbinska
- Texas A&M University-Corpus Christi, Corpus Christi, TX 78412 USA
| | - A. M. Szelc
- University of Manchester, Manchester, M13 9PL UK
| | - R. Talaga
- Argonne National Laboratory, Argonne, IL 60439 USA
| | - H. A. Tanaka
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025 USA
| | | | - A. Tapper
- Imperial College of Science Technology and Medicine, London, SW7 2BZ UK
| | - S. Tariq
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - E. Tatar
- Idaho State University, Pocatello, ID 83209 USA
| | - R. Tayloe
- Indiana University, Bloomington, IN 47405 USA
| | - A. M. Teklu
- Stony Brook University, SUNY, Stony Brook, NY 11794 USA
| | - M. Tenti
- Istituto Nazionale di Fisica Nucleare Sezione di Bologna, 40127 Bologna, BO Italy
| | - K. Terao
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025 USA
| | - C. A. Ternes
- Instituto de Fisica Corpuscular, 46980 Paterna, Valencia Spain
| | - F. Terranova
- Istituto Nazionale di Fisica Nucleare Sezione di Milano Bicocca, 3, 20126 Milan, Italy
- Università del Milano-Bicocca, 20126 Milan, Italy
| | - G. Testera
- Istituto Nazionale di Fisica Nucleare Sezione di Genova, 16146 Genoa, GE Italy
| | - A. Thea
- STFC Rutherford Appleton Laboratory, Didcot, OX11 0QX UK
| | | | - C. Thorn
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - S. C. Timm
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - J. Todd
- University of Cincinnati, Cincinnati, OH 45221 USA
| | - A. Tonazzo
- Université de Paris, CNRS, Astroparticule et Cosmologie, 75006 Paris, France
| | - M. Torti
- Istituto Nazionale di Fisica Nucleare Sezione di Milano Bicocca, 3, 20126 Milan, Italy
- Università del Milano-Bicocca, 20126 Milan, Italy
| | - M. Tortola
- Instituto de Fisica Corpuscular, 46980 Paterna, Valencia Spain
| | - F. Tortorici
- Università di Catania, 2, 95131 Catania, Italy
- Istituto Nazionale di Fisica Nucleare Sezione di Catania, 95123 Catania, Italy
| | - D. Totani
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - M. Toups
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | | | - J. Trevor
- California Institute of Technology, Pasadena, CA 91125 USA
| | | | - Y.-T. Tsai
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025 USA
| | | | - K. V. Tsang
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025 USA
| | - N. Tsverava
- Georgian Technical University, Tbilisi, Georgia
| | - S. Tufanli
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | - C. Tull
- Lawrence Berkeley National Laboratory, Berkeley, CA 94720 USA
| | - E. Tyley
- University of Sheffield, Sheffield, S3 7RH UK
| | - M. Tzanov
- Louisiana State University, Baton Rouge, LA 70803 USA
| | | | - J. Urheim
- Indiana University, Bloomington, IN 47405 USA
| | - T. Usher
- SLAC National Accelerator Laboratory, Menlo Park, CA 94025 USA
| | - M. R. Vagins
- Kavli Institute for the Physics and Mathematics of the Universe, Kashiwa, Chiba 277-8583 Japan
| | - P. Vahle
- William and Mary, Williamsburg, VA 23187 USA
| | - G. A. Valdiviesso
- Universidade Federal de Alfenas, Poços de Caldas, MG 37715-400 Brazil
| | - E. Valencia
- William and Mary, Williamsburg, VA 23187 USA
| | - Z. Vallari
- California Institute of Technology, Pasadena, CA 91125 USA
| | - J. W. F. Valle
- Instituto de Fisica Corpuscular, 46980 Paterna, Valencia Spain
| | - S. Vallecorsa
- CERN, The European Organization for Nuclear Research, 1211 Meyrin, Switzerland
| | - R. Van Berg
- University of Pennsylvania, Philadelphia, PA 19104 USA
| | | | | | - F. Varanini
- Istituto Nazionale di Fisica Nucleare Sezione di Padova, 35131 Padua, Italy
| | - D. Vargas
- Institut de Fìsica d’Altes Energies, Barcelona, Spain
| | - G. Varner
- University of Hawaii, Honolulu, HI 96822 USA
| | - J. Vasel
- Indiana University, Bloomington, IN 47405 USA
| | - G. Vasseur
- CEA/Saclay, IRFU Institut de Recherche sur les Lois Fondamentales de l’Univers, 91191 Gif-sur-Yvette Cedex, France
| | - K. Vaziri
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - S. Ventura
- Istituto Nazionale di Fisica Nucleare Sezione di Padova, 35131 Padua, Italy
| | - A. Verdugo
- CIEMAT, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, 28040 Madrid, Spain
| | - S. Vergani
- University of Cambridge, Cambridge, CB3 0HE UK
| | - M. A. Vermeulen
- Nikhef National Institute of Subatomic Physics, 1098 XG Amsterdam, The Netherlands
| | - M. Verzocchi
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | | | - C. Vignoli
- Laboratori Nazionali del Gran Sasso, L’Aquila, AQ Italy
| | - C. Vilela
- Stony Brook University, SUNY, Stony Brook, NY 11794 USA
| | - B. Viren
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - T. Vrba
- Czech Technical University, 115 19 Prague 1, Czech Republic
| | - T. Wachala
- H. Niewodniczański Institute of Nuclear Physics, Polish Academy of Sciences, Cracow, Poland
| | - A. V. Waldron
- Imperial College of Science Technology and Medicine, London, SW7 2BZ UK
| | - M. Wallbank
- University of Cincinnati, Cincinnati, OH 45221 USA
| | - H. Wang
- University of California Los Angeles, Los Angeles, CA 90095 USA
| | - J. Wang
- University of California Davis, Davis, CA 95616 USA
| | - Y. Wang
- University of California Los Angeles, Los Angeles, CA 90095 USA
| | - Y. Wang
- Stony Brook University, SUNY, Stony Brook, NY 11794 USA
| | | | - D. Warner
- Colorado State University, Fort Collins, CO 80523 USA
| | - M. Wascko
- Imperial College of Science Technology and Medicine, London, SW7 2BZ UK
| | - D. Waters
- University College London, London, WC1E 6BT UK
| | - A. Watson
- University of Birmingham, Birmingham, B15 2TT UK
| | | | - A. Weber
- University of Oxford, Oxford, OX1 3RH UK
- STFC Rutherford Appleton Laboratory, Didcot, OX11 0QX UK
| | - M. Weber
- University of Bern, 3012 Bern, Switzerland
| | - H. Wei
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | | | - D. Wenman
- University of Wisconsin Madison, Madison, WI 53706 USA
| | | | - M. R. While
- South Dakota School of Mines and Technology, Rapid City, SD 57701 USA
| | - A. White
- University of Texas at Arlington, Arlington, TX 76019 USA
| | | | | | - M. J. Wilking
- Stony Brook University, SUNY, Stony Brook, NY 11794 USA
| | | | - Z. Williams
- University of Texas at Arlington, Arlington, TX 76019 USA
| | - F. Wilson
- STFC Rutherford Appleton Laboratory, Didcot, OX11 0QX UK
| | - R. J. Wilson
- Colorado State University, Fort Collins, CO 80523 USA
| | | | | | - K. Wood
- Stony Brook University, SUNY, Stony Brook, NY 11794 USA
| | - L. Wood
- Pacific Northwest National Laboratory, Richland, WA 99352 USA
| | - E. Worcester
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - M. Worcester
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - C. Wret
- University of Rochester, Rochester, NY 14627 USA
| | - W. Wu
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - W. Wu
- University of California Irvine, Irvine, CA 92697 USA
| | - Y. Xiao
- University of California Irvine, Irvine, CA 92697 USA
| | - G. Yang
- Stony Brook University, SUNY, Stony Brook, NY 11794 USA
| | - T. Yang
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - N. Yershov
- Institute for Nuclear Research of the Russian Academy of Sciences, Moscow, 117312 Russia
| | - K. Yonehara
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - T. Young
- University of North Dakota, Grand Forks, ND 58202-8357 USA
| | - B. Yu
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - J. Yu
- University of Texas at Arlington, Arlington, TX 76019 USA
| | - R. Zaki
- York University, Toronto, M3J 1P3 Canada
| | - J. Zalesak
- Institute of Physics, Czech Academy of Sciences, 182 00 Prague 8, Czech Republic
| | - L. Zambelli
- Laboratoire d’Annecy-le-Vieux de Physique des Particules, CNRS/IN2P3 and Université Savoie Mont Blanc, 74941 Annecy-le-Vieux, France
| | - B. Zamorano
- University of Granada and CAFPE, 18002 Granada, Spain
| | - A. Zani
- Istituto Nazionale di Fisica Nucleare Sezione di Milano, 20133 Milan, Italy
| | - L. Zazueta
- William and Mary, Williamsburg, VA 23187 USA
| | - G. P. Zeller
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - J. Zennamo
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| | - K. Zeug
- University of Wisconsin Madison, Madison, WI 53706 USA
| | - C. Zhang
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - M. Zhao
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - Y. Zhao
- University of Utah, Salt Lake City, UT 84112 USA
| | - E. Zhivun
- Brookhaven National Laboratory, Upton, NY 11973 USA
| | - G. Zhu
- Ohio State University, Columbus, OH 43210 USA
| | | | - M. Zito
- CEA/Saclay, IRFU Institut de Recherche sur les Lois Fondamentales de l’Univers, 91191 Gif-sur-Yvette Cedex, France
| | - S. Zucchelli
- Università del Bologna, 40127 Bologna, Italy
- Istituto Nazionale di Fisica Nucleare Sezione di Bologna, 40127 Bologna, BO Italy
| | - J. Zuklin
- Institute of Physics, Czech Academy of Sciences, 182 00 Prague 8, Czech Republic
| | - V. Zutshi
- Northern Illinois University, DeKalb, IL 60115 USA
| | - R. Zwaska
- Fermi National Accelerator Laboratory, Batavia, IL 60510 USA
| |
Collapse
|
7
|
Kohlmaier B, Holzmann H, Stiasny K, Leitner M, Zurl C, Strenger V, Kundi M, Zenz W. Effectiveness and Safety of an Intravenous Immune Globulin (IVIG) Preparation in Post-exposure Prophylaxis (PEP) Against Measles in Infants. Front Pediatr 2021; 9:762793. [PMID: 34926346 PMCID: PMC8675579 DOI: 10.3389/fped.2021.762793] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/22/2021] [Accepted: 11/02/2021] [Indexed: 11/13/2022] Open
Abstract
Background: Administration of measles virus (MV)-specific IgG as post-exposure prophylaxis (PEP) is known to effectively prevent measles. Since the introduction of active immunization against measles, the levels of MV-specific IgG antibodies in the population have dropped. Therefore, the concentration of MV-specific antibodies in immunoglobulin products derived from human plasma donors has declined as the proportion of vaccinated donors has increased. Literature on the effectiveness of PEP with current available immunoglobulins is limited. Here we examine the effectiveness of 400 mg/kg intravenous immunoglobulin (IVIG) (IgVena®, Kendrion) as PEP in infants during a measles outbreak in Austria, 2019. Methods: After exposure to a highly contagious measles patient, identified infants were evaluated for eligibility for IVIG PEP. Infants were tested for measles maternal antibodies, if the result was expected to be available within 72 h after exposure. IVIG was administered to eligible infants with negative maternal IgG antibody levels (n = 11), infants with protective levels but result beyond 72 h (n = 2) and infants not tested for maternal IgG antibodies (n = 52). Telephone enquiries were made asking for measles infection. Effectiveness was calculated using exact logistic regression. Samples of four out of seven used IVIG batches were tested for MV-neutralizing antibody capacity. Results: In 63 (96.9%) of 65 infants PEP with IVIG was administered. The parents of two infants declined IVIG PEP. None of the infants with IVIG PEP got measles or symptoms suggestive for measles, but both infants who did not receive PEP were infected. Effectiveness of IVIG PEP was calculated to be 99.3% (CI 95%: 88.7-100%). No serious adverse event of IVIG treatment was observed. The investigation on MV-neutralizing antibody capacity showed a geometric mean titer ranging from 10.0 to 12.7 IU/ml, resulting in a 1.57-2.26-fold higher concentration than postulated as minimum level for immunity. Conclusions: Our findings suggest that the used IVIG preparation provided an at least non-inferior protection rate compared to IVIG preparations derived from donors before the global introduction of standard active immunization against measles.
Collapse
Affiliation(s)
- Benno Kohlmaier
- Department of General Pediatrics, Medical University of Graz, Graz, Austria
| | | | - Karin Stiasny
- Center for Virology, Medical University of Vienna, Vienna, Austria
| | - Manuel Leitner
- Department of General Pediatrics, Medical University of Graz, Graz, Austria
| | - Christoph Zurl
- Department of General Pediatrics, Medical University of Graz, Graz, Austria
| | - Volker Strenger
- Clinical Division of Pediatric Pulmonology and Allergology, Medical University of Graz, Graz, Austria
| | - Michael Kundi
- Department of Environmental Health, Center for Public Health, Medical University of Vienna, Vienna, Austria
| | - Werner Zenz
- Department of General Pediatrics, Medical University of Graz, Graz, Austria
| |
Collapse
|
8
|
Sastre-Perona A, Hoang-Phou S, Leitner M, Meehan S, Okuniewska M. 168 De novo PITX1 expression controls bi-stable network motifs to govern self-renewal in squamous cell carcinoma. J Invest Dermatol 2019. [DOI: 10.1016/j.jid.2019.03.244] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
9
|
Abstract
SummaryThis article provides an overview on current commercially available methods to determine primary haemostasis as a target of drug-mediated anticoagulation. It focuses on whole blood methods only, and references the currently major achievements that have been reported with each method in respect to its clinical use. Advantages and disadvantages of the various methods are presented, based on considerations of platelet physiology, and on feasibility of the procedures.
Collapse
|
10
|
Lippert K, Kedenko L, Antonielli L, Kedenko I, Gemeier C, Leitner M, Kautzky-Willer A, Paulweber B, Hackl E. Gut microbiota dysbiosis associated with glucose metabolism disorders and the metabolic syndrome in older adults. Benef Microbes 2017; 8:545-556. [PMID: 28701081 DOI: 10.3920/bm2016.0184] [Citation(s) in RCA: 200] [Impact Index Per Article: 28.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Abstract
Obesity and associated metabolic disorders have become highly prevalent diseases worldwide, and the human gut microbiota, due to its influence on host energy metabolism, has been attributed an important role therein. This pilot study explores host-microbiota relationships in men and women affected by various types of glucose metabolism disorder. Among 20 individuals aged 58 to 71 years with either normal glucose tolerance, prediabetes, or type 2 diabetes mellitus the gut bacterial communities were compared based on barcoded 454 sequencing of 16S rRNA genes amplified from stool samples. We found that specific microbiota groups were relatively enriched or reduced in different metabolic states. Further, positive or negative associations with clinical manifestations of metabolic disease suggest that these organisms indicate and possibly contribute to metabolic impairment or health. For instance, a higher prevalence of Erysipelotrichaceae and Lachnospiraceae was found associated with metabolic disorders, and the Holdemania and Blautia genera correlated with clinical indicators of an impaired lipid and glucose metabolism. The Bacteroidetes and groups therein, by contrast, displayed inverse relationships with metabolic disease parameters and were found relatively enriched in participants not diagnosed with metabolic syndrome or obesity. Further, the prevalence of specific Clostridia and Rikenellaceae members also pointed towards a healthier metabolic state. Links with diet as an intermediate factor included positive and negative associations of Lachnospiraceae with relative consumption rates of fat and carbohydrates, respectively, and positive associations of Turicibacteraceae with the consumption of protein. Identifying critical roles of major gut microbiota components in metabolic disorders has important translational implications regarding the prevention and treatment of metabolic diseases by means of preventing or reversing dysbiosis and by controlling exacerbating diet and life style factors particularly in sensitive population groups.
Collapse
Affiliation(s)
- K Lippert
- 1 AIT Austrian Institute of Technology GmbH, Bioresources Unit, 3430 Tulln a.d. Donau, Austria
| | - L Kedenko
- 2 First Department of Internal Medicine, Paracelsus Medical University/Salzburger Landeskliniken, 5020 Salzburg, Austria
| | - L Antonielli
- 1 AIT Austrian Institute of Technology GmbH, Bioresources Unit, 3430 Tulln a.d. Donau, Austria
| | - I Kedenko
- 2 First Department of Internal Medicine, Paracelsus Medical University/Salzburger Landeskliniken, 5020 Salzburg, Austria
| | - C Gemeier
- 2 First Department of Internal Medicine, Paracelsus Medical University/Salzburger Landeskliniken, 5020 Salzburg, Austria
| | - M Leitner
- 3 Department of Internal Medicine III, Division of Endocrinology and Metabolism, Unit of Gender Medicine, Medical University of Vienna, 1090 Vienna, Austria
| | - A Kautzky-Willer
- 3 Department of Internal Medicine III, Division of Endocrinology and Metabolism, Unit of Gender Medicine, Medical University of Vienna, 1090 Vienna, Austria
| | - B Paulweber
- 2 First Department of Internal Medicine, Paracelsus Medical University/Salzburger Landeskliniken, 5020 Salzburg, Austria
| | - E Hackl
- 1 AIT Austrian Institute of Technology GmbH, Bioresources Unit, 3430 Tulln a.d. Donau, Austria
| |
Collapse
|
11
|
Owen H, Buckle K, Olm J, Leitner M, Pandey S, Gaughan JB, Sullivan ML, Lees AM, Gibson JS. Isolation of Nocardia mexicana from focal proliferative tenosynovitis and arthritis in a steer. Aust Vet J 2016; 93:170-3. [PMID: 25939264 DOI: 10.1111/avj.12308] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/03/2014] [Revised: 06/14/2014] [Accepted: 08/31/2014] [Indexed: 11/29/2022]
Abstract
CASE REPORT An 18-month-old Charolais steer was presented with lameness and fluctuant swelling of the right stifle joint, which yielded neutrophils on fine-needle aspiration. A diagnosis of bacterial proliferative tenosynovitis and arthritis was made on postmortem and histological examination. Culture and 16S rRNA sequencing identified a Nocardia sp. with 99% homology with the corresponding DNA fragment of N. mexicana DSM 44952. Antimicrobial susceptibility testing revealed the isolate was susceptible to co-trimoxazole and third-generation cephalosporins. CONCLUSION We report the first case, both in Australia and internationally, of proliferative tenosynovitis and arthritis caused by Nocardia spp. infection in a bovine and the first report of pathology attributed to N. mexicana in a veterinary patient. Given the limited susceptibility of the bacteria, the poor antimicrobial penetration that would be expected and the morphological changes that had taken place in the joint; the steer would have required protracted antimicrobial treatment in addition to invasive debridement of the lesion. This case emphasises the importance of routinely performing cytology and extended incubation of cultures in cases of arthritis in order to make ethical and economically viable treatment decisions.
Collapse
Affiliation(s)
- H Owen
- The University of Queensland, School of Veterinary Science, Gatton, Queensland, 4343, Australia
| | | | | | | | | | | | | | | | | |
Collapse
|
12
|
Whittington R, Hockenhull JC, McGuire J, Leitner M, Barr W, Cherry MG, Flentje R, Quinn B, Dundar Y, Dickson R. A systematic review of risk assessment strategies for populations at high risk of engaging in violent behaviour: update 2002-8. Health Technol Assess 2014; 17:i-xiv, 1-128. [PMID: 24176100 DOI: 10.3310/hta17500] [Citation(s) in RCA: 47] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
BACKGROUND This review systematically examines the research literature published in the period 2002-8 on structured violence risk assessment instruments designed for use in mental health services or the criminal justice system. It adopted much broader inclusion criteria than previous reviews in the same area in order to capture and summarise data on the widest possible range of available instruments. OBJECTIVES To address two questions: (1) what study characteristics are associated with a risk assessment instrument score being significantly associated with a violent outcome? and (2) which risk assessment instruments have the highest level of predictive validity for a violent outcome? DATA SOURCES Nineteen bibliographic databases were searched from January 2002 to April 2008, including PsycINFO, MEDLINE, Cumulative Index to Nursing and Allied Health Literature, Allied and Complementary Medicine Database, British Nursing Index, International Bibliography of the Social Sciences, Education Resources Information Centre, The Cochrane Library and Web of Knowledge. REVIEW METHODS Inclusion criteria for studies were (1) evaluation of a structured risk tool; (2) outcome measure of interpersonal violence; (3) participants aged 17 years or over; and (4) participants with a mental disorder and/or at least one offence and/or at least one indictable offence. A series of bivariate analyses using either a chi-squared test or Spearman's rank-order correlation were conducted to explore associations between study characteristics and outcomes. Data from a subset of studies reporting area under the curve (AUC) analysis were combined to provide estimates of mean validity. RESULTS For the overall set of included studies (n = 959), over three-quarters (77%) were conducted in the USA, Canada or the UK. Two-thirds of all studies were conducted with offenders who had either no formal mental health diagnosis (43%) or forensic samples with a formal diagnosis (25%). The Psychopathy Checklist-Revised was tested in the largest number of studies (n = 192). Most studies (78%) reported a statistically significant (p < 0.05) relationship between the instrument score and a violent outcome. Prospective data collection (chi-squared = 4.4, p = 0.035), number of people recruited (U = 27.8, p = 0.012) and number of participants at end point (U = 26.9, p = 0.04) were significantly associated with predictive validity. For those instruments tested in five or more studies reporting AUC values, the General Statistical Information on Recidivism instrument had the highest mean AUC (0.73). LIMITATIONS Agreement between pairs of reviewers in the initial pilot exercises was good but less than perfect, so discrepancies may be present given the complexity and subjectivity of some aspects of violence research. Only five of the seven calendar years (2003-7) are completely covered, with partial coverage of 2002 and 2008. There is no weighting for sample or effect sizes when results from studies are aggregated. CONCLUSIONS A very large number of studies examining the relationship between a structured instrument and a violent outcome were published in this relatively short 7-year period. The general quality of the literature is weak in places (e.g. over-reliance on cross-sectional designs) and a vast range of distinct instruments have been tested to varying degrees. However, there is evidence of some convergence around a small number of high-performing instruments and identification of the components of a high-quality evaluation approach, including AUC analysis. The upper limits (AUC ≥ 0.85) of instrument-based prediction have probably been achieved and are unlikely to be exceeded using instruments alone. FUNDING The National Institute for Health Research Health Technology Assessment and Research for Patient Benefit programmes.
Collapse
Affiliation(s)
- R Whittington
- Health and Community Care Research Unit, University of Liverpool, Liverpool, UK
| | | | | | | | | | | | | | | | | | | |
Collapse
|
13
|
Raut S, Daniels S, Gärtner P, Hunfeld A, Leitner M, Hockley J, Heath A. Factor VIII Bypassing Activity (FEIBA) assays: standardization and development of the 1st NIBSC Working Standard for FEIBA--results from a collaborative study. Haemophilia 2012; 19:304-9. [PMID: 23174010 DOI: 10.1111/hae.12036] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 08/29/2012] [Indexed: 11/30/2022]
Abstract
Factor-Eight-Inhibitor-Bypassing-Activity (FEIBA) is a bypassing-agent used to control spontaneous bleeding or cover surgical interventions in Haemophiliacs who develop neutralizing antibodies against FVIII/FIX. The market lot-release of FEIBA is dependent on specific clot-based assays, carried out by both the manufacturer and regulatory authorities, relative to manufacturer's in-house standards, which are produced on a small-scale and are replaced frequently. We sought to standardize the FEIBA assay by developing a FEIBA primary standard which would be internationally available in sufficiently large quantities, with a predicted lifetime of many years. A collaborative study involving the manufacturer and three regulatory authorities, was carried out in which a candidate material, sample B (06/172), was calibrated by assays relative to the manufacturer's in-house FEIBA standards (C and D). All laboratories used their routine validated methods (16 APTT-assays, 8 ACTIN-FS-assays and 27 DAPTTIN-assays). Intra-laboratory geometric coefficients of variation (GCVs) for candidate B ranged from 3% to 29% (GCVs <9% from majority of labs). Assessment of inter-laboratory variability gave overall GCV values of 6.9% and 4.4% relative to standards C and D, respectively, for all methods. There was good agreement in potency estimation between laboratories using each of the three methods, with the overall potencies by the three methods differing by less than 10% of the overall mean, giving an overall combined potency of 28.0 units per ampoule. All participants agreed that candidate B (06/172) be established as the 1st NIBSC Working Standard for FEIBA with an assigned potency of 28.0 units per ampoule, based on combined results for both methods, relative to either standard C or D.
Collapse
Affiliation(s)
- S Raut
- Haemostasis Section, National Institute for Biological Standards and Control, Potters Bar, Hertfordshire, UK.
| | | | | | | | | | | | | |
Collapse
|
14
|
Hockenhull JC, Whittington R, Leitner M, Barr W, McGuire J, Cherry MG, Flentje R, Quinn B, Dundar Y, Dickson R. A systematic review of prevention and intervention strategies for populations at high risk of engaging in violent behaviour: update 2002-8. Health Technol Assess 2012; 16:1-152. [PMID: 22330980 DOI: 10.3310/hta16030] [Citation(s) in RCA: 38] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
BACKGROUND It has been estimated that violence accounts for more than 1.6 million deaths worldwide each year and these fatal assaults represent only a fraction of all assaults that actually occur. The problem has widespread consequences for the individual and for the wider society in physical, psychological, social and economic terms. A wide range of pharmacological, psychosocial and organisational interventions have been developed with the aim of addressing the problem. This review was designed to examine the effectiveness of these interventions when they are developed in mental health and criminal justice populations. OBJECTIVE To update a previous review that examined the evidence base up to 2002 for a wide range of pharmacological, psychosocial and organisational interventions aimed at reducing violence, and to identify the key variables associated with a significant reduction in violence. DATA SOURCES Nineteen bibliographic databases were searched from January 2002 to April 2008, including PsycINFO (CSA) MEDLINE (Ovid), Cumulative Index to Nursing and Allied Health Literature (CINAHL), Allied and Complementary Medicine Database (AMED), British Nursing Index/Royal College of Nursing, International Bibliography of the Social Sciences (IBSS), Education Resources Information Center (ERIC)/International ERIC, The Cochrane Library (Cochrane reviews, other reviews, clinical trials, methods studies, technology assessments, economic evaluations), Web of Science [Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), Arts & Humanities Citation Index (A&HCI)]. REVIEW METHODS The assessment was carried out according to accepted procedures for conducting and reporting systematic reviews, including identification of studies, application of inclusion criteria, data extraction and appropriate analysis. Studies were included in meta-analyses (MAs) if they followed a randomised control trial (RCT) design and reported data that could be converted into odds ratios (ORs). For each MA, both a fixed-effects model and a random-effects model were fitted, and both Q statistic and I2 estimates of heterogeneity were performed. RESULTS A total of 198 studies were identified as meeting the inclusion criteria; of these, 51 (26%) were RCTs. Bivariate analyses exploring possible sources of variance in whether a study reported a statistically significant result or not, identified six variables with a significant association. An outcome was less likely to be positive if the primary intervention was something other than a psychological or pharmacological intervention, the study was conducted in an penal institution, the comparator was another active treatment or treatment as usual and if a between-groups design had been used. An outcome was more likely to be positive if it was conducted with people with a mental disorder. The variation attributable to these variables when added to a binary logistic regression was not large (Cox and Snell R(2) = 0.12), but not insignificant given the small number of variables included. The pooled results of all included RCTs suggested a statistically significant advantage for interventions over the various comparators [OR 0.59, 95% confidence interval (CI) 0.53 to 0.65, fixed effects; OR 0.35, 95% CI 0.26 to 0.49 random effects, 40 studies]. However, there was high heterogeneity {I(2) = 86, Q = 279 [degrees of freedom (df) = 39], p < 0.0001}, indicating the need for caution in interpreting the observed effect. Analysis by subgroups showed that most results followed a similar pattern, with statistically significant advantages of treatments over comparators being suggested in fixed- and/or random-effects models but in the context of large heterogeneity. Three exceptions were atypical antipsychotic drugs [OR 0.21, 95% CI 0.16 to 0.27, fixed effects; OR 0.24, 95% CI 0.14 to 0.43, random effects; 10 studies, I(2) = 72.2, Q = 32.4 (df = 9), p < 0.0001], psychological interventions [OR 0.63, 95% CI 0.48 to 0.83, fixed effects; OR 0.53, 95% CI 0.31 to 0.93, random effects; nine studies, I(2) = 62.1, Q = 21.1 (df = 8), p = 0.007] and cognitive behavioural therapy (CBT) as a primary intervention [OR 0.61, 95% CI 0.42 to 0.88, fixed effects; OR 0.61, 95% CI 0.37 to 0.99, random effects; seven studies, I(2) = 21.6, Q = 7.65 (df = 6), p = 0.26]. LIMITATIONS The heterogenity of the included studies inhibits both robust MA and the clear application of findings to establishing improvements in clinical practice. CONCLUSIONS Results from this review show small-to-moderate effects for CBT, for all psychological interventions combined, and larger effects for atypical antipsychotic drugs, with relatively low heterogeneity. There is also evidence that interventions targeted at mental health populations, and particularly male groups in community settings, are well supported, as they are more likely to achieve stronger effects than interventions with the other groups. Future work should focus on improving the quality of evidence available and should address the issue of heterogenity in the literature. FUNDING The National Institute for Health Research Health Technology Assessment programme and the Research for Patient Benefit programme.
Collapse
Affiliation(s)
- J C Hockenhull
- Liverpool Reviews and Implementation Group, University of Liverpool, Liverpool, UK
| | | | | | | | | | | | | | | | | | | |
Collapse
|
15
|
Sherman A, Leitner M, Sinani E, Katsovskiy I, Cudkowicz M. Platform for Clinical Trials Data Integration and Sharing as a Unique Industry, Academic, and Foundation Collaboration Resource in ALS Research (P01.091). Neurology 2012. [DOI: 10.1212/wnl.78.1_meetingabstracts.p01.091] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
16
|
Leitner M, Kaufmann V, Mager J, Geiter S, Siegemund A, Wagner L. Evaluation of assay performance monitoring Rivaroxaban with TECHNOCHROM anti-Xa on different analyzers. Thromb Res 2012. [DOI: 10.1016/s0049-3848(12)70120-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
17
|
Leitner M, Riha M, Kaufmann V, Mager J, Geiter S, Wagner L. Evaluation of assay performance monitoring direct thrombin inhibitors with TECHNOCLOT® DTI. Thromb Res 2012. [DOI: 10.1016/s0049-3848(12)70121-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
18
|
Leiss-Holzinger E, Cakmak UD, Heise B, Bouchot JL, Klement EP, Leitner M, Stifter D, Major Z. Evaluation of structural change and local strain distribution in polymers comparatively imaged by FFSA and OCT techniques. EXPRESS POLYM LETT 2012. [DOI: 10.3144/expresspolymlett.2012.27] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
19
|
Morak J, Kumpusch H, Hayn D, Leitner M, Scherr D, Fruhwald FM, Schreier G. Near Field Communication-based telemonitoring with integrated ECG recordings. Appl Clin Inform 2011; 2:481-98. [PMID: 23616890 DOI: 10.4338/aci-2010-12-ra-0078] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/03/2011] [Accepted: 10/11/2011] [Indexed: 11/23/2022] Open
Abstract
OBJECTIVES Telemonitoring of vital signs is an established option in treatment of patients with chronic heart failure (CHF). In order to allow for early detection of atrial fibrillation (AF) which is highly prevalent in the CHF population telemonitoring programs should include electrocardiogram (ECG) signals. It was therefore the aim to extend our current home monitoring system based on mobile phones and Near Field Communication technology (NFC) to enable patients acquiring their ECG signals autonomously in an easy-to-use way. METHODS We prototypically developed a sensing device for the concurrent acquisition of blood pressure and ECG signals. The design of the device equipped with NFC technology and Bluetooth allowed for intuitive interaction with a mobile phone based patient terminal. This ECG monitoring system was evaluated in the course of a clinical pilot trial to assess the system's technical feasibility, usability and patient's adherence to twice daily usage. RESULTS 21 patients (4f, 54 ± 14 years) suffering from CHF were included in the study and were asked to transmit two ECG recordings per day via the telemonitoring system autonomously over a monitoring period of seven days. One patient dropped out from the study. 211 data sets were transmitted over a cumulative monitoring period of 140 days (overall adherence rate 82.2%). 55% and 8% of the transmitted ECG signals were sufficient for ventricular and atrial rhythm assessment, respectively. CONCLUSIONS Although ECG signal quality has to be improved for better AF detection the developed communication design of joining Bluetooth and NFC technology in our telemonitoring system allows for ambulatory ECG acquisition with high adherence rates and system usability in heart failure patients.
Collapse
Affiliation(s)
- J Morak
- Safety and Security Department , AIT Austrian Institute of Technology GmbH, Graz
| | | | | | | | | | | | | |
Collapse
|
20
|
Lyneis C, Leitner D, Leitner M, Taylor C, Abbott S. The third generation superconducting 28 GHz electron cyclotron resonance ion source VENUS (invited). Rev Sci Instrum 2010; 81:02A201. [PMID: 20192320 DOI: 10.1063/1.3271135] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/28/2023]
Abstract
VENUS is a third generation electron cyclotron resonance (ECR) ion source, which incorporates a high field superconducting NbTi magnet structure, a 28 GHz gryotron microwave source and a state of the art closed cycle cryosystem. During the decade from initial concept to regular operation, it has demonstrated both the feasibility and the performance levels of this new generation of ECR ion sources and required innovation on magnet construction, plasma chamber design, and beam transport. In this paper, the development, performance, and major innovations are described as well as a look to the potential to construct a fourth generation ECR ion source.
Collapse
Affiliation(s)
- C Lyneis
- Lawrence Berkeley National Laboratory, One Cyclotron Road, Berkeley, California 94720, USA.
| | | | | | | | | |
Collapse
|
21
|
Persaud A, Kwan JW, Leitner M, Leung KN, Ludewigt B, Tanaka N, Waldron W, Wilde S, Antolak AJ, Morse DH, Raber T. A tandem-based compact dual-energy gamma generator. Rev Sci Instrum 2010; 81:02B904. [PMID: 20192470 DOI: 10.1063/1.3258028] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/28/2023]
Abstract
A dual-energy tandem-type gamma generator has been developed at E. O. Lawrence Berkeley National Laboratory and Sandia National Laboratories. The tandem accelerator geometry allows higher energy nuclear reactions to be reached, thereby allowing more flexible generation of MeV-energy gammas for active interrogation applications. Both positively charged ions and atoms of hydrogen are created from negative ions via a gas stripper. In this paper, we show first results of the working tandem-based gamma generator and that a gas stripper can be utilized in a compact source design. Preliminary results of monoenergetic gamma production are shown.
Collapse
Affiliation(s)
- A Persaud
- E. O. Lawrence Berkeley National Laboratory, 1 Cyclotron Road, Berkeley, California 94720, USA.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
22
|
Devine DM, Leitner M, Perren SM, Boure LP, Pearce SG, Pearce SG. Tissue reaction to implants of different metals: a study using guide wires in cannulated screws. Eur Cell Mater 2009; 18:40-8. [PMID: 19844874 DOI: 10.22203/ecm.v018a04] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/31/2023] Open
Abstract
Cannulated screws, along with guide wires, are typically used for surgical fracture treatment in cancellous bone. Breakage or bending deformation of the guide wire is a clinical concern. Mechanically superior guide wires made of Co-Cr alloys such as MP35N and L605 may reduce the occurrence of mechanical failures when used in combination with conventional (316L stainless steel) cannulated screws. However the possibility of galvanic or crevice corrosion and adverse tissue reaction, exists when using dissimilar materials, particularly in the event that a guide wire breaks, and remains in situ. Therefore, we designed an experiment to determine the tissue reaction to such an in vivo environment. Implant devices were designed to replicate a clinical situation where dissimilar metals can form a galvanic couple. Histological and SEM analyses were used to evaluate tissue response and corrosion of the implants. In this experiment, no adverse in vivo effects were detected from the use of dissimilar materials in a model of a broken guide wire in a cannulated screw.
Collapse
Affiliation(s)
- D M Devine
- AO Research Institute Davos, Clavadelerstrasse 8, CH-7270 Davos, Switzerland.
| | | | | | | | | | | |
Collapse
|
23
|
Calatzis A, Leitner M, Panzer S. Monitoring anticoagulation of primary haemostasis--estimation of platelet function in whole blood assays. Hamostaseologie 2009; 29:279-284. [PMID: 19644601] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/28/2023] Open
Abstract
This article provides an overview on current commercially available methods to determine primary haemostasis as a target of drug-mediated anticoagulation. It focuses on whole blood methods only, and references the currently major achievements that have been reported with each method in respect to its clinical use. Advantages and disadvantages of the various methods are presented, based on considerations of platelet physiology, and on feasibility of the procedures.
Collapse
Affiliation(s)
- A Calatzis
- Department for Transfusion Medicine and Haemostaseology, University Hospital Munich, Munich, Germany
| | | | | |
Collapse
|
24
|
Davidson RC, Logan BG, Barnard JJ, Bieniosek FM, Briggs RJ, Callahan DA, Kireeff Covo M, Celata CM, Cohen RH, Coleman JE, Debonnel CS, Grote DP, Efthimion PC, Eylon S, Friedman A, Gilson EP, Grisham LR, Henestroza E, Kaganovich ID, Kwan JW, Lee EP, Lee WW, Leitner M, Lund SM, Meier WR, Molvik AW, Olson CL, Penn GE, Qin H, Roy PK, Rose DV, Sefkow A, Seidl PA, Sharp WM, Startsev EA, Tabak M, Thoma C, Vay JL, Waldron WL, Wurtele JS, Welch DR, Westenskow GA, Yu SS. US heavy ion beam research for high energy density physics applications and fusion. ACTA ACUST UNITED AC 2006. [DOI: 10.1051/jp4:2006133148] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
|
25
|
Roy PK, Yu SS, Henestroza E, Anders A, Bieniosek FM, Coleman J, Eylon S, Greenway WG, Leitner M, Logan BG, Waldron WL, Welch DR, Thoma C, Sefkow AB, Gilson EP, Efthimion PC, Davidson RC. Drift compression of an intense neutralized ion beam. Phys Rev Lett 2005; 95:234801. [PMID: 16384309 DOI: 10.1103/physrevlett.95.234801] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/09/2005] [Indexed: 05/05/2023]
Abstract
Longitudinal compression of a velocity-tailored, intense neutralized beam at 300 keV, 25 mA has been demonstrated. The compression takes place in a 1-2 m drift section filled with plasma to provide space-charge neutralization. An induction cell produces a head-to-tail velocity ramp that longitudinally compresses the neutralized beam, enhancing the beam peak current by a factor of 50 and producing a pulse duration of about 3 ns. This measurement has been confirmed independently with two different diagnostic systems.
Collapse
Affiliation(s)
- P K Roy
- Lawrence Berkeley National Laboratory, 1 Cyclotron Road, Berkeley, California 94720, USA
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
26
|
Abstract
BACKGROUND Sertindole is an atypical antipsychotic, which is thought to give a lower incidence of extrapyramidal side effects at clinically effective doses than typical antipsychotic drugs. In December 1998, Lundbeck Ltd., the manufacturers of sertindole, voluntarily suspended the availability of the drug due to concerns about cardiac arrhythmia and sudden cardiac death associated with its use. However, based on the advice of an appointed expert group, the Committee for Proprietary Medicinal Products (CPMP) lifted the suspension of sertindole in October 2001, a decision that was ratified by the European Commission on the 26th of June 2002. Lundbeck have committed to the CPMP to carry out two post-marketing surveillance (PMS) studies (which were initiated in July 2002) to provide additional epidemiological data under conditions of normal drug usage. Initial marketing of the product will be restricted and Lundbeck is currently in discussions with the US health authorities (FDA) to investigate whether, and if so when, it would be possible to launch Serdolect in the US market. OBJECTIVES To determine the effects of sertindole compared with placebo, typical and other atypical antipsychotic drugs for schizophrenia and related psychoses. SEARCH STRATEGY Our Initial searches included electronic searches of Biological Abstracts (1980-1999), The Cochrane Library (Issue 1, 1999), The Cochrane Schizophrenia Group's Register (August 2000), EMBASE (1980-1999), LILACS (1982-1996), MEDLINE (1966-1999), PSYNDEX (1977-1995) and PsycLIT (1974-1999). In addition, we searched pharmaceutical databases on the Dialog Corporation Datastar and Dialog services. We searched references of all identified studies for further trials. We contacted the manufacturer of sertindole and authors of trials. We updated the literature search by searching the Cochrane Schizophrenia Group's Trials Register in April 2003. SELECTION CRITERIA All randomised controlled trials that compared sertindole to placebo or other antipsychotic (atypical or typical) drug treatments for patients with schizophrenia or related psychosis . DATA COLLECTION AND ANALYSIS We independently inspected citations and, where possible abstracts; ordered papers for re-inspection and quality assessment and independently extracted data. For homogeneous dichotomous data, we calculated the risk ratio (RR), 95% confidence interval (CI) and, where appropriate, the number needed to treat (NNT) or number needed to harm (NNH) on an intention-to-treat basis. For continuous data, we calculated weighted mean differences (WMD). We inspected all data for heterogeneity. MAIN RESULTS Currently the review includes three studies with a total of 1,104 participants. One was a medium term (eight weeks) placebo controlled study that examined three different doses of sertindole (8, 12 and 20mg/day). The remaining two studies compared the use of sertindole with haloperidol (10mg/day). One was a short term study (six weeks) that looked at four different doses of sertindole (8, 16, 20, 24mg/day) and the other was a long term study (one year) that evaluated the use of sertindole 24mg/day in participants attending outpatients. We excluded two large important studies because they did not report any usable data. (Both had greater than 50% loss to follow-up and data on 'leaving the study early' was inadequately reported). SERTINDOLE VERSUS PLACEBO: Sertindole at 20mg/day was found to be more effective than placebo in terms of BPRS total scores (1 study, n=78, MD 6.2, CI -11.8 to -0.6) and CGI total end point scores (1 study, n=78, MD -0.9, CI -1.6 to -0.2). A marginally statistically significantly greater number of participants that were treated with 20 mg of sertindole were reported to have been 'very much improved' as compared to those taking placebo (1 study, n=102, RR 7.6, CI 1.0 to 57.9, NNT 7.9, CI 4.3 to 41.1). There was no statistically significant difference between sertindole at 8 or 12 mg/day and placebo for these three outcome measures. There were no statistically significant differences between sertindole (8, 12 or 20 mg) and placebo for the incidence of extrapyramidal symptoms, extrapyramidal related events or use of medication to avoid extrapyramidal symptoms. There were no statistically significant differences found between sertindole and placebo for the movement disorders akathisia, cogwheel rigidity, hypertonia and tremor or somnolence. At eight weeks a statistically significant difference between placebo and all sertindole groups (8, 12 and 20 mg) for mean change from baseline in the QT and QTc intervals were observed (p values and SD were not reported). There was a statistically significant greater mean weight gain among participants taking sertindole (20 mg, mean weight gain of 3.3 kg) as compared to placebo (mean weight gain of 0.8 kg; p<0.05). SERTINDOLE VERSUS HALOPERIDOL: At one year, a greater number of participants who were treated with haloperidol as compared to sertindole (24mg/day) were leaving the study early due to any reason (1 study, n=282, RR 0.6, CI 0.4 to 1.0, NNH 8.8, CI 4.7 to 74.0) or non-compliance (1 study, n=282, RR 0.2, CI 0.0 to 0.7, NNH 12.8, CI 7.7 to 37.8). However, at six weeks, there was no statistically significant difference between sertindole (at 8, 16, 20, or 24mg) and haloperidol for this latter outcome. The incidence of EPS was higher among those treated with haloperidol than sertindole at 8, 16, 20 or 24mg/day (8mg: 1 study, n=245, RR 0.1, CI 0.0 to 0.7, NNH 11.4, CI 7.1 to 29.8; 16mg: 1 study, n=252, RR 0.3, CI 0.1 to 1.0, NNH 15.5, CI 8.0 to 217.9; and 20mg: 1 study, n=253, RR 0.2, CI 0.1 to 0.8, NNH 13.7, CI 7.7 to 68.3; 24mg: 2 studies, n=524, RR 0.6, CI 0.4 to 0.8, NNH 8.7, CI 5.4 to 23.0). More participants treated with haloperidol experienced akathisia, tremor and hypertonia than those treated with sertindole (Akathisia - 8mg: 1 study, n=245, RR 0.2, CI 0.1 to 0.5, NNH 6.0, CI 4.1 to 11.2; 16mg: 1 study, n=252, RR 0.1, CI 0.0 to 0.3, NNH 5.4, CI 3.9 9.0; 20mg: 1 study, n=253, RR 0.3, CI 0.2 to 0.7, NNH 7.3, CI 4.6 to 17.9; 24mg: 2 studies, n=524, RR 0.5, CI 0.3 to 0.7, NNH 8.6, CI 5.6 to 18.3. Tremor - 8mg: 1 study, n=245, RR 0.3, CI 0.1 to 0.7, NNH 8.5, CI 5.2 to 24.0; 16mg: 1 study, n=252, RR 0.2, CI 0.1 to 0.5, NNH 7.3, 4.8 to 15.6; 20mg: 1 study, n=253, RR 0.2, CI 0.1 to 0.6, NNH 7.8, CI 4.9 to 18.1; 24mg: 2 studies, n=524, RR 0.4, CI 0.2 to 0.6, NNH 8.2, CI 5.6 to 15.3. For Hypertonic - 24mg: 2 studies, n=524, RR 0.5, CI 0.3 to 0.8, NNH 12.4, CI 7.5 to 35.0; for sertindole 8, 16 and 20mg there was no statistically significant differences between the treatment groups). One study reported that at six weeks, there was a statistically significant greater increase from baseline to final value in mean QTc interval in the sertindole 16, 20 and 24mg groups (20, 26, and 24msec, respectively) than in the haloperidol group (0msec; p value was not reported), but no SD or any other measure of variance for the effect sizes were reported. For one long term study only one participant from the sertindole group (24mg) had a QT interval that exceeded 500msec (1 study, n=282, RR 3.0 CI 0.1 to 73.0), but 11participants treated with Sertindole had QTc intervals of at least 500msec, compared to none in the haloperidol treated group (1 study, n=282, RR 23.0, CI 1.4 to 386.6, NNH 12.8, CI 8.2 to 29.6). At six weeks, fewer participants treated with sertindole at 8mg or 24mg were affected by somnolence than those treated with haloperidol (sertindole 8mg: 1 study, n=245, RR 0.1, CI 0.0 to 0.7, NNH 11.4, CI 7.1 to 29.8; 24mg: 2 studies, n=524, RR 0.6, CI 0.4 to 1.0, NNH 14.8, CI 7.7 to 205.2). The incidence of rhinitis was found to be statistically significantly higher among those taking sertindole at 16 or 24mg as compared to haloperidol (16mg: 1 study, n=252, RR 10.8, CI 1.4 to 82.6, NNH 12.7, CI 7.7 to 36.7; 24mg: 2 studies, n= 524, RR 2.1, CI 1.4 to 3.1, NNH 8.7, CI 5.6 to 18.6). At one year, 33 participants treated with sertindole (24mg) had experienced the sexual adverse event of decreased ejaculatory volume, compared with six participants treated with haloperidol. However the number of included male participants was not reported and therefore the RR could not be calculated. At one year, more participants taking sertindole (24mg/day) had put on weight compared to those taking haloperidol (1 study, n=282, RR 6.3, CI 1.9 to 20.9, NNH 8.8, CI 5.7 to 19.1). At six weeks, all of the sertindole groups showed an increase in body weight from baseline to final evaluation ranging from 1.3kg to 1.9kg, all of which represented a statistically significantly different weight change than that recorded for the haloperidol treatment group (-0.1Kg). However, the actual weight gain for each sertindole dosage group was not reported and no SD or any other measure of variance was given. AUTHORS' CONCLUSIONS Sertindole at a dose of 20mg/day was found to be more antipsychotic than placebo. When used at 8, 12 or 20mg/day it appears to be as acceptable as placebo (in terms of various adverse events including movement disorders and somnolence), but seems to be associated with more cardiac problems (8, 12 or 20mg/day) and an increase in weight gain (20mg/day) than placebo. Sertindole at a dose of 24mg/day was better tolerated than haloperidol (in terms of participants leaving the study early). It was also found to be was associated with fewer movement disorders (at 8, 16, 20 or 24mg/day) and sedation (8 or 24mg/day) than haloperidol. However, it was shown to cause more cardiac anomalies (16, 20 or 24mg/day), weight gain (all doses combined), rhinitis (16 or 24mg/day), and problems with sexual functioning (24mg/day) than haloperidol. One short term study reported that sertindole 16mg/day was the most optimal dose.
Collapse
Affiliation(s)
- R Lewis
- Department of General Practice, North Wales Clinical School, Cardiff University, Gwenfro Unit 5, Wrexham Technology Park, Wrexham, UK, LL13 7YP.
| | | | | |
Collapse
|
27
|
Yu SS, Barnard JJ, Briggs RJ, Callahan-Miller D, Chao LL, Davidson R, Debonnel CS, Eylon S, Friedman A, Henestroza E, Kaganovich I, Kwan JW, Lee EP, Leitner M, Logan BG, Meier W, Peterson PF, Reginato L, Rose D, Roy P, Waldron W, Welch DR. Towards a Modular Point Design for Heavy Ion Fusion. Fusion Science and Technology 2005. [DOI: 10.13182/fst05-a755] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Affiliation(s)
- S. S. Yu
- Lawrence Berkeley National Laboratory, 1 Cyclotron Road, Berkeley, CA, 94720
| | - J. J. Barnard
- Lawrence Livermore National Laboratory, P.O. Box 808, Livermore, CA 94551-0808
| | - R. J. Briggs
- Science Applications International Corporation, 10260 Campus Point, San Diego, CA 92121
| | - D. Callahan-Miller
- Lawrence Livermore National Laboratory, P.O. Box 808, Livermore, CA 94551-0808
| | - L. L. Chao
- Lawrence Berkeley National Laboratory, 1 Cyclotron Road, Berkeley, CA, 94720
| | - R. Davidson
- Princeton Plasma Physics Laboratory, P.O. Box 451, Princeton, NJ 08543-0451
| | - C. S. Debonnel
- Lawrence Berkeley National Laboratory, 1 Cyclotron Road, Berkeley, CA, 94720
- University of California, Dept of Nuclear Engineering, 4155 Etcheverry Hall, Berkeley, CA
| | - S. Eylon
- Lawrence Berkeley National Laboratory, 1 Cyclotron Road, Berkeley, CA, 94720
| | - A. Friedman
- Lawrence Livermore National Laboratory, P.O. Box 808, Livermore, CA 94551-0808
| | - E. Henestroza
- Lawrence Berkeley National Laboratory, 1 Cyclotron Road, Berkeley, CA, 94720
| | - I Kaganovich
- Princeton Plasma Physics Laboratory, P.O. Box 451, Princeton, NJ 08543-0451
| | - J. W. Kwan
- Lawrence Berkeley National Laboratory, 1 Cyclotron Road, Berkeley, CA, 94720
| | - E. P. Lee
- Lawrence Berkeley National Laboratory, 1 Cyclotron Road, Berkeley, CA, 94720
| | - M. Leitner
- Lawrence Berkeley National Laboratory, 1 Cyclotron Road, Berkeley, CA, 94720
| | - B. G. Logan
- Lawrence Berkeley National Laboratory, 1 Cyclotron Road, Berkeley, CA, 94720
| | - W. Meier
- Lawrence Berkeley National Laboratory, 1 Cyclotron Road, Berkeley, CA, 94720
| | - P. F. Peterson
- University of California, Dept of Nuclear Engineering, 4155 Etcheverry Hall, Berkeley, CA
| | - L. Reginato
- Lawrence Berkeley National Laboratory, 1 Cyclotron Road, Berkeley, CA, 94720
| | - D. Rose
- ATK Mission Research, Albuquerque, NM 87110
| | - P Roy
- Lawrence Berkeley National Laboratory, 1 Cyclotron Road, Berkeley, CA, 94720
| | - W. Waldron
- Lawrence Berkeley National Laboratory, 1 Cyclotron Road, Berkeley, CA, 94720
| | | |
Collapse
|
28
|
Abstract
It has been recommended that all patients attending hospital accident and emergency departments in the United Kingdom (UK) with self-harm should be offered adequate psychosocial assessment to identify those at risk of completed suicide or repeated self-harm. This paper focuses on the extent to which this recommendation has been implemented in a large district general hospital in Wales, and compares the characteristics and hospital management of patients who received no specialist assessment with those who were assessed by a psychiatric liaison nurse or a psychiatrist. Data were routinely collected as part of the hospital annual audit procedure and confirm previous findings that guidelines for the general hospital management of self-harm patients have not been well implemented. Whilst we found some evidence that certain high risk patient groups were more likely to receive specialist assessment, this was far from universal. We conclude that if there is to be a reduction in the rate of suicide in Wales and the UK as a whole, it is crucial that services for people who self-harm are more appropriately targeted on patients who are at greatest risk.
Collapse
Affiliation(s)
- W Barr
- Health and Community Care Research Unit, University of Liverpool, Liverpool, UK.
| | | | | |
Collapse
|
29
|
Abstract
In recent years the British government has sought to target service provision both on people with severe enduring mental illness and on those considered to be at risk of suicide. The study reported here suggests these policies may have had unforeseen repercussions on services for people who self-harm but have no identifiable mental illness. This paper compares the hospital management of self-harm patients with and without mental illness. Over the years 1996-2000, a total of 4,329 self-harm patient attendances were recorded at the accident and emergency department of a British hospital. Whilst patients in 63.7% of attendances could reasonably have been considered to have some form of mental illness, we found that in the remaining 36.3% of attendances (where patients had no indicator of mental illness) a particularly poor standard of service was given. We suggest that if government targets for a reduction in the suicide rate are to be met, it is crucial that there should be marked improvements in services for all self-harm patients presenting at accident and emergency departments. However, in improving services we must be vigilant to the danger that targeting those with a mental illness may mean we fail to provide even basic levels of care for others.
Collapse
Affiliation(s)
- W Barr
- Health and Community Care Research Unit, University of Liverpool, Brownlow Hill, Liverpool L69 3GB, UK.
| | | | | |
Collapse
|
30
|
Galabova G, Egerbacher M, Aurich JE, Leitner M, Walter I. Morphological changes of the endometrial epithelium in the bitch during metoestrus and anoestrus. Reprod Domest Anim 2003; 38:415-20. [PMID: 12950696 DOI: 10.1046/j.1439-0531.2003.00459.x] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
Although cyclic changes of the endometrium in dogs involving both stromal and glandular compartments have been described, the fate of the surface epithelium after progressive growth and secretion is still unclear. In the present study, uteri of 43 healthy bitches in metoestrus and anoestrus were examined macroscopically and histologically. Tissue biopsies were taken from three different locations (cranial and middle parts of uterine horns and bifurcation). The stage of the oestrous cycle was determined by evaluation of progesterone and oestradiol levels in plasma hormone and was also confirmed clinically. Crypts formed in the luteal phase were covered with a columnar epithelium which gradually underwent fatty degeneration. In addition, the stromal part of the crypts disappeared and finally, in early anoestrus, epithelial sheaths desquamated and shed off into the uterine lumen. The surface epithelium was replaced by new cuboidal cells proliferating and migrating from the glandular openings. These findings were confirmed by oil red O staining and immunohistochemical detection of proliferation with Ki-67 marker.
Collapse
Affiliation(s)
- G Galabova
- Clinic of Obstetrics, Gynaecology and Andrology and Institute of Histology and Embryology, University of Veterinary Medicine, Veterinärplatz 1, A-1210 Vienna, Austria
| | | | | | | | | |
Collapse
|
31
|
Leitner M, Aurich JE, Galabova G, Aurich C, Walter I. Lectin binding patterns in normal canine endometrium and in bitches with pyometra and cystic endometrial hyperplasia. Histol Histopathol 2003; 18:787-95. [PMID: 12792891 DOI: 10.14670/hh-18.787] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
Cystic endometrial hyperplasia (CEH) and pyometra in the bitch are dioestral syndromes, supposed to be caused by hormonal disturbances and changes in endometrial steroid hormone receptor levels. Histologically, the endometria show cystic dilated glands and, if bacteria succeed in invading the uterus, pyometra may develop in the following metoestrus. In this study, lectin histochemistry was performed on paraffin sections to compare carbohydrate expression of uterine glands and surface epithelium in healthy dogs and in dogs with CEH and pyometra. Lectin binding is a useful tool to identify glycoconjugates, especially of the glycocalyx, which has essential functions in the endometrium during reproduction. Uterine tissue was obtained from 18 healthy bitches in metoestrus or anoestrus and 18 bitches with a clinical diagnosis of CEH or pyometra. Normal endometria showed cycle-dependent changes in SBA, PNA, HPA and UEA binding during metoestrus and anoestrus. LCA did not show cycle-dependent changes and WGA bound to Golgi regions in the apical parts of surface epithelial cells only in metoestrous. Endometria with inflammatory alterations lost cycle-specific lectin binding patterns and, with increasing severity of pathological changes, showed a marked decrease in binding intensity to the glandular and surface epithelial glycocalyx and secretions. In dogs with CEH, unaltered glands with generally strong lectin binding to the glycocoalyx and Golgi regions were found adjacent to altered glands. The decrease of lectin binding in pyometra cases is supposed to be a result of glandular exhaustion after cystic hyperplasia. In addition, bacterial adhesion to sugar residues on the uterine surface epithelium might impede lectin binding.
Collapse
Affiliation(s)
- M Leitner
- Clinic for Obstetrics, Gynaecology and Andrology, Institute of Histology and Embryology, University of Veterinary Medicine, Vienna, Austria
| | | | | | | | | |
Collapse
|
32
|
Wrage M, Glas P, Leitner M. Combined phase locking and beam shaping of a multicore fiber laser by structured mirrors. Opt Lett 2001; 26:980-982. [PMID: 18040507 DOI: 10.1364/ol.26.000980] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/25/2023]
Abstract
We present a novel mirror geometry combining the two features of phase locking and simultaneous beam shaping of the emission of a multicore fiber (MCF) laser. In the experiments we applied a Talbot cavity to a diode-pumped MCF laser with 18 microcores placed on a ring. The feedback mirror consisted of a highly reflecting structure with 18 spokes and a circle in the center deposited on a glass substrate. The spokes increased the discrimination between the supermodes and suppressed independent lasing of the individual emitters. The central dot caused strong diffraction of the output radiation, leading to a shaped beam profile. The output power of the phase-locked MCF laser exceeded 5 W.
Collapse
|
33
|
Wrage M, Glas P, Fischer D, Leitner M, Vysotsky DV, Napartovich AP. Phase locking in a multicore fiber laser by means of a Talbot resonator. Opt Lett 2000; 25:1436-1438. [PMID: 18066240 DOI: 10.1364/ol.25.001436] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/25/2023]
Abstract
We report phase locking of a diode-pumped multicore fiber laser with a circular array of 18 Nd-doped emitters (microcores) acting as an active medium. Phase locking was achieved in a Talbot resonator configuration. We present calculations of the effective reflection coefficients that are due to self-imaging. Far-field distributions and near-field pattern of several supermodes are calculated and compared with experimental results.
Collapse
|
34
|
Cohen S, Mendelson I, Altboum Z, Kobiler D, Elhanany E, Bino T, Leitner M, Inbar I, Rosenberg H, Gozes Y, Barak R, Fisher M, Kronman C, Velan B, Shafferman A. Attenuated nontoxinogenic and nonencapsulated recombinant Bacillus anthracis spore vaccines protect against anthrax. Infect Immun 2000; 68:4549-58. [PMID: 10899854 PMCID: PMC98371 DOI: 10.1128/iai.68.8.4549-4558.2000] [Citation(s) in RCA: 115] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
Several highly attenuated spore-forming nontoxinogenic and nonencapsulated Bacillus anthracis vaccines differing in levels of expression of recombinant protective antigen (rPA) were constructed. Biochemical analyses (including electrospray mass spectroscopy and N terminus amino acid sequencing) as well as biological and immunological tests demonstrated that the rPA retains the characteristics of native PA. A single immunization of guinea pigs with 5 x 10(7) spores of one of these recombinant strains, MASC-10, expressing high levels of rPA (>/=100 microgram/ml) from a constitutive heterologous promoter induced high titers of neutralizing anti-PA antibodies. This immune response was long lasting (at least 12 months) and provided protection against a lethal challenge of virulent (Vollum) anthrax spores. The recombinant B. anthracis spore vaccine appears to be more efficacious than the vegetative cell vaccine. Furthermore, while results clearly suggest a direct correlation between the level of expression of PA and the potency of the vaccine, they also suggest that some B. anthracis spore-associated antigen(s) may contribute in a significant manner to protective immunity.
Collapse
Affiliation(s)
- S Cohen
- Departments of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness-Ziona 74100, Israel
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
35
|
Abstract
BACKGROUND Loxapine is a drug with D2/D3 receptor antagonist activity and a higher affinity for D3 than D2. Some authors have suggested that loxapine is more effective than typical antipsychotics in reducing the negative symptoms of schizophrenia, that extrapyramidal side-effects are not usually seen at clinically effective antipsychotic doses and that it should therefore be classed as atypical. OBJECTIVES To determine the effects of loxapine compared with placebo, typical and other atypical antipsychotic drugs for schizophrenia and related psychoses. SEARCH STRATEGY Electronic searches of Biological Abstracts (1980-1999), The Cochrane Library (Issue 1, 1999), The Cochrane Schizophrenia Group's Register (January 1999), EMBASE (1980-1999), MEDLINE (1966-1999), LILACS (1982-1996), PSYNDEX (1977-1995) and PsycLIT (1974-1999) were undertaken. In addition, pharmaceutical databases on the Dialog Corporation Datastar and Dialog services were searched. References of all identified studies were searched for further trials. Pharmaceutical companies and authors of trials were contacted. SELECTION CRITERIA All randomised controlled clinical trials relevant to the care of schizophrenia that compared loxapine to other treatments. DATA COLLECTION AND ANALYSIS Citations and, where possible, abstracts were independently inspected by reviewers, papers ordered, re-inspected and quality assessed. Data were independently extracted but excluded if loss to follow up was greater than 50%. For homogeneous dichotomous data the risk ratio (RR), 95% confidence interval (CI) and, where appropriate, the number needed to treat (NNT) were calculated on an intention-to-treat basis. For continuous data, weighted mean differences were calculated (WMD). All data were inspected for heterogeneity. MAIN RESULTS Compared to placebo, loxapine is antipsychotic (Global effect - not improved at 6 weeks, n=66, RR 0.6 CI 0.4-0.9 NNT 4 CI 2-62) with similar adverse effect profile to typical drugs. Is as effective as typical drugs in the short term (4-12 weeks) (Global effect - not improved, n=411, RR 0.89 CI 0.7-1.2). Very limited heterogeneous data suggest that, given intramuscularly (IM), loxapine may be at least as sedating as IM haloperidol and thiothixene. REVIEWER'S CONCLUSIONS Loxapine is antipsychotic but its effects are under researched. It is not clearly different from typical drugs in either its positive or adverse effects.
Collapse
Affiliation(s)
- M Fenton
- Leeds Social Service, Leeds Crisis Centre, 3 Spring Rd, Headingley, Leeds, West Yorks, UK, LS6 1AD.
| | | | | | | | | | | |
Collapse
|
36
|
Abstract
BACKGROUND Sertindole is an atypical antipsychotic, which is thought to give a lower incidence of extrapyramidal side effects at clinically effective doses than typical antipsychotic drugs. In December 1998, Lundbeck Ltd., the manufacturers of sertindole, voluntarily suspended the availability of the drug due to concerns about cardiac arrhythmia and sudden cardiac death associated with its use. Sertindole has therefore been withdrawn from the market pending discussion with the European Regulatory Authority over cardiac safety. OBJECTIVES To determine the effects of sertindole compared with placebo, typical and other atypical antipsychotic drugs for schizophrenia and related psychoses. SEARCH STRATEGY Electronic searches of Biological Abstracts (1980-1999), The Cochrane Library (Issue 1, 1999), The Cochrane Schizophrenia Group's Register (January 1999), EMBASE (1980-1999), LILACS (1982-1996), MEDLINE (1966-1999), PSYNDEX (1977-1995) and PsycLIT (1974-1999) were undertaken. In addition, pharmaceutical databases on the Dialog Corporation Datastar and Dialog services were searched. References of all identified studies were searched for further trials. The manufacturer of sertindole and authors of trials were contacted. SELECTION CRITERIA All randomised controlled trials that compared sertindole to placebo or other antipsychotic drug treatments were included by independent assessment. DATA COLLECTION AND ANALYSIS Citations and, where possible, abstracts were independently inspected by reviewers, papers ordered, re-inspected and quality assessed. Data were independently extracted. For homogeneous dichotomous data the risk ratio (RR), 95% confidence interval (CI) and, where appropriate, the number needed to treat (NNT) or numbers needed to harm (NNH) were calculated on an intention-to-treat basis. For continuous data, weighted mean differences (WMD) were calculated. All data were inspected for heterogeneity. MAIN RESULTS Two large important studies were excluded, because they did not report any usable data. The two that were included suggested that sertindole was more antipsychotic than placebo, as acceptable as placebo and better tolerated than haloperidol (NNT=9, RR 0.63 CI 0.41 to 0.96). Sertindole was associated with fewer movement disorders than haloperidol but was shown to cause more weight gain (NNH=9 RR 6.33, CI 1.92 to 20.92), rhinitis (NNH=8, RR 1.74, CI 1,28 to 2.36) and possibly male sexual dysfunction. Cardiac problems (QTc intervals of at least 500msec) were evident even in the randomised trials (NNH=13 RR 23, CI 1.37 to 386.60). REVIEWER'S CONCLUSIONS Because of the cardiac problems, even evident within poorly reported studies, at present sertindole should, if possible, be avoided. If sertindole is to be reintroduced, gold-standard evidence of its clinical benefits will need to far outweigh its real risks.
Collapse
Affiliation(s)
- R Lewis
- NHS Centre for Reviews and Dissemination, University of York, York, North Yorkshire, UK, YO10 5DD.
| | | | | |
Collapse
|
37
|
Abstract
BACKGROUND Typical antipsychotic drugs are widely used as first line treatment for people with schizophrenia. The atypical class of antipsychotic drugs, however, is making important inroads into this approach and zotepine is one such compound. It is a dopamine antagonist and claimed to be to be particularly effective for negative symptoms OBJECTIVES To determine the effects of zotepine compared with placebo, typical and other atypical antipsychotic drugs for schizophrenia and related psychoses. SEARCH STRATEGY Electronic searches of Biological Abstracts (1980-1999), CINAHL (1982-1999), The Cochrane Library (Issue 1, 1999), The Cochrane Schizophrenia Group's Register (January 1999), EMBASE (1980-1999), Dialog Corporation Datastar service (1999), MEDLINE (1966-1999), and PsycLIT (1974-1999) were undertaken. References of all identified studies were searched for further trials. Knoll Pharmaceuticals and authors of trials were contacted. SELECTION CRITERIA All randomised clinical trials that compared zotepine to other treatments for people with schizophrenia or other psychoses were included. DATA COLLECTION AND ANALYSIS Citations and, where possible, abstracts were independently inspected by reviewers, papers ordered, re-inspected and quality assessed. Data were independently extracted. Data were excluded if loss to follow up was greater than 50%. For homogeneous dichotomous data the relative risk (RR), 95% confidence interval (CI) and, where appropriate, the number needed to treat (NNT) and numbers needed to harm (NNH), were calculated on an intention-to-treat basis. For continuous data, weighted mean differences were calculated (WMD). All data were inspected for heterogeneity. MAIN RESULTS All outcomes were short term (4-12 weeks). Limited data suggest that zotepine is an antipsychotic, at least as effective as typical drugs. Mental state measures of 'no clinically important improvement' favour zotepine when compared to other active drugs (n=356, RR 0.8 CI 0.7-0.9, NNT 7 CI 4-22). About one third of people in both zotepine and control groups left the studies before trial completion. Zotepine may result in less movement disorder adverse effects than typical antipsychotic drugs. Trials have not highlighted clear differences between zotepine and other atypical drugs. REVIEWER'S CONCLUSIONS Zotepine may be a valuable addition to the increasing ranks of atypical antipsychotic drugs. More data from already existing studies is urgently needed to increase the confidence in the findings of this review. New data from well planned, conducted and reported long term pragmatic randomised trials are necessary. Otherwise clinical use of zotepine will be based on speculation on the meaning of the findings of short explanatory trials for everyday practice.
Collapse
Affiliation(s)
- M Fenton
- Trent Ward, South Tees Community and Mental Health Services Trust, St Lukes Hospital, Marton Road, Middlesborough, Cleveland, UK, TS4 3EE.
| | | | | | | | | | | | | |
Collapse
|
38
|
Leitner M, Glas P, Sandrock T, Wrage M, Apostolopoulos G, Riedel A, Kostial H, Herfort J, Friedland KJ, Däweritz L. Self-starting mode locking of a Nd:glass fiber laser by use of the third-order nonlinearity of low-temperature-grown GaAs. Opt Lett 1999; 24:1567-1569. [PMID: 18079865 DOI: 10.1364/ol.24.001567] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/25/2023]
Abstract
We present a diode-pumped Nd:glass fiber laser, emitting at 1060 nm, that is passively mode locked by fast nonlinear loss in low-temperature-grown GaAs (LT-GaAs). This new mode-locking mechanism is based on intensity-dependent defocusing in LT-GaAs that occurs after nonresonant generation of free carriers by two-photon absorption. Mode locking is self-starting and produces pulses as short as 4.1 ps.
Collapse
Affiliation(s)
- M Leitner
- Max-Born-Institut für Nichtlineare Optik und Kurzzeitspektroskopie, D-12489 Berlin, Germany
| | | | | | | | | | | | | | | | | | | |
Collapse
|
39
|
Sandrock T, Fischer D, Glas P, Leitner M, Wrage M, Diening A. Diode-pumped 1-W Er-doped fluoride glass M-profile fiber laser emitting at 2.8 mum. Opt Lett 1999; 24:1284-1286. [PMID: 18079781 DOI: 10.1364/ol.24.001284] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/25/2023]
Abstract
We report a novel short-length diode-pumped cw fiber laser with high output power at a wavelength of 2.8mum . The system combines continuous-wave diode pumping at 970 nm, a high doping concentration (5-mol. % ErF(3)) of the active fiber, and an annular geometry of the laser medium, an M-profile fiber. Output powers in excess of 1 W with a slope efficiency of 25% were obtained.
Collapse
|
40
|
Affiliation(s)
- J Dinnes
- NHS Centre for Reviews and Dissemination, University of York, USA
| | | | | | | |
Collapse
|
41
|
Leitner M. Too Rankian for the Freudians, or too Freudian for the Rankians: Otto Rank's contributions to psychoanalysis in the 1920s. J Am Acad Psychoanal 1997; 25:37-70. [PMID: 9284021 DOI: 10.1521/jaap.1.1997.25.1.37] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
|
42
|
Abstract
Conformational mobility of the surface omega loop (Cys-69-Cys-96) in human acetylcholinesterase (HuAChE) was recently implicated in substrate accessibility to the active center and in the mechanism of allosteric modulation of enzymatic activity. We therefore generated and kinetically evaluated the following modifications or replacements in HuAChE: (a) residues at the loop ends, (b) residues involved in putative hydrogen-bond interactions within the loop and between the loop and the protein core, (c) ChEs conserved proline residues within the loop and (d) a deletion of a conserved segment of 5 residues. All the residue replacements, including those of the prolines, had either limited or no effect on enzyme reactivity. These results suggest that unlike the case of lipase, the omega loop in the HuAChE is not involved in large lid-like displacements. In cases where modifications of the loop sequence had some effect on reactivity, the effects could be attributed to an altered position of residue Trp-86 supporting the proposed coupling between the structure of the omega loop and the positioning of the Trp-86 indole moiety, in catalytic activity and in allosterism.
Collapse
Affiliation(s)
- B Velan
- Department of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness-Ziona, Israel
| | | | | | | | | | | | | |
Collapse
|
43
|
Shafferman A, Lustig S, Inbar Y, Halevy M, Schneider P, Bino T, Leitner M, Grosfeld H, Velan B, Schödel F, Cohen S. Alphavirus hybrid virion vaccines. Adv Exp Med Biol 1996; 397:41-7. [PMID: 8718580 DOI: 10.1007/978-1-4899-1382-1_6] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]
Affiliation(s)
- A Shafferman
- Department of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness-Ziona
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
44
|
Velan B, Kronman C, Ordentlich A, Flashner Y, Leitner M, Cohen S, Shafferman A. N-glycosylation of human acetylcholinesterase: effects on activity, stability and biosynthesis. Biochem J 1993; 296 ( Pt 3):649-56. [PMID: 8280063 PMCID: PMC1137746 DOI: 10.1042/bj2960649] [Citation(s) in RCA: 78] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/29/2023]
Abstract
The role of N-glycosylation in the function of human acetylcholinesterase (HuAChE) was examined by site-directed mutagenesis (Asn to Gln substitution) of the three potential N-glycosylation sites Asn-265, Asn-350 and Asn-464. Analysis of HuAChE mutants, defective in a single or multiple N-glycosylation sites, by expression in transiently or stably transfected human embryonal 293 kidney cells suggests the following. (a) All three AChE glycosylation signals are utilized, but not all the secreted molecules are fully glycosylated. (b) Glycosylation at all sites is important for effective biosynthesis and secretion; extracellular AChE levels in mutants defective in one, two or all three sites amounted to 20-30%, 2-4% and about 0.5% of wild-type level respectively. (c) Some glycosylation mutants display impaired stability, as reflected by increased susceptibility to heat inactivation; substitution of Asn-464 has the most pronounced effect on thermostability. (d) Abrogation of N-glycosylation has no detectable effect on the enzyme activity of HuAChE; all glycosylation mutants, including the triple mutant, hydrolyse acetylthiocholine efficiently, displaying Km, kcat. and kcat./Km values similar to those of the wild-type enzyme. (e) In most mutants, inhibition profiles with edrophonium and bisquaternary ammonium ligands are identical with those of wild-type enzyme; the Asn-350 mutants, however, exhibit a slight decrease in their affinity towards these ligands. (f) Elimination of oligosaccharide side chains has no detectable effect on the surface-related 'peripheral-site' functions; like the wild-type enzyme, all mutants were inhibited by propidium and by increased concentrations of acetylthiocholine.
Collapse
Affiliation(s)
- B Velan
- Department of Biochemistry, Israel Institute for Biological Research, Ness-Ziona
| | | | | | | | | | | | | |
Collapse
|
45
|
Ordentlich A, Barak D, Kronman C, Flashner Y, Leitner M, Segall Y, Ariel N, Cohen S, Velan B, Shafferman A. Dissection of the human acetylcholinesterase active center determinants of substrate specificity. Identification of residues constituting the anionic site, the hydrophobic site, and the acyl pocket. J Biol Chem 1993; 268:17083-95. [PMID: 8349597] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/30/2023] Open
Abstract
Substrate specificity determinants of human acetylcholinesterase (HuAChE) were identified by combination of molecular modeling and kinetic studies with enzymes mutated in residues Trp-86, Trp-286, Phe-295, Phe-297, Tyr-337, and Phe-338. The substitution of Trp-86 by alanine resulted in a 660-fold decrease in affinity for acetythiocholine but had no effect on affinity for the isosteric uncharged substrate (3,3-dimethylbutylthioacetate). The results demonstrate that residue Trp-86 is the anionic site which binds, through cation-pi interactions, the quaternary ammonium of choline, and that of active center inhibitors such as edrophonium. The results also suggest that in the non-covalent complex, charged and uncharged substrates with a common acyl moiety (acetyl) bind to different molecular environments. The hydrophobic site for the alcoholic portion of the covalent adduct (tetrahedral intermediate) includes residues Trp-86, Tyr-337, and Phe-338, which operate through nonpolar and/or stacking interactions, depending on the substrate. Substrates containing choline but differing in the acyl moiety (acetyl, propyl, and butyryl) revealed that residues Phe-295 and Phe-297 determine substrate specificity of the acyl pocket for the covalent adducts. Phe-295 also determines substrate specificity in the non-covalent enzyme substrate complex and thus, the HuAChE F295A mutant exhibits over 130-fold increase in the apparent bimolecular rate constant for butyrylthiocholine compared with wild type enzyme. Reactivity toward specific butyrylcholinesterase inhibitors is similarly dependent on the nature of residues at positions 295 and 297. Amino acid Trp-286 at the rim of the active site "gorge" and Trp-86, in the active center, are essential elements in the mechanism of inhibition by propidium, a peripheral anionic site ligand. Molecular modeling and kinetic data suggest that a cross-talk between Trp-286 and Trp-86 can result in reorientation of Trp-86 which may then interfere with stabilization of substrate enzyme complexes. It is proposed that the conformational flexibility of aromatic residues generates a plasticity in the active center that contributes to the high efficiency of AChE and its ability to respond to external stimuli.
Collapse
Affiliation(s)
- A Ordentlich
- Department of Biochemistry, Israel Institute for Biological Research, Ness-Ziona
| | | | | | | | | | | | | | | | | | | |
Collapse
|
46
|
Ordentlich A, Barak D, Kronman C, Flashner Y, Leitner M, Segall Y, Ariel N, Cohen S, Velan B, Shafferman A. Dissection of the human acetylcholinesterase active center determinants of substrate specificity. Identification of residues constituting the anionic site, the hydrophobic site, and the acyl pocket. J Biol Chem 1993. [DOI: 10.1016/s0021-9258(19)85305-x] [Citation(s) in RCA: 259] [Impact Index Per Article: 8.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
47
|
Arnold B, Wertz W, Pötscher BM, Voss D, Shimizu R, Dahlhaus R, Leitner M, Krafft O, Pflug G. Book reviews. METRIKA 1992. [DOI: 10.1007/bf02613982] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
48
|
Kronman C, Velan B, Gozes Y, Leitner M, Flashner Y, Lazar A, Marcus D, Sery T, Papier Y, Grosfeld H. Production and secretion of high levels of recombinant human acetylcholinesterase in cultured cell lines: microheterogeneity of the catalytic subunit. Gene 1992; 121:295-304. [PMID: 1446827 DOI: 10.1016/0378-1119(92)90134-b] [Citation(s) in RCA: 72] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
Abstract
To allow for structural analysis of the human acetylcholinesterase (hAChE) subunit, a series of eukaryotic vectors was designed for efficient expression. Several eukaryotic multicistronic expression vectors were tested in various mammalian cell lines. All expression vectors contained the selectable neo gene under control of a weak promoter, while the hAChE cDNA was under control of the cytomegalovirus (CMV) immediate-early or Rous sarcoma virus long terminal repeat (RSV LTR) or simian virus 40 (SV40) early promoters. Optimal production and secretion of recombinant hAChE (rehAChE) was achieved in the embryonal kidney 293 cell line transfected either with the RSV-hAChE or with CMV-hAChE expression vectors. Clones expressing and secreting as much as 5-25 pg of enzyme per cell per 24 h were obtained without resorting to coamplification techniques or continuous maintenance of cells under selective pressure. The purified (specific activity of 6000 units per mg protein) homodimer and tetramer enzyme molecules displayed typical AChE biochemical properties: a Km value of 120 microM for acetylthiocholine; a kcat value of 3.9 x 10(5)/min, and selective by AChE-specific inhibitors. Catalytic subunit dimers (130 kDa) exhibit differential N-glycosylation patterns, and upon reduction resolve into 67- and 70-kDa monomeric subunits. These two forms appear as a single discrete 62-kDa band following deglycosylation by N-glycanase. The N-terminal amino acid sequence analysis of the purified mature enzyme suggests the existence of two alternative cleavage sites for the removal of the signal peptide, in which the 'mature' position 1 is either Ala31 or Gly33. Both of these positions conform with the consensus signal peptide recognition sequences and demonstrate bidirected processing of signal peptides on a native molecule.
Collapse
Affiliation(s)
- C Kronman
- Department of Biochemistry, Israel Institute for Biological Research, Ness-Ziona
| | | | | | | | | | | | | | | | | | | |
Collapse
|
49
|
Shafferman A, Velan B, Ordentlich A, Kronman C, Grosfeld H, Leitner M, Flashner Y, Cohen S, Barak D, Ariel N. Substrate inhibition of acetylcholinesterase: residues affecting signal transduction from the surface to the catalytic center. EMBO J 1992; 11:3561-8. [PMID: 1396557 PMCID: PMC556814 DOI: 10.1002/j.1460-2075.1992.tb05439.x] [Citation(s) in RCA: 155] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
Abstract
Amino acids located within and around the 'active site gorge' of human acetylcholinesterase (AChE) were substituted. Replacement of W86 yielded inactive enzyme molecules, consistent with its proposed involvement in binding of the choline moiety in the active center. A decrease in affinity to propidium and a concomitant loss of substrate inhibition was observed in D74G, D74N, D74K and W286A mutants, supporting the idea that the site for substrate inhibition and the peripheral anionic site overlap. Mutations of amino acids neighboring the active center (E202, Y337 and F338) resulted in a decrease in the catalytic and the apparent bimolecular rate constants. A decrease in affinity to edrophonium was observed in D74, E202, Y337 and to a lesser extent in F338 and Y341 mutants. E202, Y337 and Y341 mutants were not inhibited efficiently by high substrate concentrations. We propose that binding of acetylcholine, on the surface of AChE, may trigger sequence of conformational changes extending from the peripheral anionic site through W286 to D74, at the entrance of the 'gorge', and down to the catalytic center (through Y341 to F338 and Y337). These changes, especially in Y337, could block the entrance/exit of the catalytic center and reduce the catalytic efficiency of AChE.
Collapse
Affiliation(s)
- A Shafferman
- Department of Biochemistry, Israel Institute for Biological Research, Ness-Ziona
| | | | | | | | | | | | | | | | | | | |
Collapse
|
50
|
Shafferman A, Kronman C, Flashner Y, Leitner M, Grosfeld H, Ordentlich A, Gozes Y, Cohen S, Ariel N, Barak D. Mutagenesis of human acetylcholinesterase. Identification of residues involved in catalytic activity and in polypeptide folding. J Biol Chem 1992; 267:17640-8. [PMID: 1517212] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022] Open
Abstract
Evidence for the involvement of Ser-203, His-447, and Glu-334 in the catalytic triad of human acetylcholinesterase was provided by substitution of these amino acids by alanine residues. Of 20 amino acid positions mutated so far in human acetylcholinesterase (AChE), these three were unique in abolishing detectable enzymatic activity (less than 0.0003 of wild type), yet allowing proper production, folding, and secretion. This is the first biochemical evidence for the involvement of a glutamate in a hydrolase triad (Schrag, J.D., Li, Y., Wu, M., and Cygler, M. (1991) Nature 351, 761-764), supporting the x-ray crystal structure data of the Torpedo californica acetylcholinesterase (Sussman, J.L., Harel, M., Frolow, F., Oefner, C., Goldman, A., Toker, L. and Silman, I. (1991) Science 253, 872-879). Attempts to convert the AChE triad into a Cys-His-Glu or Ser-His-Asp configuration by site-directed mutagenesis did not yield effective AChE activity. Another type of substitution, that of Asp-74 by Gly or Asn, generated an active enzyme with increased resistance to succinylcholine and dibucaine; thus mimicking in an AChE molecule the phenotype of the atypical butyrylcholinesterase natural variant (D70G mutation). Mutations of other carboxylic residues Glu-84, Asp-95, Asp-333, and Asp-349, all conserved among cholinesterases, did not result in detectable alteration in the recombinant AChE, although polypeptide productivity of the D95N mutant was considerably lower. In contrast, complete absence of secreted human AChE polypeptide was observed when Asp-175 or Asp-404 were substituted by Asn. These two aspartates are conserved in the entire cholinesterase/thyroglobulin family and appear to play a role in generating and/or maintaining the folded state of the polypeptide. The x-ray structure of the Torpedo acetylcholinesterase supports this assumption by revealing the participation of these residues in salt bridges between neighboring secondary structure elements.
Collapse
Affiliation(s)
- A Shafferman
- Department of Biochemistry, Israel Institute for Biological Research, Ziona
| | | | | | | | | | | | | | | | | | | |
Collapse
|